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Abstract
In biology, accurate cellular regulation in response to environmental signals is crucial
for the fitness of organisms. On the molecular level the modulation of protein activity
is often achieved by the binding of a signaling molecule or by covalent modifications
such as phosphorylation by kinases. Protein allostery, that is signal propagation from
a distant allosteric site to functional sites to regulate the output, has long been rec-
ognized but the views and perspectives have been strongly influenced by different
scientific fields and the continuous development of new methods. In particular, com-
putational approaches are suited to bridge the gap between structure and dynamics
and provide insight at an atomic level.
After reviewing experimental and theoretical methods to study allostery, results from
computational methods applied to the diguanylate cyclase PleD are presented. First,
structural and dynamical aspects of the communication between the allosteric inhi-
bition site and the active site are highlighted by energy calculations and molecular
dynamics simulations. Ligand binding may trigger a balance-like movement of the
conserved strand β2 that potentially displaces residues required for catalysis. In ad-
dition, dynamical coupling between the functional sites, i.e. simultaneous quenching
of motion upon ligand binding, is found from normal mode analysis. Furthermore,
two possible communication pathways connecting the inhibition with the active site
are proposed. Second, processes involved in PleD dimerization were elucidated. In
dynamics simulations the spontaneous active-to-inactive transition is observed and
implies changes in the D1/D2 interface together with a slight decrease in the dimer-
ization contact area. In the proposed model the β4-α4 loop repositioning is followed
by adjustments in the α4-β5-α5 face that are amplified by the extended helix α5 by a
leverage effect.
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1 Introduction
In biology, cellular regulation and control is crucial for organisms to be able to re-
spond to drastic changes in their extracellular environments, e.g. nutrient availabil-
ity, and requires adaptive responses to altered conditions. On themolecular level, this
modulation of protein activity is often achieved by binding of an effector molecule,
i.e. signaling molecules which enhance or inhibit the function of a certain protein.
Local perturbation by the ligand binding to the protein at an allosteric site influences
the activity of another, often spatially distant site. Protein allostery is the process
of propagating a structural and/or dynamical change from a specific site through-
out the protein and thereby regulating its output, e.g. catalytic activity or further
protein-molecule interactions. Detailed understanding of protein function, including
the processes of information transfer in protein allostery, is important in order to ma-
nipulate signaling cascades and provide a basis for finding new potential targets in
antimicrobial drug development.
Protein allostery has long been recognized and has been studied extensively in the
last decades with a variety of experimental and theoretical techniques developed in
the fields of physics, biology, chemistry and computer sciences. In the course of time
the views on protein allostery have changed and were substantially extended due
to influences from various scientific fields. The old-established notion of a change
in protein shape, based on the induced-fit concept, and mechanistic structure rear-
rangement is supported by the comparison of available structures of liganded and
unliganded proteins. Yet, increasing data from nuclear magnetic resonance (NMR)
studies and time-resolved methods emphasize the importance of protein motion and
dynamics. In chapter 2 opinions on protein allostery are summarized and a survey of
methods, describing the specific contributions and advantages of numerous experi-
mental and theoretical tools, is given in chapter 3. The different approaches to study
signal transduction and allosteric mechanisms are illustrated with examples. The
main focus is on the impact of computational investigation procedures in assisting
the elucidation of protein function at a molecular level.
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In this thesis, the allosteric regulation of the diguanylate cyclase PleD of C. crescentus,
which synthesizes the bacterial second messenger c-di-GMP implicated in motility,
biofilm formation and pathogenicity, is characterized by molecular dynamics sim-
ulations. In particular, PleD activity control via product inhibition is investigated
by studying the liganded, c-di-GMP present in the inhibition site, and unliganded
protein by means of structure and dynamics and results thereof are reported in the
publication "Schmid and Meuwly 2007" (section 5.2). Biochemical studies discovered
an additional level of PleD control, which is phosphorylation-mediated dimerization.
Computational methods are applied to probe the sequence of events in the dimeriza-
tion process, i.e. the local conformational loop rearrangement characteristic to CheY-
like receiver domains, reorientation of the domains and the final tightening of the
dimerization interface.
2
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Allostery describes the phenomenon that a change at one site, the allosteric site, af-
fects the activity at another, and in turn controls processes such as signal transmission,
catalysis and turning genes on or off. Various processes such as binding of ligands,
modifications via phosphorylation or glycosilation, change in pH, may trigger al-
lostery. It is fascinating how nature propagates information from the allosteric site to
functional parts of themoleculemany tens of Ångströms away. Despite decades of re-
search on allostery and the proposition of many mechanisms and models, presented
in the following, the detailed molecular characteristic underlying the communication
between distant sites is still not completely understood (see Figure 1).
Structure-function paradigm
Before three-dimensional structures of biomolecular systems became available, al-
lostery was investigated by measuring binding/reaction rates. Methods were devel-
oped to explain the measured enzymatic reaction rates, e.g. the Hill coefficient1 to
quantify cooperativity or Michaelis-Menten kinetics assuming the enzyme to be non-
allosteric. Indeed, the sigmoidal oxygen binding curve of hemoglobin was measured
in 1904 by C. Bohr, long before the first structure was solved. With the determination
of the liganded and unliganded structure of hemoglobin the concentration depen-
dence of the O2 binding affinity was explained by the existence of two quaternary
structures, the low-affinity deoxy T-state and the high-affinity oxy R-state.2,3 Since
then X-ray crystallography and NMR methods have steadily improved, and now-
adays high-resolution three-dimensional structures are available for approximately
50,000 proteins and still growing. This increasing wealth of structural data, espe-
cially if a protein is solved in different states of activation or with/without bound
ligand(s), allows the elucidation of structural features characteristic of a specific state.
In most allostery-regulated systems a change of shape between the two distinct states
was observed visually and hence allostery became tightly associated with a structural
change. Even today, protein function is often explained via structural changes, e.g.
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Figure 1: Timeline of Allostery
Illustration of the different views on protein allostery and the introduction of ground-breaking
methods.
open and closed state of a binding site to accomodate and release substrate, surface
remodelling to allow protein-protein association and movements of domains with re-
spect to each other. Allosteric conformational changes are most prominent in biolog-
ical motors, i.e. proteins that convert chemical energy to mechanical energy such as
ATP-ase or myosin, but the scale of structural changes ranges from tens of Ångströms
to sub-Ångströms (see Table 1).
Energy-landscape concept & population-shift model
The "structure-function" relationship states distinct key structures for different func-
tional states. The two classical models put forward shortly after the structure de-
termination of tetrameric hemoglobin are the following: The Koshland-Nemethy-
Filmer (KNF) model4 describes the structural transition between the T- and R-state
as an induced-fit mechanism, where binding of a ligand causes a subsequent struc-
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Table 1: Amplitudes and timescales of protein motions
The complex process of allostery involves subtle sub-Ångström structural changes to large-scale
domain motions and protein-ligand associations occurring on a timescale of femtoseconds to hours
which requires many different techniques for detection.
tural change. The subunits of hemoglobin switch independently but cooperatively
facilitate further transitions to the high-affinity state. In contrast, the main idea of
the Monod-Wyman-Changeux (MWC) model5 is the existence of different intercon-
vertible states, e.g. all subunits of hemoglobin must exist in either the T- or R-state.
Binding of a ligand leads to a shift in the thermal equilibrium towards one state. Sup-
port for the latter model comes from nuclear magnetic resonance (NMR) studies that
demonstrate the co-existence of different conformations.6,7 Even in the absence of an
allosteric trigger both functional states are observed, although differently populated.
Hence, ligand binding favors a pre-existing structure and the allosteric process can be
viewed as a shift in the thermal equilibrium. The different co-existing conformations
can be attributed to local minima on an energy landscape8,9, a model originally devel-
oped for protein folding, that are divided by energy barriers. The energy landscape
is defined as the potential energy of the system as a function of all coordinates. In
this concept, the allosteric process changes the energy landscape by either lowering
the end state minima or lowering the energy barriers, thereby allowing transitions to
other conformations.
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Role of dynamics
A complete description of proteins includes not only an ensemble of conformational
states, but also information about the dynamics, i.e. the interchange of the popu-
lations.10,11 Static structures representing different functional states are so prevalent
that it is easy to forget that proteins are dynamic molecular machines and rates of
ligand binding or release may be governed by conformational gating owing to the
intramolecular dynamics. Advances in nuclear magentic resonance (NMR) methods
provided data on exchange rates, populations and differences in chemical shift.10,12–14
In addition, real-time dynamics can be observed by single-molecule fluorescence res-
onance energy transfer (FRET)15, a "spectroscopic ruler" to monitor distances, and
more recently using time-resolved X-ray experiments16–18 which allows the occupa-
tion of intermediate states and the kinetics of conformational changes to be followed
at atomic level. Such studies reveal that proteins are highly flexible, not only through
movements of surface loops and sidechains, but also by collective motion of the core
structure.
Since the energy landscape is an intrinsic property of a protein and determines the
dynamics of the system, efforts are made to map out this complex energy-landscape
which contains the necessary information about the conformation ensembles, energy
barrier heights and transition pathways. In particular, computational approaches
to complement experimental data can prove very useful in providing links between
structure, energy and dynamics. The phenomenal increase in computer power, par-
ticularly through the development of massively parallel machines, allows the study
of biomolecular systems in explicit solvent approaching microsecond timescales. In
addition, methods exist to sample the conformational space19, to probe the instrinsic
flexibility inherent in the shape of the molecule20–24 and combine experimental NMR
parameters with simulations7,25.
Enthalpy vs. entropy
An allosteric event such as ligand binding changes the energy landscape and the
subsequent change in free energy governs the equilibrium shift. The free energy in-
volves enthalpic and entropic contributions: structural changes and protein-ligand
interactions contribute to the enthalpic term whereas changes in protein flexibility
and dynamics alter the system’s entropy. Taking this into consideration, Tsai et al.26
proposed three types of allosteric proteins based on the protein’s main driving force:
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First, proteins showing large structural rearrangements and being dominantly gov-
erned by enthalpy. Second, entropy driven systems where protein motion rather than
structure is affected, and third proteins where both enthalpy and entropy contribute.
There exist numerous examples for structural changes, evident from the acceptance
of the "structure-function" relationship. Yet, a first example of a biological system
where allostery is mediated exclusively by the change in protein motions was discov-
ered.27. Thus, allostery surely is not restricted to a "change in shape"28 and it was
even proposed that every protein has allosteric potential29.
How to get a signal from one site to the other?
Knowledge of functional key structures, their interconversion rates and protein flex-
ibility are accumulating. The next major challenge is to elucidate low-energy path-
ways connecting the different known stable conformations of a system and to iden-
tify motions or structural features crucial for protein function. It is believed that lo-
cal fluctuations (ps to ns timescale) modulate global structural transitions (µs to ms
timescale) and indeed, normal mode analysis (NMA) indicates that motions driv-
ing the allosteric conformational change already exist in the (crystallographic) end
states.23,30–32 Hence, analysis of these usually low-frequency modes assists the eluci-
dation of functional motion. Collective motion of distant parts potentially indicates
dynamical coupling of the remote sites and domain reorientations can often be de-
scribed by a hinge or shear mechanism.
It is believed that pathways connecting conformational substates are not random but
predefined and inherent to the protein because biological function is the result of evo-
lutionary selection. Analysis of co-evolved residues33,34 and tracking of the energy
flow through the protein35,36 highlight a communication network and argue for the
existence of specific signal transduction pathways, a concept further corroborated by
mutagenesis experiments.
Understanding how a signal is communicated through a protein is a major challenge
in structural biology. Albeit crystallographic structures are silent about the nature of
the transitions from one state to the other and the forces involved, increasing time-
resolved data start to shed light on the dynamic processes. A complete insight into
allostery requires not only to highlight structural changes, but also the knowledge
of when and where they occur and whether these changes are correlated or sequen-
tial. A useful tool to detect direct causality and coupling in allosteric processes is to
drive conformational changes and watch the protein structure respond to the pertur-
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bation.37–40
Clearly, protein allostery has many different aspects41 that are all to some extent ob-
served in biological systems, and which need to be reconciled in a comprehensive
model.37,42 Yet, to fully understand allostery, a continuous information exchange be-
tween experimentalists and theoreticians is necessary. Based on combined data from
simulations and experiment, mechanistic models can be proposed which in turn need
verification by further experiments. In addition, advances and innovation of methods
in different scientific fields will have a considerable impact.
Views on protein allostery:
• functional states have different conformations, e.g. opening/closing of active
site
• the signal propagates along a predefined communication network which is
consistent with the sequential KNF model
• co-existing conformations on an energy landscape with ligand binding in-
ducing a population-shift and being related to the concerted MWCmodel
• enthalpy or entropy driven protein allostery
8
3 Methods Survey
Methods were developed and/or adopted from the fields of biochemistry, physics
and computer science to get insight into protein function, regulation and allosteric
control. The many techniques collect complementary data, such as structure, kinetics,
dynamics and pathways at different levels of resolution. Together they give a more
complete picture of how biological systems work. The following survey presents
common tools with emphasis on the contribution of computational methods. The
list is far from being exhaustive, but should rather illustrate aspects of signal transfer
from past successes.
3.1 Elucidating biological function and pathways
Allostery, a change in structure or dynamics induced by a modulator, is involved
in the cellular response to signals and regulation of metabolic pathways. Biological
function is the complex consequence of the action of a large number of molecules that
interact in many different ways. Comprehensive characterization and identification
of intracellular proteins, metabolites, and description of their interplay in biochemical
pathways requires analysis at the transcriptome, proteome, metabolome, and pheno-
typic level (see Figure 2).
Genomics
Genomics includes the intensive efforts to determine the entire DNA sequence of or-
ganisms and the investigation of single genes, their functions and roles. Understand-
ing of the latter is essential and involves genetic manipulation, e.g. gene deletion or
gene overexpression, followed by the determination of changes in the phenotype and
metabolism. Microarray technology is commonly used for genetic screens, a proce-
dure to identify and select individuals who possess a phenotype of interest. Genome
sequencing has showed that there exist conserved functional units and the study of
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Figure 2: Biological levels to understand cellular function
Schematic illustration of the different levels of cell control giving rise to a specific phenotype, here
surface attached bacterial community (bottom left) vs. motile individual cell (bottom right) which
is regulated by the bacterial second messenger c-di-GMP. Genomics studies the genetic information
including evolutionary relationships. Common manipulation tools are gene deletion or overex-
pression and introducing mutations. The process of purification, identification and assessing of
function of the expressed protein is called proteomics and involves in vitro experiments and kinetic
studies. Information from genomics and proteomics are then integrated into complex metabolic
pathways eventually providing the basis to understand and influence the phenotype.
homologous proteins can help to find a common mechanism, a concept utilized in
bioinformatics. Evolutionary relationships can also assist in finding interaction part-
ners assuming two interacting proteins evolved by gene fusion and separation there-
after.43 In the laboratory, genetic techniques are useful to produce a large amount of
a specific protein and even allow to introduce point mutations in defined locations.
Alanine scanning mutagenesis and site directed mutagenesis are key experimental
tools to probe or confirm the importance of a specific residue involved in signal trans-
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fer, binding or enzymatic activity. However, it is a very time-consuming process and
suggestions coming from computational methods could narrow the search.
Proteomics
Proteins are the main components of the physiological metabolic pathways of cells
and proteomics is considered the next step in the study of biological systems, after
genomics.
Determine the existence of proteins in complex mixtures. Cell lysis is followed by gel elec-
trophoresis of the sample separating proteins according to their characteristics, such
as charge or molecular weight. The distinct bands can be visualized with either un-
specific dyes, e.g. Coomassie blue, or the protein of interest can be detected with anti-
bodies specific to the target protein carrying a radioactive label or a reporter enzyme
such as horseradish peroxidase. The latter approach, enzyme-linked immunosorbent
assay (ELISA) is a common tool in biochemistry and cell biology studies and allows
quantitative determination of protein amounts. In addition, chromatographic sepa-
ration methods including gas chromatography (GC), high-performance liquid chro-
matography (HPLC) and capillary electrophoresis (CE) can be used. The presence of
the target protein is then identified using mass spectrometry techniques.
In vitro testing for protein functionality. The study of enzyme kinetics can help us under-
stand the function and regulation of enzymes. The most simple experiment is to mea-
sure the enzyme velocity at different substrate concentrations and fit the data to the
Michaelis-Menten model assuming steady-state conditions.44 The maximum enzyme
velocity, vmax, and the concentration of substrate needed to get half-maximal velocity,
Km, are easily extracted from graphical representations such as the Lineweaver-Burk
plot45 or the Eadie-Hofstee diagram46 or nowadays calculated more accurately by
non-linear regression analysis. More importantly, the effect of small molecules and
protein modifications such as phosphorylation or glycosylation on the enzymatic ac-
tivity of a protein is readily detected by kinetics measurements. A modulator can act
as activator or inhibitor and can bind to the same site as the substrate (competitive)
or to another allosteric site (non-competitive, uncompetitive) and measurements at
several concentrations of inhibitor help to distinguish between the models of enzyme
inhibition. If the modulator is identical to the substrate the term feedback control is
used. If the enzyme has cooperative subunits a sigmoidal curve is observed and the
additional parameter h, the Hill coefficient, is introduced.1 A value of h = 1 corre-
sponds to no cooperativity and is identical to the standard Michaelis-Menten equa-
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tion, while h > 1.0 and h < 1.0 correspond to positive and negative cooperativity
where the binding of a molecule is facilitated or hindered.
Protein selection, identification and characterization of enzymatic properties enables
the assignment of protein function. With the knowledge of substrate and product
compounds as well as allosteric mediator molecules the protein can be integrated
into a metabolic network.
Protein-protein interactions
Most proteins only function in collaboration with other proteins, RNA molecules or
other small ligands. They may even require protein modifications to become a target
for binding or interacting with a distinct set of other proteins. It is especially useful
to determine potential partners in cell signaling cascades, and methods to detect and
analyze protein-protein interactions have been reviewed.47
The yeast two-hybrid screen is a traditional method to detect protein-protein interac-
tions and was originally developed by Fields and Song in 1989.48 In brief, the tran-
scription factor is split into two separate fragments, the binding domain and the acti-
vating domain. A "bait" protein to be tested for interaction is fused to a DNA-binding
domain, while a library of proteins (the "prey") are fused to the activation domain
and transformed into yeast. An interaction between "bait" and "prey" brings the two
fragments in close proximity and initiates transcription of a reporter gene. Utilizing
genetically engineered strands that allow positive or negative selection, i.e. cells with
successful protein interactions live or die on the provided media, allows easy read-
out. After this selection the proteins displaying the appropriate characteristics need to
be determined. This method has since been extended to detect DNA/RNA-binding
proteins and molecules that disrupt protein interactions.
In crosslinking experiments49 a covalent bond is introduced and transient interacting
partners can be identified. Exposure to UV light causes an incorporated photoreac-
tive group to covalently link to nearby molecules, thus "freezing" in place any inter-
acting protein as a complex. Subsequent digestion and mass spectrometric detection
of linked fragments identifies the position of binding and assists in the determination
of multimeric states.
Protein-protein interactions are of central importance for virtually every process in a
living cell. To study associations and elucidate signal transduction networks, high-
throughput screening techniques were developed. Recent advances in microscopy
have begun to visualize their dynamic behavior and the localization of specific pro-
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teins within the cell.
Phenotype determination and establishing biochemical pathways
The phenotype is any detectable characteristic of an organismwhich is determined by
its genotype and environment e.g. morphology, development or physiological prop-
erties. To detect changes in the cellular response coming from genetic manipulation,
assays have to be designed to screen for the presence or absence of the function in-
vestigated. Finally, combined gene and protein information must be correlated with
particular phenotypic settings and a network of metabolic reactions can be devised,
though it is a difficult task because the outputs of one enzymatic chemical reaction are
inputs to other chemical reactions, creating very complex cellular signaling pathways.
All three levels - genomics, proteomics and phenotype - are interweaved and required
to draw conclusions. In the case of the bacterial signaling molecule c-di-GMP which
controls motility and biofilm formation, its presence or absence is easily tested by the
determination of the morphology of the colony, the attachment to surfaces and cel-
lulose production. The protein domains synthesizing and degrading the compound
were confirmed by in vitro studies, and genome screens for these domains discovered
the ubiquity in bacteria. Detailed information on the function and regulation of the
second messenger c-di-GMP is given in section 4.
Biochemical and genetics techniques
• identify the molecule of interest, e.g. protein or signaling compound, deter-
mining a specific phenotype
• detect interacting partners and effects on functionality when bound
• in particular evolutionary relationships assist in elucidating common regula-
tion mechanisms
3.2 Structure determination
Biochemical and genetics techniques determine the interaction partner(s) of a given
protein, highlight the ultimate cellular characteristics known as phenotype, and at-
tempt to describe the inter-relations of functional modules in biochemical pathways.
13
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However, the knowledge that a molecule binds to a protein and thereby modulates
its function gives no information on how the protein exerts function or what mech-
anisms are involved in allosteric control. Thus, three-dimensional (3D) structural
data is invaluable and has contributed tremendously to our understanding of protein
function at an atomic level.
Figure 3: Insight from Structure Determination
A) Highlighting the different levels of resolution from cryo-EM and X-ray methods. The shape of
the GroEL/GroES complex is given at the bottom left and the green slice is magnified showing the
fitted components at atomic resolution. Taken from the publication Nat. Struct. Mol. Biol. (2006),
Vol. 13, p. 147. B) Comparison of different functional states elucidates structural changes. Superpo-
sition of inactive and active CheY shows the prominent loop repositioning (blue→ yellow) and the
characteristic sidechain reorientation ("out" → "in") which follow the phosphorylation at residue
Asp57. Taken from ref.37.C)Mapping of evolutionary data onto the protein structure may indicate
(continuous) signaling pathways between functional sites. Taken from ref.33. D The common pro-
tein motions are hinge bending resulting in an "open" and "closed" conformation and shear motion
where one domain slides along the surface of another.
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3.2.1 X-ray crystallography
Obtaining high-resolution structures
X-ray crystallography is the traditional method to elucidate structure at high reso-
lution (≤ 3 Å). A beam of X-rays is directed at a crystalline sample and the diffrac-
tion pattern is then interpreted to produce a 3D model of the protein. Using this
method, the structures of numerous proteins and complexes, e.g. protein-protein,
protein-small molecules, protein-DNA/RNAwere solved, and it has become the ma-
jor source of structural information (85% of all PDB entries). However, it is limited
to molecules that form regular crystals, hence structural information on membrane
proteins and flexible fibril-like proteins is scarce. Although structural features may
be distorted by unphysiological crystallization conditions or lattice contacts, X-ray
crystallography proved useful in identifying structural changes such as large-scale
domain motions or more subtle loop and sidechain reorientations that are related to
protein function. Web-based programs offer analysis and visualization of potentially
functional motions for two protein conformations provided (see section 3.5.6).
CheY is the response regulator of bacterial chemotaxis and serves as a model system
for receiver domains. Comparison of two functional states of CheY – an inactive and
BeF−3 -activated state – first revealed repositioning of the β4-α4 loop together with the
coupled sidechain movement of residues T87 and Y106 which is now a commonly
accepted characteristic of the activation process.50 These changes are subtle and the
RMSD is of a few Ångströms only. Although key structural changes were identified
their exact role in the allosteric process is still under investigation and requires in-
put from further methods. Another example where structural knowledge assisted
in establishing a mechanistic model of function is the diguanylate cyclase PleD.51,52
Allosteric product inhibition of PleD involves cross-linking of two domains by the
ligand thereby frustrating domain flexibility and blocking productive encounter of
two active sites (the model is depicted in Figure 6 B). Moreover, the structure allowed
localization and characterization of ligand binding.
Watching a protein function
In general, X-ray crystallography provides static snapshots of the system. Time-
independent acquisition of diffraction data of short-lived intermediates can be ob-
tained by chemical trapping or freeze-trapping, where molecular motion is frozen by
substantially lowering the temperature. In this case the time resolution is defined by
the offset between the reaction initiation and the flash-cooling conserving the current
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conformation. Advancement to true time-dependent crystallography, where pump-
probe methods are used and the time progress is studied, leaving very short time for
data collection, required various technical efforts.53,54 First, triggering of the studied
reaction must be very fast (fs to ns pulse) and uniform throughout the entire crystal,
e.g. adding substrate or photoactivation. Second, data acquisition time must be re-
duced whilst maintaining high completeness in covering the reciprocal space. And
third, sampled intermediate structures must be extracted from the time-dependent
data.
Although still in its early days, the technique of time-resolved protein crystallogra-
phy, i.e. the capturing of a sequence of pictures allowing to "watch" the protein as it
executes its function, has demonstrated its capability to detect quite subtle but essen-
tial structural changes in myoglobin following the ligand photodissociation.16,17 Re-
cently, the allosteric R-to-T transition upon ligand dissociation in dimeric hemoglobin
of the mollusk Scapharca inaequivalvis was followed with time-resolved X-ray.18 On
the timescale of microseconds, a two-step mechanism was observed: Structural
changes in the heme region, rearrangements in the neighboring F-helix and CD-loop
region as well as disruption of the water molecule network facilitate the sidechain
reorientation of residue F97 and the subsequent structural transition. Hence, time-
resolved crystallography clearly provides the unique opportunity to obtain high-
resolution structure information as the protein undergoes structural changes. The
conformational changes must, however, be accomodated within the crystal.
3.2.2 Cryo-electron microscopy
Cryo-electron microscopy (EM)55,56 uses a transmission electron microscope to ex-
amine frozen hydrated samples providing low-resolution structures (≥ 7 Å) of large
complexes and agglomerates. The 3D pictures indicate the overall shape and are
best suited for analysis of secondary, tertiary and quarternary structure, the levels at
which structure-activity relationships operate. The possibility to image the shape of
large assemblies renders cryo-EM a complementary tool to X-ray and NMR. A most
promising approach to structural analysis is then to combine the high-resolution with
the low-resolution data. Atomic resolution structures of individual components are
fitted into the EM density maps offering a more complete picture at various levels of
detail.57
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The now routine collection of 3D structural information mainly using X-ray, NMR
and more recently cryo-EM remains essential to characterize potentially important
structural features and binding modes leading to mechanistic proposals for pro-
tein function. Furthermore, biochemical and genetics information such as mutations
or residue conservation can be mapped onto the protein structure, establishing the
structure-function relationship. Atomic structures then provide a basis for compu-
tational simulations. Additional information on time-dependent changes in struc-
ture and the observation of transient intermediates will help to clarify protein mech-
anisms, especially pathways between resolved structures.
Based on the three-dimensional structure
• mechanistic models are proposed from comparison of different functional
states,
• interaction sites and binding modes are identified and characterized,
• biochemical and genetics data can be integrated to study structure-function
relationships.
• very recently, time-resolved X-ray provides motion picture of processes.
3.3 Protein dynamics
With more and more stuctures of proteins known with high accuracy, one can eas-
ily forget that proteins are dynamic machines and flex to function. Many proteins
undergo thermally driven transitions, so-called conformational changes, between
two or more equilibrium structures: The transitions have important functional con-
sequences for binding affinities and switching of regulatory proteins. Yet, little is
known about the dynamics of these macromolecules, although growing evidence for
the population-shift model stems from nuclear magnetic resonance (NMR) spectro-
copy studies. In the following, advances in NMR to characterize dynamic processes,
and fluorescence-resonance energy transfer (FRET) visualizing motion in real-time
are reported.
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Figure 4: "Watching" proteins move
A) The exchange between two conformational states A and B can be characterizedwith NMR, yield-
ing thermodynamics, kinetics and structural information simultaneously. If they do not exchange,
their relative population is given directly by the peak integral, and the chemical shifts provide
structural data. The rate of interconversion, kex, can be deduced from the lineshape distinguishing
fast and slow exchange. B) Hydrogen/deuterium exchange is rapid for solvent exposed sites and
detects changes in the solvent exposed surface. The time scale of the protein motion observed is
given by the time between quenching and analysis, often ranging from subseconds to hours. C)
Fluorescence-resonance energy transfer (FRET) spectroscopy provides real-time data of distances
between two labeled sites. However, single-molecule resolution is required and limits the observa-
tion time period.
3.3.1 Nuclear magnetic resonance (NMR) spectroscopy
Initially, nuclear magnetic resonance (NMR) experiments, a spectroscopic method
that takes advantage of the nucleus magnetic moment by alignment with the electro-
magnetic field, were applied to elucidate the solution structure of small proteins up to
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100 kDa. The time-consuming crystallization process required for X-ray crystallogra-
phy is avoided, but the structure needs to be deduced from chemical shifts describing
the local structure and nuclear Overhauser effect (NOE) data measuring short inter-
atomic distances. However, NMR can be used beyond pure structural description
offering site-specific information about protein motions over a very wide range of
timescales, from picoseconds to hours. Recent advances in NMR relaxation methods
and chemical exchange measurements allow characterization of both fast, picosec-
ond to nanosecond, and slow, millisecond to microsecond, protein motion.12–14,58
Slow motions are of considerable interest to allosteric transitions and ligand bind-
ing, whereas fast motions have an effect on the entropy of the system.
NMR spin relaxation is an indicator of internal motion
Relaxation rates, i.e. the time needed for excited nuclear spins to return to their origi-
nal equilibrium state, contain information about intramolecular dynamics at specific
atomic sites. Specialized relaxation dispersion experiments have been developed,
allowing determination of exchange rates between conformational states (kex), their
population (pA and pB) and backbone dynamics.14,58 The dynamics information is en-
coded in the intensities or lineshapes of the resonance signals, shown in Figure 4 A,
but unfortunately does not provide direct structural information about the different
conformational states. To simultaneously obtain structure and dynamics, experimen-
tal structural information from NOEs together with NMR relaxation data are used as
restraints in ensemble-averaged simulations.7,25 Thus, computational methods pro-
vide ameans to link these spatial and dynamic characteristics. This approach success-
fully demonstrated that the opening movement of the two EF hands in each domain
is coupled via correlated motion of the helices. Structural fluctuations in free calmod-
ulin overlap with complex-like substates.7
Two distinct populations that interchange. NMR results strongly support the population-
shift model,the co-existence of two different states with redistribution of their popu-
lation during the allosteric event.6,7 If the exchange rate, kex, is sufficiently slow then
resonances from both states are observed and can be analyzed in terms of structure.
The relative population, pA to pB, of exchanging species is given by the ratio of the
peak integrals and provides thermodynamics information. As the exchange becomes
faster, the two individual peaks disappear and a single averaged resonance line is
observed at the population-weighted average shift.
Identification of binding sites. Differences in 15N relaxation dispersion values reflect
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variations in the chemical shift between the two protein states, and can identify
residues which are affected directly by ligand binding. This equilibrium perturbation
NMR method proved effective in the regulatory unit of protein kinase A to identify
the known phosphate binding cassette region and hot-spot sites found previously.59
In addition, in paramagnetic NMR relaxation enhancement effects (PRE), an unpaired
electron increases the relaxation rate of other nuclei in an r−6 distance-dependent
manner, and will detect all residues within a 15− 35 Å radius of the spin label.60 Re-
cent work involves site-directed spin labels in which the label has been inserted into
proteins at a specific position to confirm, for example, conformational changes30.
Long-range information from residual dipolar couplings (RDC)
A traditional weakness of NMR is that all the structural restraints are short-range
in terms of distance, e.g. NOE restraints are only between atoms < 5 Å apart. For
large macromolecules the uncertainties will add up and the overall structure will
be poor even though individual regions of the structure are well defined. Residual
dipolar coupling (RDC) measurements of macromolecules that are partially aligned
in diulte liquid crystal solution, preventing complete averaging of the dipolar in-
teraction, yield long-range angular information. This method proved useful to ac-
curately define the relative orientation of individual parts with known structure in
the overall system, e.g. domains, secondary structure or subunits of complexes, and
the graphical rigid-body modelling program "Module" facilitates the reorientation of
user-defined protein parts into a common display frame.61
Slow correlated motion. In addition to providing global structural information, RDCs
also comprise dynamics data, specifically at slow timescales in the submicro to mil-
lisecond range at which allosteric processes occur. The 3D-Gaussian axial fluctua-
tion (GAF) model was used to interpret the dynamics of the peptide plane in the
Ig-binding domain of streptococcal protein G.62 A long-range network of slow corre-
lated motion transmitted across interstrand hydrogen-bonds was found. This prop-
agation of slow motion across the entire β-sheet clearly has implications for under-
standing collective motions and long-range information transfer in proteins in gen-
eral. Furthermore, the ability to measure scalar couplings across hydrogen bonds63
allows unambiguous identification of the donor and acceptor atom, measures the
strength of interaction and can even be related to geometry64.
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H/D exchange studies to observe motions on the subsecond to hours timescale
Hydrogen-deuterium (H/D) exchange is a chemical reaction in which a covalently
bonded hydrogen atom is replaced by a deuterium atom when rapidly changing the
solvent from from H2O to D2O, or vice versa (illustrated in Figure 4). Usually the
examined protons belong to the amides in the protein backbone. Based on the as-
sumption that the exchange rate reflects the exposure of a particular amide to the
solvent, changes in local dynamics are observed from changes in the exchange rate,
e.g. upon partial unfolding or conformational changes altering the solvent accessible
surface. H/D exchange is followed using NMR or mass spectrometry and the time
scale of milliseconds to hours, inaccessible using relaxation methods, is given by the
elapsed time between initiation and analysis. In NMR the disappearance or appear-
ance of signals is observed by measuring multiple spectra. It is a powerful method
not only to track slow conformational changes, but also protein-protein interactions
and protein folding.
NMR spectroscopy is an exceptionally versatile technique having exquisite time and
spatial resolution, and providing the time scale of transitions, the population of
the different states and the atomic resolution structure. NMR confirmed the co-
existence of different functional states underpinning the protein energy landscape
and population-shift model to explain allostery, and is also valuable to map binding
sites. However, raw experimental data needs to be combined with additional infor-
mation for interpretation. Often structure ensembles that satisfy the experimental
NMR restraints are generated with molecular dynamics simulations7,25, and NMR
data can serve to improve force fields65,66.
3.3.2 Fluorescence-resonance energy transfer (FRET)
Spectroscopy measures the interaction between light and matter, i.e. absorbance and
emission. Besides time-resolved infrared (IR) and Raman spectroscopy, fluorescence-
resonance energy transfer (FRET) experiments prove very promising to discover pro-
tein motions, particularly in view of single-molecule resolution.
Single-molecule techniques show details of individual molecules
Recently, new techniques have been developed to measure and manipulate single
biomolecules.67 Specific particles can be identified and tracked, and protein interac-
21
3 Methods Survey
tions or conformational changes can be observed which lead to new insights. Study-
ing a single molecule, information can be obtained that otherwise would disappear
in the ensemble-average, e.g. two conformations such as open and closed show dif-
ferent distances but average out to a medium length in the ensemble. Moreover, it
may help validate models from molecular dynamics simulations, and even ensem-
ble properties can be reconstructed from many single-molecule observations using
occurrence-histograms.
A "spectroscopic ruler"
Fluorescence-resonance energy transfer (FRET) is based on the observation by T. För-
ster in 1948 that energy is transferred non-radiatively from an excited chromophore
(the donor, D) to another chromophore (the acceptor, A) by means of intermolecular
long-range dipole-dipole coupling.68 The efficiency of energy transfer (E) strongly
depends on the sixth power of the distance r between D and A,
E =
1
1+ ( rR0 )
6 =
photons transferred from D to A
photons absorbed by D
(3.1)
where R0 is the Förster radius an intrinsic property of the fluorophore. Hence, FRET
is a sensitive reporter of distances in the range of 10-100 Å and often quoted as a
"spectroscopic ruler" (see Figure 4 C). Improvements in site-specific attachment of flu-
orescent molecules, in addition to the use of the intrinsic fluorophores Tyrosine and
Tryptophane, allow the measurement of specific spatial distances that are suggested
to change during protein function or allosteric processes. Suitable FRET pairs are cho-
sen based on their overlap integral, excitation/fluorescence wavelength and the dis-
tance of interest, being around the Förster distance R0, to have maximum sensitivity.
After labeling, the functionality and proper structure of biomolecules must be con-
firmed because bulky fluorophores might disturb the system. The observation time
of single-molecule fluorescence is in the range of milliseconds, and is limited by pho-
tobleaching processes and the diffusion time through the observation volume if no
immobilization is used. E is generally measured using ratiometric intensity measure-
ments characterizing pair distances over time (see Equation 3.1) or fluorescence life-
timemeasurements. FRET is a popular tool for accuratemeasuring of single-molecule
distances applied to monitor protein movement, complex formation and to detect en-
zymatic turnover.69,70 If the timescale of interconversion between an open and closed
conformation is of the order of the residence time of the molecule in focus or slower,
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two separate E distributions are observed. One example for real-time observation
of conformational motion is the demonstration of the three-step rotary movement of
the γ subunit in F0F1-ATP synthase during catalysis.15 The detailed topological in-
formation provided from FRET confirmed the opposite direction of γ rotation during
ATP synthesis and hydrolysis, respectively. In addition, the duration of the FRET
states were shown to correspond to the timescale of the catalytic event. Furthermore,
labeling of each interaction partner will give information on complex formation and
their respective orientation. In FRET-based bioassays enzymatic cleavage releases the
donor and acceptor moiety separately into the solution, and the donor fluorescence
is no longer quenched. Fluorescence lifetime imaging microscopy (FLIM) provides
the localization of labeled particles within a cell, e.g. the membrane or the nucleus,
which is of particular importance in in vitro studies.
FRET provides accurate spatial information over the course of time and has become a
very useful tool of structural biology, indeed. Due to the fact that distances are mea-
sured, structure is needed to relate them to corresponding conformational changes.
The remaining challenge is to find appropriate labeling sites that characterize func-
tional motion in proteins.
Protein dynamics
• NMR yields
1. populations together with their structure
2. timescale of exchanging states
3. identifies residues involved in binding molecules that show structural or
dynamics changes
• single-molecule techniques detect characteristics of individual molecules other-
wise hidden in the population average
• FRET detects distance changes in real-time
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3.4 Thermodynamics
3.4.1 Isothermal titration calorimetry (ITC)
Calorimetry measures the heat of chemical reactions or physical changes and is often
used to study the thermodynamics of ligand binding. Isothermal titration calorimetry
(ITC) directly determines binding affinity (Ka), enthalpy changes (∆H) and binding
stoichiometry (n). The association free energy ∆G and the entropic component can
thereby be calculated using the formula
∆G = −RTlnK = ∆H − T∆S. (3.2)
Known amounts of ligand are titrated into the sample cell causing a temperature
in-/decrease in the case of exothermic or endothermic reactions, respectively. The
heat needed to maintain constant temperature is usually plotted as a function of time
showing spikes at every ligand injection. The calculated total heat as a function of
the molar ligand-protein ratio eventually yields thermodynamic information about
the binding process. Knowledge about the enthalpic and entropic components to
binding affinity became particularly relevant in view of protein dynamics governing
allostery.27
Thermodynamics
• yields information about the total free energy change (∆G) which is related to
the binding affinity
• extracts separate contribution from enthalpy (∆H) and entropy (∆S), i.e. struc-
ture and dynamics of the biomolecular system
3.5 Computational contributions to mechanistic
understanding
Computational approaches serve as a link between structure and dynamics.71–73 The
widely used classical molecular dynamics (MD) simulations start from a given atom-
istic structure, provided by X-ray crystallography, NMR spectroscopy or homology
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modeling, and numerically calculate the motion of each atom according to Newton’s
equations of motion. Atoms are assigned van der Waals radii and atomic partial
charges. The interaction potential between the atoms is given by a so-called "force
field", which contains bonded and non-bonded terms (electrostatic and van derWaals
forces). The level of accuracy of the force field depends on the question being ad-
dressed and the CPU resources available. Besides classical empirical models74, force
fields containing quantummechanics suitable to simulate chemical reactions75,76, po-
larizability77 and more recently reactive force fields78,79 were developed.
The phenomenal advances in computer technology in the last decades, especially
high-performance parallel computing, has opened the possibility to investigate large
protein systems in explicit solvent for timescales reaching microseconds, and cul-
minated in the simulation of an entire virus.80 However, following full atomistic
motions in biomolecules in the time range of microsecond to seconds at which in-
terconversion of allosteric subconformations take place is still not feasible with con-
ventional simulations. Methods have been devised to tackle the time limitations,
for example coarse-graining, the use of multiple-timescales, normal mode analysis,
steered/targeted MD or Monte-Carlo sampling.
Computational approaches not only provide direct insight into protein dynamics at
an atomic level, but also give energetic information. Atomic motions are easily vi-
sualized, and following the propagation of structural changes often results in the
proposal of mechanistic models for protein function, highlighting the role of various
structural motifs. Lately, the transition between known structural states is increas-
ingly addressed in terms of causality, i.e. a sequence of events, and changes in pro-
tein flexibility. In addition, it is relatively straightforward to introduce mutations,
to generate and characterize short-lived intermediates or to perturb the system and
monitor subsequent changes, the latter being important to study signal transfer as in
allostery. Computational methods are complementary to experiments insofar as po-
tential mechanistic models based on simulations need verification with experimental
data, while computations can assist in interpreting these data.
3.5.1 Root-mean square deviation (RMSD)
The root-mean square deviation (RMSD) is a quantitative measure of the distance
between two superimposed structures, for example X-ray structures of different con-
formations.
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RMSD =
√√√√ 1
N
N
∑
i=1
(ri − r
0
i )
2 (3.3)
N is the total number of atoms and ri is the current position of atom iwhile r0i denotes
the reference position. In MD simulations, the RMSD with respect to the initial start-
ing structure is often plotted as a function of time, and is used to assess the extent
of structural relaxation in the equilibration phase and to ensure the stability of the
system throughout the entire simulation. Generally, the RMSD for backbone atoms is
of the order of a few Ångströms. Large distortions from the experimental structure
may be prevented by energy minimization using position constraints prior to molec-
ular dynamics simulations. Prominent structural changes during the trajectory are
readily observed as a sudden in- or decrease in RMSD simultaneously indicating the
timescale.
Before calculating the RMSD the two structures need to be aligned with care to re-
move contributions from translation and rotation of the entire molecule. In multido-
main proteins this process is especially delicate. Reorientation of domains with re-
spect to each other can be detected by fitting on one domain but calculating the RMSD
for the entire protein. Corresponding hinge axes can be identified using additional
methods (details in section 3.5.6). One possible drawback of calculating RMSDs is
the fact that it is an overall property, i.e. the same overall RMSD is obtained for rear-
rangement of "rigid-like" domains and structural changes within the domains with-
out affecting their global orientation.
3.5.2 Root-mean square fluctuation (RMSF)
Root mean-square fluctuations (RMSF) correspond to the time-averaged fluctuations
of the atom position around a reference position, e.g. average structure or initial
structure, and characterize the atom’s mobility. Superposition of all snapshots is nec-
essary to exclude rotational and translational motion of the molecule occuring during
the simulation, thereby restricting analysis to internal motions of the molecule only.
Calculated RMSF values can be related to B-factors from X-ray experiments:
B−factor =
8pi2
3
· RMSF2 (3.4)
RMSF and B−factors are a measure of flexibility, e.g. regions of high RMSF values
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correspond to very flexible regions, and agreement between the pattern of flexible
and rigid regions obtained from theory and experiment corroborates the usefulness
of MD simulations. However, it should be noted that crystal contacts have a poten-
tial influence. Comparing the RMSF profile for free and ligand-bound proteins can
indicate changes in protein dynamics that may be related to protein function such
as providing the necessary flexibility to orient residues allowing enzyme reactions or
ligand accomodation, and having entropic consequences.
3.5.3 Dynamic cross-correlated motion
Analysis of correlated motion is important to highlight regions of the protein that
move in a concerted manner, that is sites which are motionally coupled and possibly
could communicate signals.81,82 Correlation maintained during simulations denotes
contact between structural parts and that a change in one site is reflected by residues
at another. After removing rotational and translational motion by superpositioning
each snapshot, the cross-correlation coefficient Cij between two atoms i and j is de-
fined as
Cij =
〈∆ri∆rj〉√
〈∆ri〉2 · 〈∆rj〉2
(3.5)
where ∆ri is the displacement from the mean position of atom i, for a specific pe-
riod of time. The trajectory is usually divided into successive blocks to examine the
time-dependence of the correlation, Cij is determined for each block and then aver-
aged. The value of Cij ranges from +1 to -1, for fully correlated and anti-correlated
motions, respectively. If the motions of atoms i and j are random with respect to
each other, Cij is equal to 0. Commonly, cross-correlation matrices, also called dy-
namic cross-correlation maps (DCCM), are used to visualize individual residues or
secondary structure elements that move in a concerted manner. In contrast to the
detection of long-range couplings implying distant communication, coupled motion
due to secondary structure, i.e. spatial or sequence proximity, present as broadening
of the diagonal for α-helices and off-diagonal for β-sheets is less interesting. Unfortu-
nately, correlation coefficients do not show any information about the magnitude or
the direction of the motion.
27
3 Methods Survey
Elucidating signaling pathways based on correlated motion
Cross-correlated motion analysis was applied successfully to the elucidation of sig-
nal transduction in immunoglobulin G.82 A small β-sheet (NC sheet) was identified
as the key structure to transmit conformational changes between domain V and C.
A further example is the observation of ligand induced changes of correlated motion
in PleD detected even at long distances from the binding site.81 Enhancement of the
coupling between domains D2 and DGC is easily explained by the presence of c-di-
GMP linking the two domains. In contrast, stronger correlation between the remote
domains D1 and D2 in free PleD seems to be allostery based and potentially influ-
ences the dimerization behavior. From a more detailed analysis, two communication
pathways connecting correlated motion of the inhibition and active site can be envis-
aged.
Identification of compact entities
Correlation maps can outline movements of protein parts that are strongly correlated,
forming a "rigid" entity, and are often used in conjunction with normal mode analy-
sis. Low-frequency normal modes describe large-scale motions which are likely func-
tionally important motions, and it is desirable to dissect these into structural motifs
moving concomitantly in the same or opposite direction. Even so, careful analysis
is vital and one should note that coupling of structural motifs in a small number
of low-frequency modes does not necessary imply that perturbation at one site will
propagate to the others. Many low-frequency modes must be considered to obtain
proper convergence of the dynamics correlation.83
3.5.4 Normal mode analysis (NMA)
The now classic method of normal mode analysis (NMA) is a powerful approach
to analyze dynamical features of biological systems, particularly in characterizing
large-scale conformational changes and granting valuable insight at timescales of mi-
croseconds or longer.20–22,31,32,84,85 Normal modes approximate the motion of the sys-
tem as harmonic vibrations around a local minimum on the potential energy surface.
The essential tasks to calculate normal modes are first protein minimization, and sec-
ond diagonalization of the second derivatives, often called the Hessian, to yield the
normal modes and their frequencies which are the eigenvectors and eigenvalues, re-
spectively.86 The most difficulties arise from the diagonalization of the 3Nx3N Hes-
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sian matrix, where N is the number of atoms. Storage of the Hessian requires large
amounts of computer memory, and full-scale diagonalization is often not feasible for
medium to large biomolecular systems. However, several methods have been put for-
ward to reduce the size of calculation considerably without sacrificing the accuracy of
the low-frequency modes, e.g. diagonalization in a mixed basis (DIMB)87,88and block
normal mode (BNM)22,89. Further simplifications, e.g. the elastic network model
(ENM)90, where the protein is modeled as a network of oscillators (Cα-atoms) cou-
pled together by uniform harmonic springs (within a given distance cutoff) are com-
putationally inexpensive but still capture the system’s intrinsic flexibility reasonably
well. As long as the Hessian matrix is maintained, low-frequency modes are deter-
mined by the protein shape and are largely robust against coarse-graining levels and
the potential function.23 NMA provided useful insight into the nature of collective
motions in proteins and its usefulness and limitations are described in a comprehen-
sive review.24
Simplification of complex protein motion
One of the main attractions of normal mode analysis is that the complex protein
motion is simplified as a "superposition" of orthogonal, i.e. independent of each
other, harmonic normal modes. Each normal mode (NM) coordinate specifies a set of
atomic displacements at a specific frequency which can be analyzed separately. Low-
frequency NMs are thermally well accessible and often correspond to functionally
relevant motions. However, in no case does the lowest frequency NM correspond to
such a functional mode and the challenge is to identify those involved in biological
function.
Involvement coefficient In for specific transition. If two functional conformations are
known, e.g. active and inactive state or liganded and unliganded structure, the con-
tribution of each NM to this transition can be calculated.
In =
−→
X1 −
−→
X2
|
−→
X1 −
−→
X2|
·
−−→
EVn (3.6)
The involvement coefficient In quantifies the geometrical similarity between the n-
th NM and the structural change, while
−→
X1 −
−→
X2 is the displacement vector between
the two conformations and
−−→
EVn the eigenvector of the n-th NM. Thus, one can sort
the modes in terms of their contributions and concentrate on only those with the
largest contributions. Statistically the motion lies most often along the direction of
29
3 Methods Survey
Table 2: Web-based programs to retrieve normal modes
El Némo91
http://igs-server.cnrs-mrs.fr/elnemo/start.html
Elastic network model that provides several models based on low-frequency
NMs together with their visualization.
Requires conformation, if two conformations are given the contribution to
the transition is calculated additionally.
WEBnm92
http://services.cbu.uib.no/tools/normalmodes
Requires conformation.
NOMAD (Normal Mode Analysis Deformation, and Definement)
http://lorentz.immstr.pasteur.fr/overlap/overlap_submission.php
Uses elastic network model to calculate the overlap between the difference
vectors of the two forms and each set of eigenvectors of lowest frequency
normal modes.
Requires two structure superposed conformations.
oGNM (Normal Mode Analysis Deformation, and Definement)
http://ignm.ccbb.pitt.edu/GNM_Online_Calculation.htm
Requires conformation.
AD-ENMWebserver
http://enm.lobos.nih.gov/
Uses elastic network model.
Requires conformation.
DC-ENM 93 - builds a structural model for a protein in an unknown state by
using NMA and distance constraints.
PATH-ENM 94 - generates transition path between two given structures.
two modes. Though, to obtain few significant low-frequency modes the two confor-
mations must differ substantially in structure which is the case for motor proteins, i.e.
proteins that convert chemical to structural energy, but not in signaling proteins that
undergo only subtle structural changes. Characterization of the NMs implicated in
the conformational change give hints regarding hinge regions and collectively mov-
ing substructures.
NM frequency
The NM frequencies can be related to experimental spectroscopy techniques, such
as infrared and Raman spectroscopy. Though one must be aware that the har-
monic approximation may not provide an adequate physical model of a biological
molecule under physiological conditions. In any case the frequency is an indicator
of the entropy of the system. High frequencies describe a stiff system, whereas low-
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frequencies are soft and involve many atoms being most relevant to allostery.
NMA provides motions that are easily accessible by the protein in a given conforma-
tion, i.e. around an energy minimum, although approximated by the use of harmonic
functions. Even so, biologically interesting motions can be explored without the
much more computationally expensive and time-consuming MD simulations. Defi-
nitely, NMA has provided a great deal of insight into the nature of collective motions
in proteins.
3.5.5 Biased molecular dynamics simulations
Introducing a biased force into the conventional force field can significantly speed
up processes that are not feasible yet with equilibrium MD simulations, e.g. lig-
and binding/unbinding processes.38,40,95 The thereby sampled intermediate struc-
tures are events that presumably happen naturally on longer time scales and reveal
details of molecular interactions such as sidechain rearrangements and H-bond net-
works. In addition, thermodynamic potentials can in principle be reconstructed even
from irreversible processes.96,97
Steered molecular dynamics (SMD)
Steered MD simulations require "knowledge" of the direction in which the pulling
force is exerted and is at best a straight line. Recording of ligand positions and ap-
plied forces reveal important structural information about binding pathways and in-
teractions. In the avidin-biotin complex the ligand moves in discrete steps due to for-
mation and rupture of a H-bond network.95 It should be noted that the choice of the
pulling force or speed must be chosen carefully and may be guided from experimen-
tal results, e.g. data from atomic force microscopy or optical tweezer experiments.
Targeted molecular dynamics (TMD)
Structural transition paths between two known conformations, an initial and a de-
sired target structure, can be explored by the targeted MD method. To drive the
system from one known state to another constraints of the form
V = k · (x− xtarget)
2 (3.7)
where k is the force constant and x and xtarget are the atomic coordinates of the cur-
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rent and target structure, are used. The protein’s response to the induced change
is analyzed. Biased simulations driving the repositioning of the β4-α loop and the
sidechain of residue Y106 were used to elucidate temporal relation and causality in
the allosteric "Y-T coupling" mechanism in CheY.37 It is essential to drive initial to end
state transitions in both directions to ensure consistence of observed binding events.
If a structural change is truly cooperative similar effects are expected if the induced
and observed change are exchanged.
Umbrella sampling to construct potential of mean force (PMF)
Potential of mean force (PMF) is the energy profile along a predefined pathway.
Along a meaningful reaction coordinate introduction of a harmonic potential ensures
extensive sampling at a specific point, commonly termed umbrella sampling. Mov-
ing the position of the biased potential along the path while ensuring the windows
are overlapping, data of interest is acquired rapidly, even sampling events that are
otherwise rare. From these data free energy barriers of conformational transitions are
calculated using the weighted histogram analysis method (WHAM). The energy bar-
riers found can be compared to kinetics data and help to model the system’s energy
landscape.
Anisotropic thermal diffusion (ATD) / pump-probe MD
The mechanism of signal transduction in allostery is still heavily under investigation.
The propagation of local perturbations may either be transmitted through coupled
motion relying on global dynamics which are intrinsic to the protein shape and can
be explored usingNMA (see section 3.5.4), or the signalmay follow a defined commu-
nication pathway. The latter is probed by visualizing the flow of excess energy from
a specific site throughout the protein. The general idea is to introduce a perturbation
at a specific residue or protein part, e.g. adding excess heat energy35 or introducing
a driving force36,and to monitor the propagation through the protein. Thermal diffu-
sion can be observed if the protein is first equilibrated at low temperature, freezing
atomic motion (T = 10 K, RMSD < 0.05 Å), and then coupling a selection to a high
temperature bath (T = 300 K).35 The energy flow is monitored by conformational dis-
tortions from the starting structure after several time-delays, taking into considera-
tion the elapsed time for a signal to travel through proteins. For good path resolution
the use of implicit solvent, using a distance dependent dielectric, is necessary. The
use of non-equilibrium simulations greatly enhances signal-to-noise and simultane-
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ously decreases the simulation time needed (< 10 ps). The found diffusion process
is highly non-isotropic highlighting a residue network. Results for the PDZ domain
family are in remarkable agreement with previous co-evolution studies33, but addi-
tionally indicated that van der Waals interactions is the main component of signal
transduction. Thus fast and efficient intramolecular energy propagation relies on the
precise positioning of residues and is sensitive to point mutations or minor structural
changes such as sidechain orientations. Computational approaches are vital, provid-
ing a physical basis for signal propagation.
The main application of biased MD simulations is to drive the system through some
specific transition or sequence of events which are not yet accessible to conventional
MD. Using these techniques the protein’s response to perturbation can be followed,
and temporal relation and coupling of events in allosteric processes can be detected
and even energetic information can be deduced. However, the remaining challenge
is to find suitable reaction coordinates to obtain meaningful information. This prob-
lem is circumvented in the pump-probe approach where the flow of excess energy
from a specific site throughout the protein directly highlights possible communica-
tion routes.
3.5.6 Domain identification
A key concept to study protein structure is the domain, a compactly folded region
of a protein that has independent stability and is relatively rigid, which is jointed to
other domains by flexible regions and can move relative to them. For example, the
opening-closing mechanism to accomodate a substrate is a long-known functional
motion emphasizing the structure-function relationship. Databases98–100 store collec-
tions of potentially functional motions. Common proteinmotions identified are hinge
bending resulting in an "open" and "closed" conformation, shear motion where one
domain slides along the surface of another, and partial un-/refolding of the protein,
the first two being illustrated in Figure 3 D.
Difference-distance plots and graph theoretic methods101 are commonly used to iden-
tify rigid regions in proteins. Residues of rigid parts in the protein have small differ-
ence changes in distance between two conformations. Although easy to implement
and fast, this method does not provide information about the geometric proximity of
residues. In the graph theoretic method the protein is represented as a graph whose
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vertices are atoms and whose edges are distance constraints described by strong local
forces. Rigidity theory determines the rigid clusters and the flexible joints connecting
them, and has the advantage of requiring only a single conformation. In addition,
web-based programs offer analysis and (animated) visualization for two conforma-
tions provided.
Table 3: Web-based programs to highlight structural changes
DynDom102,103
http://fizz.cmp.uea.ac.uk/dyndom/
Automatically determines domains, hinge axes and hinge bending residues
in proteins.
Requires two structural conformations.
Output: domains and hinge residues colored, axis indicated by arrow.
MolMovDB98,99 (Database of Macromolecular Movements)
http://www.molmovdb.org/
Information on protein motion for given Protein Data Bank ID.
Morph Server – generates and animates chemically realistic interpolations
between two conformations.
Hinge Prediction – predicts hinge locations in a single protein structure.
DomainFinder104 (Database of Macromolecular Movements)
http://dirac.cnrs-orleans.fr/DomainFinder/
Variant of normal mode analysis based on deformation energy.
Free download of program.
Requires single structure (PDB format).
DomainParser101 (Database of Macromolecular Movements)
http://compbio.ornl.gov/structure/domainparser/
Based on network flow problem.
Requires Protein Data Bank ID.
Characterization of conformational changes in terms of hinge axes, rotation points
and shifting along surfaces offers a basis for mechanistic description of functional
motion and critical residues for flexibility and interaction, e.g. hinge residues or H-
bond networks, can be identified. The availability of web-based programs indicated
in the list below, particularly animated movies describing a possible pathway be-
tween two structural conformations, has encouraged this approach to study protein
allostery.
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3.5.7 Calculation of energy contributions and hot-spot residue
identification
The interactions between proteins and other molecules are critical to many processes
in biology, and estimations of binding free energies are desirable. Approaches for esti-
mating either relative or absolute binding free energies at different levels of accuracy
and computational requirements have been developed. A widely applied technique
is the molecular mechanics generalized Born surface area (MM-GBSA) model105
which is computationally efficient and allows the decomposition of the binding free
energy into residual contributions. This is especially useful to identify residues that
contribute most to the association free energy105,106, so-called hot-spot residues107. In
contrast to experimental mutagenesis experiments it is relatively straightforward to
introduce mutations computationally, and hence a computational alanine scanning
approach has been described.108,109 Lately, methods were developed to estimate ab-
solute binding free energies110–112 that can directly be compared to experimentally
measured binding constants, and the effect from displacing solvent molecules is be-
ing studied113. However, stringent accuracy is required to be of use in drug discovery
where correct ranking of a list of ligands can be vital.
3.5.8 Bioinformatics: sequence-structure relationship
Knowledge of the three-dimensional structure of the protein is invaluable to start
computational studies and to understand protein function in a mechanistic sense.
Genome sequencing projects provided vast data of protein sequences. However, the
majority of sequences remain without known 3D structure despite great advances in
experimental structure determination such as X-ray crystallography, NMR and high-
resolution electron microscopy. To bridge this gap a lot of effort has been put into the
development of computational methods to predict 3D structures (see refs.114,115 and
the comprehensive book chapters116,117).
Homology modeling
Homology modeling, also known as comparative modeling or template-based mod-
eling, attempts to construct atomic-resolution of a protein based on its amino acid
sequence. The general procedure involves the selection of a known structure with
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high sequence identity which is used as the template structure. Alignment of the
template with the unknown so called target sequence is followed by the model con-
struction. Coordinates are generated first for the structurally conserved core from
those of the known structure. Structurally variable loops and side-chain conforma-
tions are built thereafter, and finally the model structure is refined. The success of
homology modeling is based on the fact that evolutionary related sequences gener-
ally have similar 3D structures due to the constraints of proper protein folding and
protein function. The final accuracy of the homology model is greatly affected by the
sequence identity and the correctness of sequence alignment. If the sequency identity
is below 30%, a region often referred to as the "twilight zone", serious errors such
as misprediction of the protein fold can occur. If no suitable template structure is
available for comparative modeling, de novo modeling methods also called ab initio
modeling may be used. The quality of homology models does not allow processes
such as drug-design, where the exact sidechain orientation is crucial. Nevertheless,
the models are useful for qualitative conclusions and can guide mutagenesis exper-
iments and structure-function hypotheses. In conjunction with molecular dynamics
simulations, homology models are useful to obtain kinetics and dynamics informa-
tion of the protein system.
The structural genomics project attempts to generate a diverse set of representative
experimental structures for each class of protein folds, so that every newly discov-
ered protein sequence is within modeling distance of a solved structure.118,119 Thus,
reliable structure prediction methods have become very important and are assessed
in the bi-annual Critical Assessment of Techniques for Protein Structure Prediction
(CASP) providing a community wide platform challenging prediction teams to pre-
dict structures which have been solved but not yet published. Because the volume of
data is too large to process manually, automated structure prediction servers120 are
necessary.
Folding of intrinsically disordered regions induced by target binding
Intrinsically disordered proteins can adopt folded structures upon binding to their
biological target. For example the TipAL protein, a bacterial transcriptional regula-
tor, forms two additional α-helices induced upon complex formation with the antibi-
otic, whereas in the apo structure this part is unstructured as revealed by NMR spec-
troscopy.121 Based on the ligand-induced helix formation a possible mechanism for
TipAL transcriptional activation was proposed where the introduced rigidity trans-
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Table 4: Web-based programs to generate homology models
SwissModel120
http://swissmodel.expasy.org/SWISS-MODEL.html
A fully automated protein structure homology-modeling server.
Requires protein sequence or UniProt AC code.
WHAT IF
http://swift.cmbi.kun.nl/servers/html/index.html
Protein structure analysis program for mutant prediction, structure verifica-
tion and molecular graphics.
Requires aligned sequences and PDB file of template structure for homology
modeling.
mits forces to the DNA-binding parts. Intact secondary structure is also particularly
important for immunological signal transduction. Molecular dynamics simulations
showed that the small NC β-sheet is the key structural fragment to transmit confor-
mational changes between domains V and C, the variable and constant domains of
the Fab fragment of immunoglobulin G.82 Coupled folding and binding is realized
to be a general mechanism of molecular recognition122, where the inherent flexibil-
ity allows structural modification in response to different targets controlling cellular
signaling. Attempts to predict regions of native disorder from sequence have been
made.123–127
Evolutionary conserved networks from sequence analysis
Evolution can be viewed as large-scale random mutagenesis with selection con-
straints imposed by protein function. Residues important for function, e.g. active
site residues for enzymatic reactions or implicated in allosteric signalling, are not
only highly conserved within domain families but also co-evolved. Ranganathan and
co-workers33 proposed a method to quantitatively calculate the level of conservation,
comparing amino acid frequencies to their mean values after multiple sequence align-
ment, and to detect energetic coupling between two residues i and j. If sites i and j
co-evolved, for functional or structural reason, a perturbation at site i will lead to a
change in the amino acid distribution at site j highlighting their mutual dependence.
This sequence-based statistical method was successfully applied to several protein
families of distinct folds and functions33,34 such as the protein domain PDZ, trans-
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Table 5: Web-based programs to find potentially functional disordered parts
DISOPRED2123
http://bioinf.cs.ucl.ac.uk/disopred/disopred.html
Identifies dynamically disordered regions with no stable secondary structure
and high flexibility in solution.
Requires protein sequence.
DisEMBL124
http://dis.embl.de
Predicts intrinsic protein disorder.
Requires protein sequence or SwissProt ID.
DisProt
http://www.disprot.org
Database of protein disorder providing information about proteins that lack
fixed 3D structure in their putatively native states, either in their entirety or
in part.
Requires search entry by keyword or sequence.
RONN125 (Regional Order Neural Network)
http://www.strubi.ox.ac.uk/RONN
Database of protein disorder providing information about proteins that lack
fixed 3D structure in their putatively native states, either in their entirety or
in part.
Requires protein sequence.
GLOBPLOT2126 (Intrinsic Protein Disorder, Domain & Globularity
Prediction)
http://globplot.embl.de
Identifies the tendency of order/globularity and disorder.
Requires sequence or SwissProt ID.
Domain prediction from sequence
DomCut128
http://www.bork.embl.de/~suyama/domcut/
Identifies domain linkers.
Requires protein sequence.
DomPred128
http://bioinf.cs.ucl.ac.uk/dompred/DomPredform.html
Identifies domain linkers.
Requires sequence.
membrane signaling receptors GPCRs or the multi-subunit protein hemoglobin. This
method can be automated using cluster analysis of perturbation matrices for protein
families to map the global network of amino acid interactions. This method allows
identification of potentially important residues from sequence only. Nevertheless,
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knowledge of structure contributes strongly to the visualization, identified residues
that often form pathways of connected residues, and helps to find a signal transduc-
tion mechanism.
Profound understanding of the relationship between protein sequence and structure
is ofmajor interest. In particular bioinformatics tools attempt to close the gap between
the rapid protein sequencing and the slow structure determination. Additionally, the
protein sequence can tell us about intrinsically flexible regions that are potentially
functional and long-range communication routes that have developed during evolu-
tion.
Contributions from computational methods:
• bioinformatics assists in providing structural models and bridges the gap be-
tween vast protein sequence data and very limited protein structures
• MD gives structure at atomistic level and dynamics simultaneously
• probe signaling mechanisms: energy flow or coupled motion
• provide energetics information: binding affinity and mapping the protein en-
ergy landscape
• dissect complex motion into simple movements of individual NMs and assist in
the mechanistic description of domain motion
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4 Bacterial Second Messenger
c-di-GMP and PleD as Model
System
4.1 Ubiquitous bacterial second messenger c-di-GMP
Cyclic di-guanosine-monophosphate (c-di-GMP) was first discovered as an activator
of cellulose synthase in Acetobacter xylinum (currently Gluconacetobacter xylinus) in the
1980’s by Benziman and co-workers.129 However, its impact as a major cell regulator
was discovered only recently.130–133 C-di-GMP is a novel second messenger in bacte-
ria, but not in eukaryotes or Archae and intense research is conducted to elucidate its
biological function and the interplay with cellular components134,135. To date, c-di-
GMP is known to orchestrate cellular pathways implicated in bacterial cell adhesion
and motility, including the swarmer-to-stalk cell transformation136,137, biofilm for-
mation138,139, pathogenicity and virulence140 described in recent reviews141,142 and
references therein.
DGCs, PDEs and c-di-GMP control the concentration of the second messenger
High cellular levels of c-di-GMP inhibit motility and activate biofilm formation, a
surface-attached bacterial community embedded in an extracellular matrix. Thus, to
secure adequate regulation of the transition between motile and sessile lifestyles a
tight control of the cellular c-di-GMP concentration is critical. The c-di-GMP concen-
tration is regulated by the opposing activity of diguanylate cyclases (DGCs), which
synthesize c-di-GMP from two GTP molecules, and c-di-GMP specific phosphodi-
esterases (PDEs) cleaving the cyclic compound into the inactive linear pGpG (see
Figure 5 A).143 Genetic analysis and biochemical characterization demonstrated that
DGC activity resides exclusively in the GGDEF domain (earlier termedDUF1)131,144–149,
named after the conserved sequence motif that constitutes part of the active site. PDE
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activity is assigned to the EAL domain (earlier termed DUF2).144,150–152 The high
abundance of GGDEF domains in the bacterial kingdom, often associated with the
EAL domain, found by subsequent genome screens underlines the importance of the
second messenger c-di-GMP and its regulation by these domains. In addition, c-di-
GMP itself can modulate DGC activity by allosteric control. The ability for product
inhibition was first discovered in the multidomain protein PleD of Caulobacter crescen-
tus51 and later identified as a general feature, intrinsic to the GGDEF domain and re-
quiring the motif RxxD of conserved residues in the inhibition site (see section 5.1).148
Based on the X-ray structure of PleD with bound c-di-GMP a "domain immobiliza-
tion" model was proposed, where c-di-GMP links domains preventing the productive
encounter of two loaded active sites (illustrated in Figure 6 B).51,52
C-di-GMP network
Fusion of the catalytically active domain GGDEF to numerous sensory domains147
allows the conversion of environmental stimuli such as change in temperature, light,
pH-shift, availability of oxygen and nutrients into internal signals via synthesis of
small diffusible molecules, here c-di-GMP. The variety of sensory domains combined
with GGDEF domains creates a complex network of regulatory interactions and may
link different signaling pathways. The search for c-di-GMP downstream elements has
just begun, and the PilZ protein family was recently identified as a class of specific
diguanylate receptors.153–156
The demonstration that binding of c-di-GMP to an I-site of the GGDEF domain pre-
vents further production of c-di-GMP is of medicinal relevance and renders DGCs
a protential target to combat biofilm-related infections. However, unlike the estab-
lished c-di-GMP controlled switch frommotile single-cell lifestyle to surface-attached
multicellular communities, a complete picture of the regulatory pathways of c-di-
GMP and a detailed understanding of the mechanism of allosteric control of c-di-
GMP on the GGDEF domain are still lacking. In the following PleD of C. crescentus,
serving as a model system for which extensive structural and biochemical data is
available, is characterized in detail and computational results on the allosteric regu-
lation are presented in section 5.
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Biological function of the second messenger:
• c-di-GMP regulates motility, biofilm formation and pathogenicity
• c-di-GMP concentration is controlled by DGC and PDE activity
• c-di-GMP inhibits DGC activity which is intrinsic to the GGDEF domain
• c-di-GMP binds to the PilZ domain, a downstream receptor family
Figure 5: Biological function of c-di-GMP
A) Schematic diagram of the signaling pathway of c-di-GMP. Upon input from various sensory
domains c-di-GMP is synthesized from 2 GTP molecules by diguanylate cyclases (DGCs) and de-
graded into the linear dinucleotide pGpG by c-di-GMP specific phosphodiesterases (PDEs), shown
in yellow, green and purple, respectively. The second messenger is sensed by diguanylate recep-
tor proteins (DGR) that have diverse output functions such as inhibition of flagellar function and
biofilm formation. Illustration according to ref. 155. B)Chemical structure of intercalated c-di-GMP
and a spatial representation of dimeric c-di-GMP. C) Dynamic localization of the histidine kinases
PleC and DivJ which regulate the response regulator PleD during the cell cycle of C. crescentus.
Illustration according to ref. 147.
4.2 PleD activity under allosteric control
Diguanylate cyclase PleD is a response regulator
Themultidomain protein PleD ofCaulobacter crescentus is a well characterized diguany-
late cyclase.51,52,136,147,148,157,158 The domain architecture and a structural representa-
tion of the protein is given in Figure 6 A and D. The C-terminal catalytically active
GGDEF domain (DGC) synthesizes the second messenger c-di-GMP as output signal
and in turn regulates the pole remodeling which is required for the swarmer-to-stalk
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cell transition in the bacterial lifestyle (see Figure 5 C).136,137,159,160 The DGC domain
is fused to two N-terminal CheY-like receiver domains arranged in tandem (D1 and
D2), which have the (βα)5 topology typical for response regulator receiver domains
(REC).51,136 The domain architecture of N-terminal sensory domains linked to a C-
terminal effector domain is characteristic for response regulator proteins. Response
regulators (RR) are part of a phosphotransfer pathway, commonly referred to as two-
component signal transduction, which is widespread in bacteria to "process" external
stimuli.161,162 Changes in the environment are sensed by kinases, usually located in
the membrane, and trigger the transfer of a phosphate group to a conserved residue
on the RR. Phosphorylation induces a conformational change in the regulatory do-
main that results in the activation of an associated domain that effects the response,
and is the most common covalent modification used to achieve allosteric control in
proteins. PleD is phosphorylated and dephosphorylated at residue D53 of the first
REC domain D1 by the action of the DivJ and PleC histidine kinases, respectively.
Fluorescence experiments showed co-localization of DivJ with PleD to the flagellated
pole restricting c-di-GMP production spatially and triggering flagella ejection and
stalk synthesis.147,157,163
Inhibition via domain immobilization
Structure determination of non-phosphorylated PleD (code 1W2551), co-crystallized
with c-di-GMP identified an allosteric site for the mutually intercalated c-di-GMP
dimer, here referred to as c-di-GMP though in reality it is [c-di-GMP]2. Binding of
c-di-GMP to this allosteric site (inhibition site, I-site) leads to strong non-competitive
inhibition of PleD as demonstrated by kinetic studies.51,148 C-di-GMP binds to the
DGC domain through residues R359, D362 and R390. Moreover, c-di-GMP present
in the I-site can crosslink to either the neighboring domain D2 or to another close-
by DGC domain by additional interactions to residues R148 and R178 or R313, re-
spectively.51,52 Based on these structural findings a mechanistic model was suggested
where bound c-di-GMP locks the DGC domain in a non-productive orientationwhich
blocks the encounter of two GTP-loaded active sites and subsequent conversion to
c-di-GMP (see Figure 6 B). The two different immobilization modes found, namely
DGC-D2 and DGC-DGC crosslinking, are redundant and the integrity of only one is
required for non-competitive product inhibition. The occurrence of DGC-DGC im-
mobilization extends the applicability of the proposed mechanistic model of domain
immobilization even to single domain proteins.
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Figure 6: Regulation of PleD
A) Domain architecture of PleD. The phosphoacceptor D53 and DGC activity control mechanisms
are indicated. B) Domain immobilization model. The DGC domain (green) is connected via a
flexible linker to the stem (D1 in red and D2 in yellow). Product inhibition immobilizes DGC in
a non-productive orientation (lower line), while phosphorylation facilitates dimerization which is
required for the synthesis of c-di-GMP. Illustration reproduced from ref. 52. C) Direct communi-
cation between I- and A-site. Cartoon representation of the optimized structures with (colored)
and without (grey) bound c-di-GMP highlighting the balancelike movement of β2 and depicting
c-di-GMP and GTP at their functional sites. The PleD amino acid sequence is indicated. Illus-
tration reproduced from ref. 148. D) PleD structure in cartoon representation. Domains D1, D2
and DGC (yellow, red and green) with bound c-di-GMP in the I-site, A-site labeled accordingly.
Characteristics of REC domains are indicated: phospho-acceptor D53, loop β4-α4 and residue F102
which reorient upon activation. The dimerization interface together with the contact residue Y26
are specified.
Product inhibition is intrinsic to the GGDEF domain
Subsequent studies on the single domain diguanylate cyclase DgcA of C. crescentus
confirmed unambiguously that product inhibition is a general feature of DGCs and
is intrinsic to the GGDEF domain.148 Thus, feedback inhibition allows a tight control
of the cellular level of c-di-GMP defining an upper limit for the concentration of the
second messenger. The nature of communication between I- and A-site necessary for
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self-regulation is still being investigated. The results presented in this work argue
for a combination of structural rearrangement and simultaneous changes in protein
flexibility. Comparison of optimized structures of PleD with and without the ligand
c-di-GMP present in the I-site showed a balancelike movement of the β-strand β2
which connects the two functional sites and may in turn affect the catalytic activity
by displacing the enzymatic residues (see Figure 6 C).148Moreover, a conserved RxxD
sequence motif in the I-site (α2-β2 loop) together with a conserved spacer length be-
tween the I- and A-site is found in more than 60% of GGDEF proteins. In addition to
the structural aspect, dynamical coupling between the two sites is revealed by nor-
mal mode analysis, i.e. upon c-di-GMP binding to the allosteric site a marked drop in
protein motion is observed for both I- and A-site simultaneously.81 Binding of c-di-
GMP also has long-range effects changing the domain-domain correlations, DGC-D2
coupling is enhanced where D1-D2 become less correlated. Further research on the
allosteric control in PleD and GGDEF domains in general is required. In particular,
the exact role of the RxxD motif remains to be investigated.
Additional level of control via phosphorylation-mediated dimerization
Consistent with the symmetric condensation reaction to synthesize c-di-GMP, cross-
linking experiments demonstrated that DGC activity of PleD is contained entirely
within the dimer fraction.158 The dimerization rate and hence the c-di-GMP produc-
tion depends on the phosphorylation-state of PleD and it appears that this regulation
is the sole function of the first REC domain D1 and, while D53N mutation of the
phosphoryl acceptor site abolishes activation ability completely. Unlike domain D1
which contains all functional residues of a RR50 (D9, D10, phosphoacceptor D53, T83,
F102 and K105), the role of the second REC domain is unclear and it was proposed to
function as an adaptor.51,157
In enzymatic studies and structure determinations the unstable phosphate group is
often replaced with BeF−3 , which is a stable functional and structural analog of the
phosphoryl group.50,164–167 Indeed, BeF−3 -activated PleD is approximately 35 times
more active than unphosphorylated PleD158, and could be crystallized successfully52.
In terms of structure, activation leads to a D1/D2 domain repositioning eventually
promoting tight homodimerization as indicated by a 500 Å2 increase of the buried
surface per monomer. Structural changes upon activation of receiver domains have
been studied thoroughly on CheY50,168,169 and other receiver domains161,170 detecting
the characteristic β4-α4 loop repositioning accompanied by the sidechain rotation of
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a conserved Tyr/Phe residue (F102 in PleD) and a concomitant repositioning of Thr
(T83) to interact with the phospho moiety. F102 being located in the D1/D2 interface
potentially influences the domain rearrangement facilitating dimerization. However,
little is known about how these well known conformational changes influence dimer-
ization and are transmitted to the effector domain. In addition, the functional role of
residue Y26 which is required for PleD dimerization is completely unknown.158
Combined genetic, biochemical and structural data showed two independent lay-
ers of DGC control, product inhibition and phosphorylation-mediated dimerization.
These allosteric regulations of DGC activity raise the question of how the information
is transferred between the distant functional sites. PleD X-ray structures51,52 being
available opens the possibility to complement experimental data with computer sim-
ulations providing dynamics information together with the structure at atomic reso-
lution. In the following sections, the effect of bound c-di-GMP is studied by normal
mode analysis and cross-correlation maps derived from trajectories. Furthermore,
the signal transmission in the dimerization process is investigated on a truncated
PleD system, considering simply the D1/D2 stem domains. Due to the substantial
orientational freedom of the DGC domain vs. the stem domains that form the dimer
interface, the DGC domain is neglected. Here, we focus on events following the local
β4-α4 loop reorientation with regard to PleD dimerization.
Allosteric regulation in PleD
• "domain immobilization": c-di-GMP locks domains in non-productive orien-
tation
• phosphorylation-mediated dimerization
• dynamic coupling between inhibition- and active-site (this work)
• change in interdomain correlated motion (this work)
• extended α5-helix has leverage effect (this work)
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5 Results
5.1 Allosteric control of cyclic di-GMP signaling
B. Christen, M. Christen, R. Paul, F. Schmid, M. Folcher, P. Jenoe,
M. Meuwly and U. Jenal
J. Biol. Chem. (2006) 281:32015-32024
My contribution: Computational simulations and molecular modeling.
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Cyclic di-guanosine monophosphate is a bacterial second
messenger that has been implicated in biofilm formation, anti-
biotic resistance, and persistence of pathogenic bacteria in their
animal host. Although the enzymes responsible for the regula-
tion of cellular levels of c-di-GMP, diguanylate cyclases (DGC)
and phosphodiesterases, have been identified recently, little
information is available on the molecular mechanisms involved
in controlling the activity of these key enzymes or on the specific
interactions of c-di-GMPwith effector proteins. By using a com-
bination of genetic, biochemical, and modeling techniques we
demonstrate that an allosteric binding site for c-di-GMP (I-site)
is responsible for non-competitive product inhibition of DGCs.
The I-site was mapped in both multi- and single domain DGC
proteins and is fully contained within the GGDEF domain itself.
In vivo selection experiments and kinetic analysis of the evolved
I-sitemutants led to the definition of an RXXDmotif as the core
c-di-GMP binding site. Based on these results and based on the
observation that the I-site is conserved in a majority of known
and potential DGC proteins, we propose that product inhibi-
tion of DGCs is of fundamental importance for c-di-GMP
signaling and cellular homeostasis. The definition of the
I-site binding pocket provides an entry point into unraveling
the molecular mechanisms of ligand-protein interactions
involved in c-di-GMP signaling and makes DGCs a valuable
target for drug design to develop new strategies against bio-
film-related diseases.
A global signaling network that relies on the production of
the second messenger cyclic diguanylic acid has recently been
discovered in bacteria (1, 2). The c-di-GMP3 system emerges as
a regulatory mastermind orchestrating multicellular behavior
and biofilm formation in a wide variety of bacteria (2). In addi-
tion, c-di-GMP signaling also plays a role in bacterial virulence
and persistence (3–7). The broad importance of this novel sig-
naling molecule in pathogenic and non-pathogenic bacteria
calls for careful analysis of themolecularmechanisms that con-
trol cellular levels of c-di-GMP and regulate its downstream
targets. c-di-GMP is formed by the condensation of two GTP
molecules (8–10) and is hydrolyzed toGMPvia the linear inter-
mediate pGpG (11–14). Two widespread and highly conserved
bacterial protein domains have been implicated in the synthesis
and hydrolysis of c-di-GMP, respectively (15). The breakdown
of c-di-GMP is catalyzed by the EAL domain (12–14), and the
diguanylate cyclase (8) activity resides in the GGDEF domain
(10, 16). The highly conserved amino acid sequence GG(D/
E)EF forms part of the catalytically active site (A-site) of the
DGC enzyme (8). In agreement with this, mutations that
change the GG(D/E)EF motif generally abolish the activity of
the respective proteins (14, 16–18).
GGDEF domains are often found associated with sensor
domains, arguing that DGC activity is controlled by direct sig-
nal input through these domains (1). The best understood
example for controlled activation of a DGC is the response reg-
ulator PleD, which constitutes a timing device for Caulobacter
crescentus pole development (17, 19, 20). PleD is activated dur-
ing C. crescentus development by phosphorylation of an N-ter-
minal receiver domain and, as a result, sequesters to the differ-
entiating cell pole (17, 19). An additional layer of control was
suggested by the crystal structure of PleD solved recently in
complex with c-di-GMP (8) (Fig. 1). A c-di-GMP binding site
was identified in the crystal, spatially separated from the cata-
lytically active site (A-site). Two mutually intercalating c-di-
GMP molecules were found tightly bound to this site, at the
interface between the GGDEF and the central receiver-like
domain of PleD (Fig. 1). Based on the observation that PleD
activity shows a strong non-competitive product inhibition, it
was proposed that this site might constitute an allosteric bind-
ing site (I-site) (8). Based on the observation that functionally
important residues of the PleD I-site are highly conserved in a
majority of GGDEF proteins listed in the data base, we tested
the hypothesis that allosteric product inhibition is a general
regulatory principle of bacterial diguanylate cyclases.
MATERIALS AND METHODS
Strains, Plasmids, and Media—Escherichia coli and Salmo-
nella enterica serovar Typhimurium strains were grown in
Luria broth (LB). C. crescentus strains were grown in complex
peptone yeast extract (21). For DGC activity assays in vivo,
E. coliwas plated onto LB Congo Red plates (Sigma, 50 g/ml).
To determine the IPTG induction phenotype, 3 l of a liquid
log phase culture was spotted onto LB Congo Red plates with-
* This work was supported by Swiss National Science Foundation Fellowship
3100A0-108186 (to U. J.) and by a Swiss National Science Foundation
Fo¨rderprofessur (to M. M.). The costs of publication of this article were
defrayed in part by the payment of page charges. This article must there-
fore be hereby marked “advertisement” in accordance with 18 U.S.C. Sec-
tion 1734 solely to indicate this fact.
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supplemental text and Figs. S1–S4.
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41-61-267-2118; E-mail: urs.jenal@unibas.ch.
3 The abbreviations used are: c-di-GMP, cyclic diguanylic acid; pGpG, linear
diguanylic acid; LB, Luria broth; DGC, diguanylate cyclase; PDE, phospho-
diesterase; H6, hexa-histidine tag; rdar, red, dry, and rough; IPTG, isopropyl
1-thio--D-galactopyranoside; DgcA, diguanylate cyclase A; PdeA, phos-
phodiesterase A; CR, Congo Red; AC, adenylate cyclase; GC, guanylate
cyclase.
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out and with 1 mM IPTG. Biofilm formation was quantified
after overnight growth by staining with 1% Crystal Violet as
described (22). Motility phenotypes were determined using LB
or peptone yeast extract motility plates containing 0.3% Difco-
Agar. The exact procedure of strain and plasmid construction is
available on request.
Random I-site Tetrapeptide Library—The dgcA gene
(CC3285)was amplified by PCRusing primers #1006 and #1007
(for primer list see supplemental text). The PCR product was
digested with NdeI and XhoI and cloned into pET21a (Nova-
gen). In a next step adgcARESDallelewith a silent PstI restric-
tion site was generated by splicing with overlapping extension
PCR using primers #1129, #670, and #1132. The resulting PCR
product was digested with NdeI and XhoI and cloned into
pET42b (Novagen) to produce pET42::dgcARESD. The PstI/
XhoI fragment of pET42b::dgcARESD was replaced by 20
independent PCR products, which had been generated using
pET42b::dgcARESD as a template and primers #1131 and
#670. The resulting 20 independent random libraries were indi-
vidually transformed into E. coli BL21 and screened on Congo
Red plates (LB plates supplementedwith 50g/ml Congo Red).
As a control reaction, the deleted I-site was reverted back to the
wild-type RESD motif by cloning the PCR product generated
with primers #1130 and #670 into the PstI and XhoI site of
pET42b::dgcARESD.
Diguanylate Cyclase and Phosphodiesterase Activity Assays—
DGC reactions were performed at 30 °C with 0.5 M purified
hexahistidine-tagged DgcA or 5 M PleD in DGC reaction
buffer containing 250 mM NaCl, 25 mM Tris-Cl, pH 8.0, 5 mM
-mercaptoethanol, and 20 mM MgCl2. For inhibition assays
the protein was preincubated with different concentrations of
c-di-GMP (1–100 M) for 2 min at 30 °C before 100 M
[33P]GTP (Amersham Biosciences) was added. The reaction
was stopped at regular time intervals by adding an equal volume
of 0.5 M EDTA, pH 8.0. DGC/PDE tandem assays were carried
out using 1M hexahistidine-taggedDgcA, which was preincu-
bated for 2 min in the presence or absence of 4.5 M hexahisti-
dine-tagged phosphodiesterase PdeA. The reaction was started
by adding 100 M [33P]GTP. The reactions were stopped at
regular time intervals of 15 s by adding equal volumes of 0.5 M
EDTA, pH 8.0, and their nucleotide composition was analyzed
as described below.
Initial velocity (Vo) and inhibition constants were deter-
mined by plotting the corresponding nucleotide concentration
versus time and by fitting the curve according to allosteric prod-
uct inhibited Michaelis-Menten kinetics with the program
ProFit 5.6.7 (with fit function [c-di-GMP]t  a(1)*t/(a(2)  t),
where the initial velocity Vo is defined as a(1)/a(2)) using the
Levenberg-Marquardt algorithm.Ki values were determined by
plotting Vo versus c-di-GMP concentration and using the fol-
lowing fit function, Vo[c-di-GMP]  Vo[c-di-GMP]  0 *(1  ([c-di-
GMP]/(Ki  [c-di-GMP])).
Polyethyleneimine Cellulose Chromatography—Samples were
dissolved in 5 l of running buffer containing 1:1.5 (v/v) satu-
rated NH4SO4 and 1.5 M KH2PO4, pH 3.60, and blotted on
Polygram CEL 300 polyethyleneimine cellulose TLC plates
(Macherey-Nagel). Plates were developed in 1:1.5 (v/v) satu-
rated NH4SO4 and 1.5 M KH2PO4, pH 3.60 (Rf(c-di-GMP) 0.2,
Rf(pGpG) 0.4), dried, and exposed on a storage phosphor imag-
ing screen (Amersham Biosciences). The intensity of the vari-
ous radioactive species was calculated by quantifying the inten-
sities of the relevant spots using ImageJ software version 1.33.
Vo and Ki were determined with the Software ProFit 5.6.7.
UVCross-linking with [33P]c-di-GMP—The 33P-labeled c-di-
GMP was produced enzymatically using [33P]GTP (3000
Ci/mmol) and purified according to a previous study (14). Pro-
tein samples were incubated for 10 min on ice in DGC reaction
buffer (25mMTris-HCl, pH 8.0, 250mMNaCl, 10mMMgCl2, 5
mM -mercaptoethanol) together with 1 M c-di-GMP and
33P-radiolabeled c-di-GMP (0.75Ci, 6000 Ci/mmol). Samples
were then irradiated at 254 nm for 20 min in an ice-cooled,
parafilm-wrapped 96-well aluminumblock in an RPR-100 pho-
tochemical reactor with a UV lamp RPR-3500 (Southern New
EnglandUltraviolet Co.). After irradiation, samples weremixed
with 2 SDS-PAGE sample buffer (250mMTris-HCl at pH 6.8,
40% glycerol, 8% SDS, 2.4 M -mercaptoethanol, 0.06% brom-
phenol blue, 40 mM EDTA) and heated for 5 min at 95 °C.
Labeled proteins were separated by SDS-PAGE and quantified
by autoradiography.
Nucleotide Extraction andAnalysis—2.0ml of E. coli cell cul-
tures (A600 0.4) were harvested by centrifugation, and superna-
tant was discarded. The cell pellet was dissolved in 200l of 0.5
M formic acid, and nucleotides were extracted for 10 min at
4 °C. Insoluble cell components were then pelleted, and the
supernatant was directly analyzed by chromatography. Nucle-
otides were extracted and separated according to a previous
study (23) on a 125/4 Nucleosil 4000-1 polyethyleneimine col-
umn (Macherey-Nagel) using the SMART-System (Amersham
Biosciences). The nucleotide peak corresponding to c-di-GMP
was verified by co-elution with a chemically synthesized c-di-
GMP standard.
DgcA Protein Expression Levels—DgcA protein expression
levels in E. coli BL21 were determined byWestern blot analysis
usingAnti-His(C-Term) antibody (Invitrogen) andhorseradish
peroxidase conjugate of goat anti-mouse IgG (Invitrogen) as
secondary antibody. The protein concentration was deter-
mined by measuring the intensities of the relevant spots using
ImageJ software version 1.33. Signals were calibrated to defined
concentrations of purified wild-type DgcA.
Molecular Modeling of PleD—All-atom simulations were
carried out using the CHARMM (24) program and the
CHARMM22/27 force field (25). For additional information
see the supplemental material.
RESULTS
Feedback Inhibition of the PleDDiguanylate Cyclase Requires
Binding of c-di-GMP to the I-site—The PleD crystal structure
indicated the existence of an allosteric binding pocket (I-site) at
the interface of theGGDEF and REC2 domains (8). Binding of a
c-di-GMP dimer in the I-site is mediated by specific electro-
static interactions with charged residues of the GGDEF and
REC2 domain (Fig. 1). To provide evidence for c-di-GMP bind-
ing to the I-site pocket in solution, trypsin digests were per-
formed with purified PleD protein (5 M) in the presence or
absence of c-di-GMP (25 M). The resulting peptide fragments
were separated on a C18 column and analyzed by matrix-as-
Diguanylate Cyclase Feedback Control
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sisted laser desorption ionization time-of-flight. Both chro-
matograms were identical, with the exception of two peaks that
were only detected in the absence of ligand but were protected
when c-di-GMP present during tryptic digest (supplemental
Fig. S1). One of the two peptides (T47, retention time 25.6min)
was identified by mass spectrometry and corresponds to the
amino acids 354–359 (supplemental Fig. S1), arguing that c-di-
GMP specifically protects from trypsin cleavage at Arg-359. To
provide additional evidence for ligand binding in solution, we
performedUVcross-linking assays using 33P-labeled c-di-GMP
(14). Residues Arg-148 and Arg-178 of the REC2 domain and
Arg-359, Asp-362, and Arg-390 of the GGDEF domain were
replaced with alanine, and the resulting protein variants were
analyzed. As shown in Fig. 2, mutating I-site residues of the
GGDEF domain abolished (R359D362) or strongly reduced
(R359A and R390A) c-di-GMP binding. In contrast, mutations
in theA-site (E370Q, E371Q, and EE370GG), which completely
abolished enzymatic activity (Table 1), had no effect on c-di-
GMP binding (Fig. 2), indicating that labeling with radioactive
c-di-GMP results from ligand binding at the I-site. Although
mutations R359A, R359V, R359D362, and D362A all
showed a dramatically reduced or complete loss of enzymatic
activity, mutant R390A showed wild-type-like DGC activity
(Table 1). In agreement with the reduced binding of c-di-GMP
(Fig. 2), the Ki of mutant R390A was increased 20-fold (Table
1). PleD proteins harboring mutations in the REC2 portion of
the I-site (R148A and R178A) showed an increased binding
of c-di-GMP (Fig. 2) and slightly lower Ki values than wild
type (Table 1). Surprisingly, R148A/R178A single and double
mutants displayed a 5- to 20-fold higher DGC activity com-
pared with wild-type PleD (Table 1). Finally, c-di-GMP binding
was normal in mutant proteins that either lacked the REC1
receiver domain or had a bulky tryptophan residue introduced
at the REC2-GGDEF interface (G194W, Fig. 2). Together these
results implied that the structural requirements for c-di-GMP
binding are contained within the GGDEF domain of PleD and
that residues Arg-359, Asp-362, and Arg-390 form the core of
an allosteric binding pocket for c-di-GMP.
FIGURE 1. Crystal structure of the response regulator PleD. A, domain
architecture of PleD with receiver domain REC1 (blue), receiver domain REC2
(green), and GGDEF domain harboring diguanylate cyclase activity (red). The
active site (A-site) loop and the allosteric binding site (I-site) are indicated. B,
zoom in view of the I-site pocket with a bound dimer of c-di-GMP with inter-
calated purine bases. Residues Arg-148 and Arg-178 (green) from the REC2
domain and residues Arg-359, Asp-362, and Arg-390 (red) from the GGDEF
domain make specific contacts to the ligand in the crystal structure. C, sche-
matic of c-di-GMP synthesis and degradation reactions.
FIGURE 2. c-di-GMP labeling efficiency of different PleD mutants. The
upper lane shows autoradiographs of [33P]c-di-GMP UV cross-linked hexahis-
tidine-tagged PleD mutant proteins separated by SDS-PAGE. Relative label-
ing efficiency with c-di-GMP is shown below with wild-type PleD correspond-
ing to 100%. Specific mutants in different domains are colored in gray (REC1),
dark gray (REC2) and light gray (GGDEF).
Diguanylate Cyclase Feedback Control
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Evidence for an in Vivo Role of I-site-mediated Feedback
Control—To test a possible role for feedback inhibition of
diguanylate cyclases in vivo, we developed a simple assay based
on the observation that in E. coli and other Enterobacteriaceae
increased cellular levels of c-di-GMP correlate with Congo Red
(CR) staining of colonies on plates (28). Low level expression (in
the absence of the inducer IPTG) of active pleD alleles caused a
red colony phenotype in the E. coli B strain BL21, whereas cells
expressing inactive pleD alleles under the same conditions
stained white (Fig. 3). Interestingly, PleDmutants with dramat-
ically different diguanylate cyclase activities in vitro showed
only minor differences of CR staining in vivo. For instance,
PleDR148A/R178A, which showed a 20-fold increased activity
(Table 1), or PleD*, a constitutively active mutant of PleD sev-
eral 100-fold more active than wild-type (9), caused virtually
identical CR values like PleD wild type (Fig. 3). In contrast,
expression of the feedback inhibition mutant PleDR390A
resulted in a significantly higher CR staining even though its in
vitro DGC activity was lower than wild-type PleD (Table 1).
This argued that in vivo steady-state concentrations of c-di-
GMP were determined mainly by the PleD inhibition constant
(as opposed to the overall activity of the enzyme) and that a
functional I-site is critical for DGC control in vivo.
DgcA, a Single Domain Diguanylate Cyclase, Is Subject to
Allosteric Product Inhibition—Sequence alignments of 1000
annotated GGDEF domain proteins revealed that that I-site
residues Arg-359 and Asp-362 of PleD are highly conserved.
57% of the proteins containing a GGDEF domain and 27% of
GGDEF/EAL composite proteins possess this motif. This sug-
gested that c-di-GMP product inhibition could be a general
regulatorymechanism of bacterial diguanylate cyclases. To test
this, hexahistidine-tagged derivatives of two C. crescentus
GGDEF domain proteins were analyzed biochemically with
respect to their DGC activities and c-di-GMP binding proper-
ties. Purified DgcA (diguanylate cyclase A, CC3285), a soluble,
single domain GGDEF protein that lacks an obvious N-termi-
nal input domain, showed strong diguanylate cyclase activity
(Fig. 5A). DgcA has an RESDmotive five amino acids upstream
of the conservedGGDEF active site andwas readily labeledwith
[33P]c-di-GMP in a cross-linking experiment (Fig. 4). Consist-
ent with this, DgcA showed strong feedback inhibition (Fig. 5A)
with its Ki (1 M) being in the same range as the inhibition
constant determined for PleD (8). In contrast, the GGDEF
domain of PdeA (phosphodiesterase A, CC3396), which lacks
catalytic activity (14), had no conserved I-site residues and did
not bind radiolabeled c-di-GMP (Fig. 4). Thus, specific binding
of c-di-GMP correlated with the presence of a conserved I-site
motif RXXD (Fig. 4).
Diguanylate cyclase activity assays revealed strong and rapid
product inhibition of DgcA. DgcA alone was able to convert
only a small fraction of the availableGTP substrate pool into the
product c-di-GMP (Vo  2.8 mol of c-di-GMP mol pro-
tein1 min1) (Fig. 5B). In contrast, GTP consumption and
conversion into c-di-GMP and pGpG was rapid (Vo  43.0
mol of c-di-GMP mol protein1 min1) and almost com-
plete when the PDE CC3396 was added in excess to the enzy-
matic reaction (Fig. 5B). This argued that c-di-GMP feedback
inhibition is abolished in a sequential DGC-PDE reaction,
because the steady-state concentration of the inhibitor c-di-
GMP is kept low by continuous degradation of c-di-GMP into
the linear dinucleotide pGpG. As a consequence of rapid feed-
back inhibition, the experimentally determinedVo values of the
DGC reaction are generally underestimated. In conclusion,
these results strengthen the view that allosteric product inhibi-
FIGURE 3. In vivo activity of different PleD and DgcA mutant proteins.
E. coli BL21 strains expressing different pleD alleles and dgcA wild type were
spotted onto Congo Red plates. Relative Congo Red binding was determined
using imageJ software with BL21 corresponding to 100%. FIGURE 4. UV cross-linking of different GGDEF domains with 33P-labeled
c-di-GMP. A, Coomassie-stained SDS-PAGE and B, autoradiograph of BSA
(control), PleDREC1, DgcA, and the isolated GGDEF domain of the c-di-GMP-
specific phosphodiesterase PdeA (CC3396) after UV cross-linking with [33P]c-
di-GMP. C, alignment of I- and A-site sequence of PleD, DgcA, and PdeA. I-site
(RXXD) and A-site residues (GGDEF) are marked in black and gray,
respectively.
Diguanylate Cyclase Feedback Control
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tion is a general principle of diguanylate cyclases and that high
affinity binding of c-di-GMP requires an RXXD I-site motif
positioned in close proximity to the active site.
Development of an in Vivo Assay to Genetically Probe Allos-
teric Control of DgcA—DGCs from different bacterial species
have been shown to be functionally interchangeable (17, 26, 27).
To determine if DgcA is active in vivo we expressed a plasmid-
based copy of the dgcA gene in C. crescentus, S. enterica, and
Escherichia coli B and tested the respective strains for the phe-
notypes known to result from increased cellular levels of c-di-
GMP (17, 26, 27). Consistentwith these earlier findings, expres-
sion of dgcA strongly inhibited flagellar-based motility in all
three organisms, dramatically increased the ability of S. enterica
and E. coli for surface colonization, and produced the charac-
teristic red, dry, and rough (rdar) colony morphotype when
plated on CR plates (Fig. 6, A–F) (29). The red phenotype pro-
vided the basis for a visual genetic screen on CR plates. Under
these conditions, cells producing active DgcA variants would
produce dark red single colonies, whereas cells producing inac-
tive DgcA mutants would remain white. This prompted us to
use the CR screen to isolate dgcAmutants, which had a specific
defect in feedback regulation, and to define the minimal
requirements for product inhibition of this class of enzymes.
Randomization of c-di-GMP Binding Pocket Reveals Three
Mutant Classes—To probe the minimal requirements of the
I-site for c-di-GMP binding and product inhibition, a dgcA
mutant library was constructed with the RESD signature
replaced by a randomized tetrapeptide sequence (see “Materi-
als and Methods”). In short, a dgcA gene, which carried a dele-
tion of the four I-site codons, was used as template for a PCR
reaction. For the amplification step a primer complementary to
the 3-end of dgcA was used in combination with a mixture of
oligonucleotides that spanned the deletion site and contained
12 randomized base pairs at the position coding for the deleted
amino acids. The resulting PCR fragments were fused in-frame
with the 5-end of dgcA in the expression plasmid pET42b and
were transformed into E. coli BL21. The resulting gene library
contains a theoretical number of 1.67 107 (412) different dgcA
alleles, coding for DgcA variants with different combinations of
I-site residues.
When plated onCR plates, colonies transformedwith a wild-
type dgcA allele showed the typical rdar colony morphology
(Fig. 6G). Transformation of E. coli BL21 with a plasmid
expressing a mutant DgcA, which lacked the four amino acids
of the I-site (DgcARESD), produced white colonies on CR
plates (Fig. 6H), indicating that this mutant form had lost DGC
activity. About 10% of the clones with random tetrapeptide
insertions stained red on CR plates and thus had retained DGC
activity (Fig. 6I). This result is consistent with the observation
that alanine scanning of the PleD I-site almost exclusively pro-
duced non-active enzyme variants (Table 1) and argues that the
majority of amino acid substitutions introduced at the I-site are
detrimental for the catalytic activity of the DGC. To further
characterize active DgcA I-site variants, a total of 800 red col-
onies was isolated and patched onto CR plates without (Fig. 6, J
andK) or with the inducer IPTG (Fig. 6, L andM). This second-
ary screen was based on the observation that IPTG-induced
expression of the pleDR390A allele (Table 1), but not of the
pleDwild-type allele, abolished growth of E. coli BL21 (data not
shown). This suggested that at elevated protein levels, DGCs
that lack feedback control are toxic in vivo (see below). The
majority of the I-site library clones tested failed to grow on
plates containing IPTG, indicating that their activity is no lon-
ger controlled by product inhibition (Fig. 6, L and M). Only 7
mutants (out of 9000 colonies screened) showed a wild type-
like behavior in that they stained dark red on CR plates and
tolerated the presence of the inducer IPTG (Fig. 6, L andM).
This genetic screen led to the isolation of three different
I-site mutant classes with the following characteristics: 1) cat-
alytically inactive mutants (A, frequency 90%); 2) feedback
control negative mutants (IA, frequency 10%); and wild-
type-like mutants (IA, frequency 0.1%). A subset of class 1
and 2 mutants and all seven class 3 mutants were selected, and
hexahistidine-tagged forms of the respective proteins were
purified for biochemical characterization. Kinetic parameters
of activity (Vo) and feedback inhibition (Ki) were determined
FIGURE 5. c-di-GMP product inhibition of DgcA. A, initial velocities of the
wild-type diguanylate cyclase DgcA (squares) and the non-feedback inhibited
I-site mutant DgcA0244 (circles) in the presence of increasing concentrations
of c-di-GMP. B, conversion of GTP into c-di-GMP by DgcA (dashed lines) and
accelerated GTP consumption, c-di-GMP synthesis, and cleavage into pGpG
by a diguanylate cyclase-phosphodiesterase tandem reaction (plain lines).
Diguanylate Cyclase Feedback Control
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individually using an in vitro diguanylate cyclase activity assay
(16). Consistent with their rdar-like in vivo phenotype, only
class 2 and class 3 mutants showed detectable diguanylate
cyclase activity with an initial velocity between 1.93 and 14.21
mol of c-di-GMP mol protein1 min1 (Table 2). Only
mutant proteins from the IPTG tolerant class 3 showedproduct
inhibition withKi values close to 1 M (Table 2). In contrast, all
proteins from class 2mutants showed no feedback inhibition in
vitro, arguing that their in vivo toxicity is the result of uncon-
trolled run-off DGC activity (Fig. 5A and Table 2). Support for
this hypothesis comes from experiments determining the cel-
lular concentration of c-di-GMP and DgcA protein expression
levels in E. coli BL21 carrying selected dgcA alleles on plasmid
pET42b (see “Materials and Methods”). Alleles dgcA0244,
dgcA1229, and dgcA1250were chosen, because the DGC activ-
ity of these enzymes is similar towild typeDgcA (Table 2). Basal
level expression (no IPTG) of dgcA0244, the allele coding for a
DGC that completely lacks feedback inhibition, resulted in a
more than 100-fold increased cellular level of c-di-GMP as
compared with cells expressing wild-type dgcA (Table 3). This
was due to an almost 100-fold higher overall turnover of the
mutant enzyme as compared with wild type (Table 3). In con-
trast, enzymatic turnover and cellular concentration of c-di-
GMP was increased only marginally in E. coli cells expressing
alleles dgcA1229, and dgcA1250 with restored feedback inhibi-
tion control (Table 3).
Sequence analysis of the tetrapeptide insertions of class 2 and
class 3 mutants revealed several important characteristics of a
functional allosteric I-site binding pocket. All catalytically
active and feedback inhibition competent mutants restored the
wild-type Arg and Asp residues at positions one and four of the
RXXDmotive (Table 2).Whereas most of themutants that had
lost feedback inhibition had altered either one or both of these
charged residues (Table 2) only two feedback inhibition
mutants had retained both charges with changes in the inter-
vening residues (Table 2). Obviously, Arg and Asp, while being
strictly required for feedback inhibition, need to be placed in
the appropriate sequence context of the I-site loop. These
experiments define the minimal requirements of the I-site core
region and demonstrate that the Arg and Asp residues that
make direct contacts to the c-di-GMP ligand in the crystal
structure are of critical functional importance for DGC feed-
back inhibition in vivo and in vitro. This provides a plausible
FIGURE 6. Phenotypic characterization of ectopically expressed diguanylate cyclase dgcA in E. coli and S. enterica. Behavior of E. coli strain BL21 with
empty pET42b plasmid (A) and pET42b::dgcA (B) on motility plates. Colony morphology of E. coli strain BL21 with empty pET42b plasmid (C ) and with
pET42b::dgcA (D) on Congo Red plates. Biofilm formation of S. enterica serovar Typhimurium trp::T7RNAP with empty pET42b (E ) and pET42b::dgcA (F ) grown
in liquid culture and stained with crystal violet. E. coli BL21 transformed with PCR-restored dgcA wild type on pET42b::dgcA (G), with the inactive allele
dgcARESD (pET42b::dgcARESD) (H), and with a library of random tetrapeptide insertions in the I-site (pET42b::dgcAXXXX) (I) and plated on Congo Red plates.
E. coli BL21 expressing different I-site mutant alleles were spotted onto Congo Red plates without (J and K ) and with 1 mM IPTG (L and M) to screen for feedback
inhibition dgcA alleles.
TABLE 1
Kinetic analysis of PleD mutants
Protein Vo Vo Ki Ki
mol c-di-GMP/
(mol protein*min)
M
PleD wild type 0.202 	 0.023 5.8 	 1.0
PleDR359A 0.005 NDa 100 ND
PleDR359V 0.0 ND
PleD359362 0.0 ND
PleDD362A 0.0 ND
PleDR390A 0.076 	 0.007 115.0 	 18.1
PleDR148A 0.822 	 0.020 2.8 	 1.2
PleDR178A 0.918 	 0.292 3.6 	 0.1
PleDR148AR178A 3.75 	 0.43 2.9 	 0.6
PleDG194W 0.161 	 0.005 6.3 	 1.9
PleDEE370GG 0.0 ND
PleDE370Q 0.0 ND
PleDE371Q 0.0 ND
a ND, not determined.
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explanation for the strong conservation of the RXXD motif in
GGDEF domains.
The molecular mechanism of product inhibition through
I-site binding remains unclear. To assist the interpretation of
the present data and provide information on binding induced
mobility, atomistically detailed simulations were carried out.
Normal mode calculations on ligated and unligated PleD were
used to analyze the structural transitions that occur during
I-site binding of c-di-GMP. Normal mode calculations on the
optimized structures yielded no imaginary frequencies, and
translational and rotational frequencies were close to zero (
 0.02 cm1). This indicated that the minimized structures
correspond to real minima on the potential energy surface. The
displacements calculated for the ligated and the unligated pro-
tein showed a significant decrease in mobility for both I- and
A-site residues upon complexation (supplemental Figs. S2 and
S3). Whereas motion in the I-site is suppressed due to steric
interactions upon ligand insertion, quenching of the A-site res-
idues suggested that the two sitesmight be dynamically coupled
via the short connecting -strand (2). Backbone C-atoms
and side chains of the I-site and A-site loops were displaced by
an average of 1–4 Å in opposite directions, arguing that a bal-
ance-like movement centered around 2 could be responsible
for direct information transfer between the two sites (Fig. 7).
The cumulated displacements per residue over all 147 modes
(supplemental Fig. S3) showed differentmobilities in additional
regions of the protein. The C atoms of residues exhibiting
large changes in flexibility upon ligand binding are depicted as
spheres in supplemental Fig. S3. Reduced flexibility (yellow
spheres) is found at the I-site, A-site, phosphorylation site, and
the dimer interface, whereas the flexibility is enhanced (black
spheres) at the REC1/REC2 interface. In summary, these simu-
lations show that I-site binding of c-di-GMP not only reduced
the mobility around the RXXDmotif but also of the residues of
the A-site loop.
DISCUSSION
Feedback Inhibition Is a General Control Mechanism of
Diguanylate Cyclases—The data presented here propose a gen-
eral mechanism to regulate the activity of diguanylate cyclases
(DGCs), key enzymes of c-di-GMP-based signal transduction
in bacteria. High affinity binding of c-di-GMP to a site distant
from the catalytic pocket (I-site) efficiently blocks enzymatic
activity in a non-competitive manner. Mutational analysis of
multi- and single-domain DGC proteins has provided convinc-
ing evidence for the role of several charged amino acids in c-di-
GMP binding and allosteric regulation. Furthermore, these
experiments indicated that the allosteric binding site is func-
tionally contained within the GGDEF domain. An in vivo selec-
tion experiment using a random tetrapeptide library, and
TABLE 2
Diguanylate cyclase activity and inhibition constant of DgcA I-site mutant proteins
Protein Motif Vo Vo Ki Ki
mol c-di-GMP/
(mol proteinmin)
M
DgcA wt RESD 2.79 	 0.01 0.96 	 0.09
DgcA1406 RQGD 5.35 	 0.05 7.02 	 2.92
DgcA1040 RLVD 4.92 	 0.19 4.52 	 1.81
DgcA1229 RGAD 2.03 	 0.01 1.84 	 0.26
DgcA1524 RSAD 3.70 	 0.13 7.36 	 2.69
DgcA1529 RLAD 2.79 	 0.04 1.01 	 0.23
DgcA0751 RCAD 3.65 	 0.10 3.51 	 0.52
DgcA1250 RGGD 2.07 	 0.02 2.24 	 0.49
DgcARESD 0.14 	 0.06 NDa
DgcA0207 GMGG 14.21 	 0.54 No inhibition
DgcA0244 VMGG 2.57 	 0.05 No inhibition
DgcA0613 GGVA 4.29 	 0.06 No inhibition
DgcA0646 GRDC 8.90 	 0.10 No inhibition
DgcA0913 GVGD 3.81 	 0.04 No inhibition
DgcA1300 MEGD 0.87 	 0.02 No inhibition
DgcA1733 GGNH 11.47 	 0.17 No inhibition
DgcA3018 RESE 11.1 	 0.11 No inhibition
DgcA0230 RNRD 3.02 	 0.06 No inhibition
DgcA0642 RVDS 4.17 	 0.08 No inhibition
DgcA1007 RAGG 6.06 	 0.05 No inhibition
DgcA2006 RGQD 1.93 	 0.01 No inhibition
a ND, not determined.
TABLE 3
DgcA protein levels and cellular c-di-GMP concentrations in the absence or presence of IPTG induction at 1 mM
Protein conc.a c-di-GMP conc. Turnoverb
No induction 1 mM IPTG No induction 1 mM IPTG No induction 1 mM IPTG
pmol protein/mg dry weight pmol c-di-GMP/mg dry weight pmol c-di-GMP per pmol protein
DgcA0244 4.1 22 1466.3 1570.7 357.6 71.4
DgcA1229 3.5 31 87.6 139.5 25.0 4.5
DgcA1250 2.7 43 24.2 305.4 9.0 7.1
DgcA wt 2.9 33 13.75 189.4 4.7 5.7
DgcARESD 3.5 23 NDc ND NAd NA
a See “Materials and Methods.”
b As derived from the cellular c-di-GMP concentration divided by the cellular protein concentration.
c ND, not detectable.
d NA, not applicable.
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designed to re-engineer the I-site has led to the definition of a
highly conserved RXXD core motif of the c-di-GMP binding
pocket. The RXXD motif forms a turn at the end of a short
five-amino acid -sheet that directly connects the I-site with
the conserved catalytic A-site motif, GG(D/E)EF (Fig. 7). This
raised the question of how I-site ligand bindingmodulatesDGC
enzyme activity. In the multidomain protein PleD, c-di-GMP
bound to the I-site physically connects the GGDEF domain
with the REC1-REC2 dimerization stem. It was speculated that
product inhibition occurs by domain immobilization, which
would prevent the encounter of the twoDGC substrate binding
sites (8). Several observations argue in favor of a more direct
communication between I- and A-sites. First, with a large vari-
ety of domains found to be associated with GGDEF domains, it
seems unlikely that functional I-sites are generally formed by
the interface of a GGDEF with its neighboring domain (2). In
agreement with this, residues of the PleD REC2 domain are
not required for c-di-GMP binding and feedback inhibition.
Second, the single domain DGC protein, DgcA, shows I-site-
dependent allosteric control with aKi of 1 M. Third, the intro-
duction of a bulky tryptophan residue (G194W) at the GGDEF-
REC2 interface did not affect activity, I-site binding, or
feedback inhibition of PleD (Fig. 2 and Table 1). Fourth, atom-
istic simulations of ligated and unligated PleD predicted a
marked drop in flexibility of C-atoms both in the I- and A-site
upon ligand binding. Simultaneous with motion quenching, 2
and its flanking I- and A-loops undergo a balance-like move-
ment that repositions A-site residues in the catalytic active site
(Fig. 7). This is consistent with the idea that structural changes
within the GGDEF domain upon binding of c-di-GMP at the
I-site lead to repositioning of active site residues and possibly
altered kinetic parameters. Thus, we propose that c-di-GMP
binding and allosteric control represents an intrinsic regulatory
property of DGCs that contain an RXXDmotif.
Like guanylate and adenylate cyclases (GCs and ACs) and
DNApolymerases,DGCs catalyze the nucleophilic attack of the
3-hydroxyl group on the -phosphate of a nucleoside triphos-
phate. Despite the lack of obvious sequence similarities, the
PleD x-ray structure revealed that DGCs possess a similar
domain architecture like ACs and GCs (8, 30). Based on muta-
tional analysis (8, 14, 16) and on structural comparisons
between DGC, AC, GC, and DNA polymerases (31–34), a
model for DGC catalysis can be proposed. In contrast to the
heterodimeric ACs and GCs, DGCs form homodimers, with a
GTP molecule bound within the catalytic core of each DGC
monomer (8). Two Mg2 ions are coordinated by the highly
conserved glutamic acid residue Glu-371, which is part of the
GGDEF motif, and possibly by Asp-327 on the opposing
-sheet. The divalent Mg2 carboxyl complex coordinates the
triphosphate moiety of GTP and activates the 3-hydroxyl
group for intermolecular nucleophilic attack. Substrate speci-
ficity of AC and GC can be interchanged by converting a few
key residues involved in purine recognition (31, 34, 35). This
includes an arginine residue, which in PleD corresponds to the
highly conservedArg-366 located in the-sheet connecting the
I- and A-sites. Based on the active site model, two alternative
inhibition mechanisms can be envisaged. In a first scenario,
binding of c-di-GMP to the I-site would change the orientation
of Arg-366 and would thereby disturb the guanine binding
pocket resulting in an increased Km for GTP. Alternatively,
inhibitor binding could rearrange the Mg2 carboxyl complex
and thus destabilize the active state.
In Silico Analysis of the GGDEF Protein Family Indicates
That Product Inhibition Is a General Regulatory Mechanism—
DGC activity of GGDEF domain proteins seems to strictly
depend on conserved GGDEF or GGEEF motifs in the active
site (10, 16, 18, 36–38). Consistent with this, 90% of the
GGDEF and 62% of the GGDEF/EAL composite proteins show
a conserved GG(D/E)EF A-site motif. Of the GGDEF proteins
with a highly conserved A-site motif, 60% have conserved
RXXD I-site residues and a conserved spacer length between I-
and A-site, arguing that the three-dimensional arrangement of
catalytic and allosteric pocket is likely to be similar in all DGCs.
From a total of 19 GGDEF proteins, for which convincing evi-
dence for a DGC activity exists, 14 have a conserved I-site (sup-
plemental Fig. S4). Ryjenkov and coworkers (10) reported
severe toxicity problems when expressing diguanylate cyclases
lacking I-site residues inE. coliBL21. This is consistentwith the
growth defect observed upon expression of dgcA feedback inhi-
bitionmutants inE. coliBL21 and argues that these proteins are
not feedback-controlled. The molecular basis of growth inter-
ference under these conditions is unclear. It is possible that
depletion of the GTP pool or adverse effects of unphysiologi-
cally high levels of c-di-GMP are responsible for this effect.
Although the experiments presented here define a role for the
I-site in DGC feedback inhibition, the c-di-GMP binding
pocket could also be exploited for other roles in c-di-GMP sig-
naling. It has been proposed recently that non-catalyticGGDEF
FIGURE 7. Comparison of the energy-minimized structures of the PleD
GGDEF domain with and without ligand bound to the I-site. For improved
clarity, the domain is sliced through the I-site loop/2/A-site loop plane. The
unligated protein is shown in gray and the I-site loop (green), 2 (black), and
A-site loop (gold ) of the bound structure are shown as an overlay. GTP bound
to the active site is modeled according to the orientation of c-di-GMP bound
to the A-site in the crystal structure. The PleD amino acid sequence of I-site,
2, and A-site is indicated below.
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domains with variant A-site motifs can fulfill regulatory func-
tions (14). It is attractive to speculate that a subgroupofGGDEF
proteins that has degenerate catalytic A-sites but conserved
c-di-GMP binding pockets, represents a novel class of c-di-
GMP effector proteins that regulate cellular functions in
response to c-di-GMP binding.
Regulatory Significance of DGC Feedback Control—GGDEF
domains are often associated with sensory domains in one- or
two-component signaling systems (39, 40). Thus it is reasona-
ble to assume that in most cases DGC activity is controlled by
direct signal input through these domains. But why then would
a substantial portion of these enzymes also be subject to feed-
back inhibition? There are several possibilities, which among
themselves are not mutually exclusive. Given the anticipated
regulatory complexity of the c-di-GMP signaling network (2,
39) and the potentially dramatic changes in cellular physiology
and behavior caused by fluctuating levels of c-di-GMP, it is in
the cell’s best interest to rigorously control the production of
the second messenger. Product inhibition of DGCs allows the
establishment of precise threshold concentrations of the sec-
ond messenger, or, in combination with counteracting PDEs,
could produce short spikes or even generate oscillations of c-di-
GMP. In addition, negative feedback loops have been impli-
cated in neutralizing noise and providing robustness in genetic
networks by limiting the range over which the concentrations
of the network components fluctuate (41, 42). Similarly, prod-
uct inhibition of DGCs could contribute to the reduction of
stochastic perturbations and increase the stability of the c-di-
GMP circuitry by keeping c-di-GMP levels in defined concen-
tration windows. Alternatively, DGC autoregulationmay influ-
ence the kinetics of c-di-GMP signaling. Mathematical
modeling and experimental evidence suggested that negative
autoregulation in combination with strong promoters substan-
tially shortens the rise-time of transcription responses (43–45).
In analogy, a desired steady-state concentration of c-di-GMP
can in principle be achieved by two regulatory designs: (a) a low
activity DGCwith no product inhibition, and (b) a high activity
DGC with built-in negative autoregulation. In cases where cir-
cuits have been optimized for fast up-kinetics, design B will be
superior. It is plausible that DGCs with or without I-site motifs
can be divided into these two kinetically different classes.
This study contributes to the emerging understanding of the
c-di-GMP regulatory network in bacteria. The current empha-
sis lies on the identification of effector molecules, regulatory
mechanisms, and processes controlled by c-di-GMP. With the
long term goal in mind of approaching a detailed systems-level
understanding of c-di-GMP signaling, kinetic parameters of
signalingmechanismswill require our particular attention.Our
experiments provide an entry point into the kinetic analysis of
individual DGCs and the quantitative assessment of the c-di-
GMP circuitry.
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SUPPLEMENTAL MATERIAL: 
 
MATERIALS AND METHODS: 
 
 
Purification of His-tagged proteins - E. coli BL21 cells carrying the respective expression 
plasmid were grown in LB medium with ampicillin (100Dg/ml) or kanamycin (30Dg/ml) and 
expression was induced by adding IPTG at OD600 0.4 to a final concentration of 0.4 mM. After 
harvesting by centrifugation, cells were resuspended in buffer containing 50 mM Tris-HCl, pH 
8.0, 250 mM NaCl, 5 mM ?-mercaptoethanol, lysed by passage through a French pressure cell, 
and the suspension was clarified by centrifugation for 10 min at 5,000 x g. Soluble and insoluble 
protein fractions were separated by a high-spin centrifugation step (100,000 x g, 1 h). The 
supernatant was loaded onto Ni-NTA affinity resin (Qiagen), washed with buffer, and eluted with 
an imidazol-gradient as recommended by the manufacturer. Protein preparations were examined 
for purity by SDS-PAGE and fractions containing pure protein were pooled and dialyzed for 12 h 
at 4°C. 
Molecular modeling of PleD  
All-atom simulations were carried out using the CHARMM (25) program and the 
CHARMM22/27 force field (26). The A chain of the X-ray dimer structure (PDB entry: 1W25 
(17)) was used. All titratable side chains were generated in their standard protonation state at pH 
7. Parameters and partial charges for the non-standard residue c-di-GMP were adopted from the 
extended CHARMM parameter sets for nucleic acids. The structure of the ligated (intercalated c-
di-GMP bound to the I-site) and the unligated protein, to which hydrogen atoms were added, 
were minimized using a distance-dependent dielectric with ?=4 and a cutoff of 12 Å for non-
bonded interactions. 5000 steps of steepest descent minimization were followed by adopted 
Newton Raphson minimization until a RMS gradient of 10-7 kcal/mol·Å was reached. Such a 
threshold is found to be sufficient for normal mode calculations (49). Normal modes were 
calculated with the diagonalization in a mixed basis (DIMB) method, as implemented in 
CHARMM. The DIMB method is an approximate scheme retaining the full atomistic description 
of the protein, where the Hessian is approximated iteratively. The total number of basis functions 
was 153 and cumulated displacements were calculated for T = 300 K.  
For ligated PleD motion is suppressed at L(?1,?1) (res.10-12), L(?3,?3) domain REC1, the C-
terminal end of ?3 (res. 220-224) of domain REC2, the unstructured linker between REC2 and 
GGDEF domain (res. 282-284), the residues forming the A-site (res. 352), L(?2,?2) (res. 357-
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360, I-site), L(?2,?3) (res. 367-373, A-site) and at the C-terminal end of ?3 (res. 396-398) of  the 
GGDEF domain. By contrast upon ligand binding mobility increases for ?1 (res. 24), ?4 (res. 96-
99) of domain REC1, residues (res. 149, 175), L(?2,?2) (res. 205-207), L(?5,?5) (res. 254-257) 
of domain REC2 and residues L(?3',?3'') (res. 404-407) and L(?4,?4) (res. 422-424) of the 
GGDEF domain. 
 
Primer list 
The following primers were used: #1006, ACA CGC TAC ATA TGA AAA TCT CAG GCG 
CCC GGA C; #1007, ACT CTC GAG AGC GCT CCT GCG CTT; #1129, CAA GCG GCT 
GCA GGC CAA TGT GAT CGT CGG CCG CAT GGG TGG TGA; #670, TGC TAG TTA TTG 
CTC AGC GG; #1006 ACA CGC TAC ATA TGA AAA TCT CAG GCG CCC GGA C; #1130, 
CAA GCG GCT GCA GGC CAA TGT GCG CGA AAG CGA CAT CGT CGG CCG CAT 
GGG TGG TGA; #1132, CAC ATT GGC CTG CAG CCG CTT GGC GAC; #1131, CAA GCG 
GCT GCA GGC CAA TGT GNN NNN NNN NNN NAT CGT CGG CCG CAT GGG TGG 
TGA.  
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FIGURE LEGENDS: 
Figure S1: Separation of peptides yielded from tryptic digest of PleD in the presence (red 
chromatogram) or absence of c-di-GMP (black chromatogram) on a C18 column. Peaks 
identified by ESI-MS: c-di-GMP m/z 691, tR 7.70 min, T47 (amino acids 354-359) m/z 659.3 tR 
25.64 min. T49 (amino acids 367-386) m/z 2167.7 tR 47.73 min. 
 
Figure S2: Normal modes of PleD I-site and A-site residues. The displacements for each mode 
of the ligated and unligated structures are shown in Å for the residues of the REC2 domain 
(green) and the GGDEF domain (red). Insertion of intercalated c-di-GMP in the I-site quenches 
motion in both the I-site (R359-D362, R390) and the A-site (G368-E371), suggesting that the two 
sites are dynamically coupled. 
 
Figure S3: Representation of the PleD protein (blue: REC1, green: REC2, red: DGC) with c-
di-GMP bound to the I-site. C?-atoms at positions of considerable changes in flexibility upon 
ligand binding are shown as spheres; reduced flexibility (yellow) and enhanced flexibility (black). 
Note that binding of c-di-GMP at the I-site (I) affects mobility not only in the I-site, but also in 
other regions of the protein, e.g. A-site (A), phosphorylation site (P) and dimer interface. 
 
Figure S4: Alignment of I- and A-site sequence of biochemically characterized diguanylate 
cyclases.  I-site residues (RXXD) are underlined in green and A-site residues (GGDEF) are 
underlined in yellow. 
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FIGURE LEGENDS: 
Figure S1: Separation of peptides yielded from tryptic digest of PleD in the presence (red 
chromatogram) or absence of c-di-GMP (black chromatogram) on a C18 column. Peaks 
identified by ESI-MS: c-di-GMP m/z 691, tR 7.70 min, T47 (amino acids 354-359) m/z 659.3 tR 
25.64 min. T49 (amino acids 367-386) m/z 2167.7 tR 47.73 min. 
 
Figure S2: Normal modes of PleD I-site and A-site residues. The displacements for each mode 
of the ligated and unligated structures are shown in Å for the residues of the REC2 domain 
(green) and the GGDEF domain (red). Insertion of intercalated c-di-GMP in the I-site quenches 
motion in both the I-site (R359-D362, R390) and the A-site (G368-E371), suggesting that the two 
sites are dynamically coupled. 
 
Figure S3: Representation of the PleD protein (blue: REC1, green: REC2, red: DGC) with c-
di-GMP bound to the I-site. C?-atoms at positions of considerable changes in flexibility upon 
ligand binding are shown as spheres; reduced flexibility (yellow) and enhanced flexibility (black). 
Note that binding of c-di-GMP at the I-site (I) affects mobility not only in the I-site, but also in 
other regions of the protein, e.g. A-site (A), phosphorylation site (P) and dimer interface. 
 
Figure S4: Alignment of I- and A-site sequence of biochemically characterized diguanylate 
cyclases.  I-site residues (RXXD) are underlined in green and A-site residues (GGDEF) are 
underlined in yellow. 
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Cyclic diguanosine monophosphate is a bacterial second messenger
involved in a lifestyle switch from single cells to biofilm formation.
Atomistic simulations are used to characterize inhibited diguanylate cyclase
(DGC) PleD with emphasis on the feedback inhibition mechanism. Normal-
mode calculations show a rigidification particularly in both the inhibition
site and the active site of the protein upon ligand binding. Extensive
molecular dynamics simulations in explicit solvent and analysis of the
dynamical cross-correlation maps suggest two distinct coupling pathways
between the active and the inhibition site: direct information transfer either
through the β-strands β2 and β3 of the DGC domain (pathway I) or via the
disordered regions connecting domains D2 and DGC (pathway II). In
addition, dynamical cross-correlation maps show differences in the
correlation between neighboring domains upon ligand binding and upon
the point mutation R390A. The correlated motions between domains D1
and D2, which form the dimerization interface, are stronger for free PleD.
Complementary to the experimentally observed short-range interactions in
ligated PleD, the present work also characterizes the long-range, delocalized
interactions between domains that are important for understanding
activation and allosteric control of the protein. Based on the results,
experimental characterization of the point mutant R353 and of the double
mutant N357/H394 is proposed to differentiate between pathways I and II.
© 2007 Elsevier Ltd. All rights reserved.
Edited by M. Levitt
Keywords: MD simulations; second messenger c-di-GMP; diguanylate
cyclase; product inhibition; protein function
Introduction
Cyclic diguanosine monophosphate (c-di-GMP)
has recently been identified as a second messenger
in bacteria important for multicellular behavior and
persistence. Bacterial biofilm formation is involved
in life-threatening infectious diseases, such as cystic
fibrosis, or the colonization of medical devices.
Cellular levels of c-di-GMP are controlled through
diguanylate cyclases (DGCs) and c-di-GMP-specific
phosphodiesterases.1 DGCs convert two molecules
of guanosine triphosphate (GTP) into c-di-GMP,
while phosphodiesterases cleave the cyclic com-
pound into the linear dinucleotide pGpG.2 Recently,
an involvement of c-di-GMP in regulation of host
pathogen interactions including antioxidant defense
and cytotoxicity have been proposed.3 Thus, inhibi-
tion of DGCs is a potential target to combat biofilm-
related infections.
Genetic studies support the notion that DGCs
control bacterial growth on surfaces by regulating
motility and cellular adhesion.4 This rests to some
extent on investigations of PleD from Caulobacter
crescentus, a protein that efficiently catalyzes the
conversion of GTP into c-di-GMP.5 PleD is a multi-
domain regulator protein with a C-terminal DGC
domain that serves as an output module.5,6 The
DGC domain (also called GGDEF or DUF1) is highly
conserved in many bacterial species and corre-
sponds to one of the largest protein families in the
database. The DGC domain of PleD is associated
*Corresponding author. E-mail address:
m.meuwly@unibas.ch.
Abbreviations used: ABNR, adopted NewtonRaphson;
BNM, block normal mode; c-di-GMP, cyclic diguanosine
monophosphate; DCCM, dynamical cross-correlation map;
DIMB, diagonalization in a mixed basis; DGC, diguanylate
cyclase; GTP, guanosine triphosphate; MD, molecular
dynamics; NMs, normal modes; NMA, normal-mode
analysis; RMSF, root-mean-square fluctuation.
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with two N-terminal CheY-like receiver domains
(D1 and D2). The PleD DGC is activated by specific
phosphorylation of the first receiver domain (D1).7
Very recently, the structure of PleD complexed
with c-di-GMP has been successfully determined
using X-ray crystallography.8 This structure identi-
fied a potential allosteric inhibition site (I-site) with
two mutually intercalated c-di-GMP molecules
tightly bound to the DGC/D2 domain interface.8
Structure/function analysis of PleD and DgcA, a
related DGC, has confirmed the role of the I-site in
feedback inhibition control.2 Biochemical, genetic
and structural analysis of CheY had indicated that
phosphorylation induces a structural change upon
activation.913 However, it is unclear how much the
phosphorylation-induced conformational changes
contribute to the observed stabilization of the active
state over the inactive state in CheY.9 It is interesting
to note that the structural difference between the
active and the inactive form of CheY is quite small
(on average below 1 Å) and restricted to a small
region of the protein (around residues 90 and 113,
which are loop regions).10
So far, little is known about how DGCs work at a
molecular level. For example, the mechanism of
DGC feedback inhibition, mentioned above, is not
known. For this, structural information on the pro-
tein and its ligand is required. Possible modes of
action have been suggested on the basis of the X-ray
structure and general features based on structure
function relationships.8 One possibility is that the
binding of c-di-GMP results in domain intercalation
and immobilization of the DGC and D2 domains.
Alternatively, upon I-site occupation, the dimeriza-
tion interface may be altered, preventing dimer
formation and thus inhibiting DGC activity.8 The
latter proposal is consistentwith the observation that
PleD has to form a dimer for activation. Finally, it is
possible that binding of c-di-GMP to the I-site leads
to intradomain rearrangements that would alter the
catalytic properties of the active site.2
The present study investigates inhibited mono-
meric PleD with intercalated c-di-GMP present in
the inhibition site in view of a possible biological
mechanism for allosteric control. Traditionally,
protein function has been inferred from its structure,
and possibly additional information (such as kinetic
and spectroscopic data). However, contrary to the
static view of protein function, the view emerged
that protein dynamics contributes considerably to
function.14 One example are collective, usually low
frequency vibrations (so-called functional modes)
that can play important roles in conformational tran-
sitions relevant to protein function.14
Results
In the following, results are presented for struc-
tural properties (energy-minimized structures and
B-factors), which are compared to data from experi-
ments, for the exploration around the energy-
minimized structures (normal modes), and for the
dynamics [through molecular dynamics (MD) simu-
lations and analysis of the correlated motions].
Results are first presented for the ligated native
protein, for which experimental data are available.
Then, changes compared to ligated PleD are dis-
cussed upon removing the ligand. To describe
structural features the following nomenclature is
used: αX for α-helices, βX for β-strands where X is a
number. Loop regions are written as L(x,y) where x
and y are the flanking secondary-structure elements.
Structures and validation of the ligated and
unligated protein
Ligated PleD
Figure 1 gives an overview of the structure of one
monomer of ligated PleD. The DGC domain (top)
contains the active site (cyan), whereas the inhibition
site (orange) is located between domains DGC and
D2. The active site (A-site production site for c-di-
GMP) is located in the region of the α1 and α2
helices with the conserved GGDEF motif in the loop
L(β2,β3) of the DGC domain (residues G368, G369,
E370, E371).5
Optimized structures were calculated as described
in Materials and Methods for ligated PleD starting
from the X-ray structure. The final RMS difference
between the calculated and experimentally deter-
mined structure is 0.97 Å (constrained) and 1.77 Å
(free) for the backbone atoms (residues 2454),
respectively. Such an RMSD is quite typical for
force field optimizations of medium to large pro-
teins using a similar minimization protocol.15,16
Normal-mode calculations [block normal-mode
(BNM) method] using the X-ray structure of inhi-
bited PleD yielded 149 negative normal-mode
frequencies and hence this is not a minimum-energy
structure. Regions showing considerable rearrange-
ments during structural optimization also exhibit
large fluctuations in the imaginary modes, namely,
the unstructured parts connecting the domains
D1D2 and D2DGC.
B-factors for ligated PleD
The MD simulations of ligated PleD (for details,
see below) also allow one to calculate root-mean-
square fluctuations (RMSFs), which are a measure of
the flexibility and fluctuations around the average
protein structure and which are related to measured
B-factors. They are calculated over the last 1.25 ns of
the MD simulations. Figure 2 shows that, in general,
the location of the flexible regionscharacterized
by larger B-factors and RMSFand the more rigid
parts of the protein agree quitewell. In regionswhere
no electron density was found in the experiment
residues 138146 and residues 283285), the calcu-
lated RMSFs are large. These parts of the protein
correspond to linking regions between the different
domains.
Experimental B-factors and RMSFs differ in the
region of residues 325 to 345, which are adjacent to
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the A-site (see Fig. 1). The increased mobility in
the MD simulations compared to the more rigid
behavior found experimentally is consistent with the
fact that in the crystal c-di-GMP is present8 in the
A-site, while in the simulations this position is not
occupied. Further differences between mobilities
from experiment and simulations are found in
domain D1 for helix α2 and the adjacent loop
L(α2,β3) (residues 3650). Analyzing the X-ray
structure (Swiss PDB Viewer17), we found these
two elements are involved in crystal contacts, which
explains the observed difference in motility.
Characterization of the structure of unligated PleD
It is also of interest to characterize possible
structural changes upon removing the ligand from
PleD. The experimental results suggest that the
structures of ligated PleD (as a dimer) and the
unligated monomer differ.5 In general, it is not
possible to predict changes in the protein structure
upon removal or insertion of the ligand based solely
on knowledge of the ligand size, for example.
The structural optimizations for unligated PleD
were started from the ligated X-ray structure from
Fig. 1. Structure of c-di-GMP-ligated PleD. Overview of PleD ligated with c-di-GMP: the guanylate cyclase domain
(DGC) in green, domains D1 and D2 in red and yellow, respectively. The ligand c-di-GMP (colored by atom type; C, cyan;
N, blue; P, yellow; O, red; H, white) is shown in ball-and-stick representation. Protein residues forming the active (cyan)
and the inhibition site (orange) are highlighted.
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which c-di-GMP was removed. The final RMS
difference is 0.98 Å (constrained) and 1.88 Å (free)
for the backbone atoms (residues 2454), similar to
the RMSD found for ligated PleD. Ligand removal
leads to structural differences mainly in the DGC
domain and the unstructured regions connecting the
different domains. BNM calculations yield two
(constrained) and three (free) slightly negative
normal modes (≤0.001 cm−1), respectively, which
shows that the structures correspond to real minima
on the potential energy surface. However, it is
quite likely that the structures investigated do not
correspond to a low-energy structure (see also
Discussion and Conclusions).
Fluctuations and change of flexibility upon
complexation
To characterize the influence of ligand binding on
the flexibility of the protein, the Cα RMSFs of ligated
and unligated PleD are compared (see Fig. 2).
Differences are found in the following regions:
RMSF values for unligated PleD are higher for
L(β1,α1) (residues 815), L(β3,α3) and neighboring
α3 (residues 5470) and the C-terminal half of α5
(residues 120138) of domain D1, α3 (residues 210
225) of domain D2, the linking region between D2
and DGC (residues 283289) and L(α0,β1) (residues
315319) of the domain DGC. In contrast, RMSF
values for unligated PleD are lower for the linking
region between D1 and D2 (residues 138150),
L(β4,α4) (residues 234239) of domain D2 and
L(β3,β3) (residues 402408) of domain DGC.
To summarize, it is found that the structure and
B-factors of ligated PleD agree well with experi-
mental findings, while for unligated PleD the struc-
ture can be further relaxed upon removing the
ligand. This is consistent with experiments, which
find that the structures of ligated and unligated PleD
differ. Comparing the RMSFs between ligated and
unligated PleD indicate subtle but potentially im-
portant differences in the local flexibilities of second-
ary-structure elements also away from the I site and
in the linker regions between domains. This point
will be further discussed in the MD simulations.
Normal-mode analysis
Normal modes (NMs), that is, excursions of a
molecule around a minimum-energy structure, are
usually calculated from diagonalizing the 3N×3N
Hessianmatrix (matrix of second derivatives), where
N is the number of atoms of the molecule.1820 For
free (N=7140) and complexed (N=7276) PleD the
number is too large for direct diagonalization of the
entire Hessian. Consequently, approximate methods
such as diagonalization in a mixed basis (DIMB) or
BNM are used for calculating vibrational frequen-
cies. DIMB retains the full atomistic description of
the protein, whereas BNM is a coarse-grained model
(see Materials and Methods). First, the results of
DIMB are described and then compared to BNM
calculations.
To validate DIMB for the present work, the full set
of NMs was calculated for isolated c-di-GMP and
compared with DIMB using m=103 basis functions.
This leads to 97 nonzero NMs from DIMB. For these
97 NMs, no difference was found between DIMB
and frequencies based on the diagonalization of the
full Hessian matrix. These results give confidence
that DIMB applied to the free and ligated structure
of PleD is meaningful, especially for the low-
frequency modes. Convergence studies were also
carried out for ligated and unligated PleD with m
ranging from 50 to 300 (53, 103, 153, 175, 200, 225,
250, 275 and 300). Increasing m also increases the
number of atoms in a particular block and the
normal-mode frequencies shift to lower values until
they converge for mN275. To further assess the
influence of the basis set size used with DIMB,
Fig. 2. B-factors versus calcu-
lated RMSF. Experimental B-factors
and RMSF (in angstroms) from the
MD simulations for ligated (black
and blue) and unligated PleD (red).
The secondary-structure elements
are indicated on top: arrows for
β-strands and rectangular boxes for
helices. Domains D1, D2 and DGC
are color coded in red, yellow and
green, respectively. It should be
noted that in regions where no
electron density was found experi-
mentally (residues 138146, 283
285) the B-factor in the PDB file
was arbitrarily set to 20. Prominent
differences between the calculated
B-factors for ligated and unligated
PleD occur mostly in loop regions:
L(β3, α3) and L(β5, α5) of D1
(residues 5457, 104108); disordered region and part of α3 of D2 (residues 144147, 219221); L(β4, α4) of DGC
(residues 420424). In general, the pattern from the experiment is well reproduced by the simulations (see, e.g., the region
around residues 400 and 420).
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RMSFs of the normal modes at T=300 K were
calculated for m=53, 103 and 153. The RMS fluc-
tuations from normal mode analysis (NMA) agree
qualitatively with those obtained from the MD
simulations and are shown in Fig. 3. Furthermore,
identification of the flexible regions is independent
of the basis set size. It should be mentioned, how-
ever, that NMA explores the region around the
minimum of the potential energy surface, while MD
simulations allow structural rearrangements. In
addition, the MD simulations are carried out in
explicit solvent, while for the NMA a distance-
dependent dielectric is used.
As an alternative, a coarse-grained method (BNM)
was used to calculate the normal modes. This
analysis provides a comparison of NMs based on
DIMBwith a method that allows one to calculate the
majority of low-frequency NMs. Because BNM
contains one phenomenological coupling constant
between neighboring residues and not explicit
masses,21 the frequencies are only determined up
to an approximate multiplicative factor and absolute
frequencies cannot be directly compared to a DIMB
calculation. However, it is possible to characterize
the large-scale motions of the protein.
Overview of the normal modes
Figure 4a shows the frequencies as a function of
the mode number calculated with DIMB (basis set
size 153) (solid line) and BNM (dashed line). It is
found that the BNM frequencies are lower than the
ones from DIMB, whereas the density of states is
comparable. For both methods, frequencies for most
normal modes are slightly higher for ligated PleD
(blue) than for the unligated protein (red). This is a
hint that ligand binding influences the flexibility
of the protein such that the complex is more rigid.
The mode density distribution for both DIMB
and BNM is shown in Fig. 4b and c. When com-
paring the percentage of modes with frequencies
below 10 cm− 1, one finds 7.5% and 7.9% for
unligated PleD, which is higher than 5.4% and
7.7% for the complex system, respectively. This
distribution difference is more pronounced in the
case of DIMB. The effect of ligand binding on the
protein flexibility is analyzed in more detail for
residues of the I- and A-site.
Amplitudes per mode for I- and A-site residues
From an NMA it is also possible to investigate
whether the magnitude of motion of a particular
residue is damped or enhanced upon ligand binding
and which residues and parts of the protein parti-
cipate in a particular NM. A considerable displace-
ment for a given mode suggests that this residue is
strongly involved in the mode. The displacements
for the residues in the I- and A-site for each of the
147 nonzero modes from DIMB are shown in Fig. 5.
Residues 368 to 371 are involved in binding of GTP
in the A site, whereas residues 148, 174, 177178,
359362 and 390 were identified to be important for
feedback inhibition with c-di-GMP.8
For ligated and unligated PleD, Cα displacements
for each NM were calculated at T=300 K. It is found
that the displacements for the A-site residues are
considerably larger for free PleD than for the ligated
protein. In particular, motion for modes 75 to 100 is
greatly enhanced for unligated PleD. The effect is
less pronounced for the I-site residues, albeit R359
and A360 are still more mobile for the free system.
NMA suggests that ligand insertion reduces the
flexibility of the I- and A-sites.
To ensure that the reduced flexibility in both the I-
and A-sites is indeed due to ligand binding and not
an artifact of the NMA, displacements for distant
residues were calculated. These control residues (not
shown) display random increase/decrease of dis-
placements upon ligand binding. When the basis set
size is increased to 300 (with concomitant increase
of the number of atoms per block), the difference in
Fig. 3. Residue mobility from
MD simulations and normal mode
calculations. Comparison between
RMSFs from the MD simulations
and from normal mode calculations
(DIMB) with different basis set sizes
for (a) unligated and (b) ligated
PleD. The following color code is
used: MD, black; DIMB with basis-
set size 153, blue; 103, green; and 53,
red. The secondary-structure ele-
ments are indicated on top: arrows
for β-strands and rectangular boxes
for helices. Domains D1, D2 and
DGC are color coded in red, yellow
and green, respectively. The shape
of the RMSF obtained from the MD
simulation and the NMA are very
similar. There is an improvement if
a higher number of NMs is included
(see, e.g., around residue 175).
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mobility between ligated and unligated PleD is less
pronounced. However, ligand binding still reduces
the mobility of R359, A360, I361, E362, R148, H177,
R178 and R390.
The NMs also allow one to study the influence of
ligand binding on the mobility of residues that form
the I- and A-sites (see Fig. 5). Comparing the
residual displacements in ligated and unligated
Fig. 5. Influence of ligand binding on active and inhibition site residues. Cα displacements calculated from normal-
mode calculations (DIMB) at T=300 K for I- (red) and A-site (green) residues, respectively. Ligand binding in the
inhibition site decreases the mobility of the residues involved in binding. However, the mobility of residues in the distant
A-site is also considerably damped.
Fig. 4. Normal mode frequen-
cies. (a) The normal mode frequen-
cies obtained from DIMB with
m=153 basis functions (dashed line)
and BNM calculation (continuous
line). The absolute wave numbers
from the BNM calculations are
lower but the shape of the curves
is comparable. (b) and (c) Density
distribution of the frequencies from
DIMB and BNM, respectively. In all
plots, ligand binding shifts most
normal modes to slightly higher
frequencies. The number of modes
with frequencies below 10 cm− 1 is
higher in the unligated PleD (7.5%
versus 5.4% for DIMB and 7.9%
versus 7.7% for BNM) than in the
complex structure. The difference in
mobility is more pronounced for
DIMB. In all plots, ligated PleD is
blue and unligated PleD is red.
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PleD, we find that the most striking feature is the
suppression of motion upon ligand binding in both
the I- and A-sites. The influence of ligand binding on
the dynamics of residues in both sites can be
attributed to dynamical coupling. One interesting
point is to understand how the two sites are coupled
in detail. Looking at the structure, we can envisage
two possibilities for information transfer: localized
coupling involving the short β-strand β2 that
connects the I- and the A-sites. Alternatively, the
coupling may be distributed over the entire protein.
To get information about the coupling mechanism,
for example, through which structure elements
coupling occurs, the NMs that involve residues
from the I- and A-sites are characterized. In the
following, modes 27, 56 and 78 and the range from
89 to 98 calculated with DIMB (basis set size 153)
will be considered more closely. Modes 27, 78 and
those from 89 to 98 involve both I- and A-site
residues, whereas in mode 56 only A-site residues
participate.
Modes 89 to 98
Cα atoms of A- (residues G368 to E371) and I-site
(R359, A360) residues have displacements of up to
0.1 Å for these modes and the modes are delocalized
over the entire protein. The largest amplitudes are
found in the DGC domain. Helices α3 and α1 are
anticorrelated to L(β2,β3) (A-site) andβ3. The loops
L(β2,β3) and L(α2,β2) (A- and I-site loops) are
connected via the short β-strand β2, which mediates
motion. Structural elements forming the I-site pocket
are correlated with the I-site loop. Overall, a screw-
like motion of the helices α1, α2 and α3 in the DGC
domain translates β2 along the strand direction.
Modes 27 and 78
Considerable displacements in both sites are
found for modes 27 and 78. In mode 27 the I- and
A-site loops, connected via the β-strand β2, move
together in the same direction. The helix α0 seems to
displace the β-strand β2. However, this specific
mode leads to major movement of domain D1
without the extended helix α5 as a unit and in the
DGC domain α0, L(β4,α4), β3 to β3 and L(α1,α2)
with parts of the neighboring helices. The D2
domain remains stationary. In mode 78, substantial
motion is found in the I-site region, especially the
disordered linking regions and the C-terminal part
of α5 of D1. The loops L(α2,β2) and L(β2,β3) (I- and
A-site loop) move in the opposite direction, as found
for modes 89 to 98. Other parts of the protein that
display motion in this mode are α4 to β5 and both
ends of α0 of DGC, β2 to α2 of D2 and L(β3,α3) of
D1.
Mode 56
Contrary to the above, mode 56 involves only
motion of A-site residues. Further movements are
found in the DGC domain, α1 of D2 and α2 and the
C-terminal half of α5 of D1. L(β2,β3) moves together
with α1 and α4 of DGC. The motion of the N-
terminal part of α3 is in the opposite direction. The
C-terminal half of α5 of D1 and β0 of DGC also
move in the direction opposite that of the A-site
loop.
In summary, the NMA suggests that the I- and
A-sites in DGC are dynamically coupled via the
short β-strand β2 that itself is influenced from
motion of the nearby helices. In addition, dynamical
coupling between the two sites is not restricted to a
single functional mode but is present in several low-
frequency modes.
Molecular dynamics simulations of native,
complexed PleD
Complementary to NMA, MD simulations pro-
vide additional information about collective mo-
tions within a protein, including a realistic solvation
environment. One further important difference is
that NMA is sensitive to motion around the
optimized structure, whereas MD simulations also
capture anharmonic contributions and allow, for
example, crossing of torsional barriers. Representa-
tive of all trajectories, the MD simulations for ligated
PleD are described in more detail, because for this
system a well-defined starting structure is available
from experiment.
During the MD simulations all secondary-struc-
ture elements are preserved. The average RMSD of
all Cα atoms, compared to the X-ray structure, is
2.0 Å (see Fig. 6a). Surprisingly, the RMSD for the
complex is higher than for the unligated protein.
This is mainly due to a reorientation of the DGC
domain with respect to domains D1 and D2 (see
Figs. 6b and 7c) At longer simulation times this
feature becomes less pronounced and the RMSD for
both systems is ≈2.0 Å. In particular, DGC domain
reorientation is reduced for trajectory III (see also
Fig. 3 in Supplementary Data). To distinguish
between structural changes within the domains
and rearrangement between the three domains,
snapshots taken every 10 ps were reoriented with
respect to each domain (D1, D2 and DGC). Then,
average RMSDs were calculated for all Cα atoms of
PleD (see Fig. 6b) and for the Cα atoms of each
domain, respectively (see Fig. 6c). Comparing the
average RMSDs for Cα atoms within each domain
after superposition on the domain considered gives
information about intradomain structural changes.
RMSDs for the Cα atoms in domains D1, D2 and
DGC are 1.2, 1.5 and 1.4 Å, respectively. Interdo-
main changes can be assessed from the difference in
RMSD of all Cα atoms after reorientation on a single
domain (see Fig. 6b). The RMSD considering
domains D1 and D2 give similar values (2.5 Å for
D1 and 2.2 Å for D2) However, the catalytically
active domain DGC is oriented differently with
respect to the other domains, which is also reflected
in an RMSD of 3.5 Å (see Fig. 7c).
To represent global motions of the protein, snap-
shots taken every 250 ps are superimposed (see
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Fig. 7) onto the backbone atoms. The most flexible
parts of the protein are the region β3/β3ʺ and the
C-terminus of the DGC domain. In addition, for
the complex system, one observes the reorientation
of the DGC domain with respect to domains D1
and D2 (see Fig. 7c). This is also reflected in the
RMSD of all Cα atoms after reorientation on
domain DGC (3.5 Å versus 2.4 Å for ligated and
unligated PleD, respectively). The D1/D2 interface
is also rearranged.
For unligated PleD, major shifts of secondary-
structure elements are observed in the DGC and D1
domain (see Fig. 7a) compared to the X-ray
structure. The helix α0 of the DGC domain moves
towards the unoccupied I-site pocket, and domain
D1, except for the extended helix α5, is moved along
the axis of the α-helices α2 and α3. The major
rearrangementthe RMSD for Cα atoms reaches
about 2.4 Åis the reorientation of domain DGC
relative to domains D1 andD2 for the complex. In all
cases, the X-ray structure was used for comparison.
Therefore, one cannot exclude artifacts from crystal
packing and it has to be kept in mind that simu-
lations were carried out for the PleD monomer,
whereas the asymmetric unit is a dimer.
Cross-correlation maps for native, ligated PleD
Dynamical cross-correlation maps (DCCMs) allow
analysis of persistent (anti)correlated motions of
residue pairs from the MD simulations and serve
as a quantitative measure for the collective motion in
a protein. First, the results obtained for the ligated
system are discussed in detail (see Fig. 8a). Then,
changes in the DCCMs upon removing the ligand
are described. This allows the investigation of
ligand-induced effects upon binding in PleD. Corre-
lation coefficients above 0.3 are reported. A thresh-
old of 0.3 is used to capture correlations between the
ligand and the protein. To further characterize the
computed correlations, they were calculated for the
first and second nanosecond of trajectory I and for
shorter (25 ps) and longer (70 ps) windows. The
results, shown in Figs. 1 and 2 of the Supplementary
Data, demonstrate that the reported correlations are
persistent and largely independent of the details of
the averaging procedures. A large number of
correlated motions within each domain and some
interdomain correlations are found, whereas anti-
correlated motions are rare. Most correlated motions
correspond to spatial proximity of the residues
involved.
The correlation pattern of domains D1 and D2 is
very similar, as can be expected, because both
domains are annotated CheY-like receiver domains.
The central β-strand β3 is coupled to all secondary-
structure elements of the domain, suggesting a
tightly packed domain. For the catalytically active
domain (DGC), no single secondary-structure ele-
ment with correlation to all other elements within
DGC are found. Interdomain couplings can serve to
transfer information (e.g., following a conforma-
tional transition in one domain) between individual
domains. Such interdomain couplings are cross-
correlation motions between different domains. For
PleD they are found between neighboring domains,
D1/D2 and D2/DGC, respectively. The extended
α5-helix of D2 is interacting with α4, β5 and α5 of
D1. β2 and α2 of D2 are correlated to α0 of DGC.
For the loop regions, mainly intradomain correla-
tions are found. The couplings in domains D1 and
D2 are again similar. Interdomain correlations are
found between D2 and DGC, but none between D1
and D2. The two unstructured regions connecting
neighboring domains, D1D2 and D2DGC, respec-
tively, are correlated. Additional connections are
from L(α2,β2)the I-site loopto the unstructured
region D1D2 and to L(α1,β2).
Fig. 6. RMSD during the MD
simulation. RMSDs for Cα atoms
with respect to the X-ray structure
of ligated PleD from the MD si-
mulations in explicit solvent. (a)
The RMSD calculated for all Cα
atoms reaches a constant value
after ≈250 ps for unligated PleD
(red) and ≈500 ps for ligated PleD
(blue). To ensure the full equilibra-
tion of the system, the simulation of
ligated PleD was extended to 3.0 ns.
(b) RMSD for all Cα atoms after
superposition on domains D1 (red),
D2 (orange), DGC (green) and
D1/D2 (black), respectively, are
shown in the middle panel (top,
ligated; bottom, unligated). For the
complex, superposition on the
domain DGC leads to a significantly
larger RMSD compared to the other
cases. (c) RMSD calculated for each
domain separately (same color code;
top, ligated; bottom, unligated).
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Removing the ligand from the I-site modifies the
cross-correlation pattern. In the following, only
changes upon ligand withdrawal are described,
first for secondary-structure elements and then for
the loop regions. If the ligand is removed from the
I-site, changes occur in all three domains. Some
correlations present in the complex disappear and
new correlations emerge. α4 of D2 becomes more
strongly correlated to elements within D2 and also
couples to α5 of D1, which is now correlated to α2 of
D1. Within DGC, coupling between α1 and β3 is
found. It should be noted that these secondary-
structure elements are close to the active site. Within
DGC, correlation between α0 and β3 is deleted. This
might be of interest, as β3 is part of the β-sheet
connecting the I-site with the A-site loop and α0 is at
the interface to domain D2. In D2, interactions
between α1 and α3 and between β1 and α5
disappear. In D1, α1 and β3 are no longer correlated.
Residue D53, which is phosphorylated to activate
the DGC, is part of β3. Finally, the interaction
between D2 and DGC, namely, β2 of D2 and α0 of
Fig. 7. Superposition of snapshots for ligated and unligated PleD. Superposition of eight snapshots taken every 250 ps
from the MD trajectories on the X-ray structure. The snapshots are reoriented on all backbone atoms for unligated (a) and
ligated (b) PleD. Reorientation on the backbone atoms of DGC only for ligated PleD (c). The structures are colored as
follows: X-ray structure, silver (cartoon representation); 0.25 ns, black; 0.50 ns, blue; 0.75 ns, cyan; 1.00 ns, green; 1.25 ns,
yellow; 1.50 ns, orange; 1.75 ns, red; and 2.00 ns, purple. Comparison of (b) and (c) shows the displacement of D1 and D2
versus DGC and the flexibility of the region β3/β3 of DGC.
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DGC, is weakened. Analysis of the loop regions
shows changes concerning all three domains as
found for the secondary-structure element analysis.
In D2, L(β3,α3) and L(α4,β5) become correlated
when the ligand is removed. For DGC, a new cou-
pling is found between L(α0,β1) and the C-terminus.
In addition, L(β5,α5) of D1 interacts with L(β4,α4)
across the D1/D2 interface, whereas interdomain
correlation between D2 and DGC is decreased.
The I-site loop L(α2,β2) no longer interacts with
the disordered region D1D2 and with the loop
L(α1,β2). The absence of these interdomain
correlations can be rationalized by spatial contacts
via the ligand.
In summary, ligand removal leads to stronger
correlation between D1 and the proximal part of D2.
However, ligand-induced couplings, whether due to
spatial proximity or to structural rearrangement,
disappear and are mainly located at the I-site pocket,
the interface D2DGC, in domain DGC close to the
I-site loop, β3, and in the distant domain D1 at the
activation site, D53 of β3. These trends are observed
to be persistent for different trajectories of ligated
PleD (see Supplementary Data Fig. 3 for validation
and Fig. 4 for a comparison of the DCCMs).
Finally, the direct correlations between PleD and
c-di-GMP are discussed. The ligand is coupled to
residues from both domains D2 and DGC. The
secondary-structure elements α1 and β2 of D2 and
α2 and α3 of DGC are correlated with the ligand.
The two elements of D2 show different correlations
in the ligated and unligated protein, whereas the
elements of DGC are unaffected by ligand binding.
Furthermore, the ligand is interacting with the
following loop regions: L(α1,β2) and L(β2,α2) of
D2 and L(α2,β2) (I-site) and L(β3,α3) of DGC. The
loops L(α1,β2) of D2 and L(α2,β2) of DGC show
differences in looploop correlations upon ligand
removal.
The correlation patterns for ligated and unligated
PleD and the differences between them may help to
rationalize how ligand binding at the I-site modifies
and/or controls A-site functionality. One possibility
is that control occurs directly via the short β-strand
β2 that directly connects the I-site and the A-site.
However, no direct correlation to the ligand is found
from the cross-correlation analysis. Another route is
coupling through the neighboring β-strand β3 or the
α-helices α2, α3 situated above the β-sheet. The
cross-correlations display couplings from β2 to both
the antiparallel β-strand β3 and the helix α0 situated
at the interface to the neighboring domain D2, and
the correlation pattern of the neighboring β-strand
β3 is sensitive to the presence or absence of the
ligand. The motion of the I-site loop is correlated
with L(β3,α3), and if the ligand is present the I-site
loop is coupled to L(α1,β2) of D2 and the disordered
region D1D2. The A-site loop, consisting of the
residues important for substrate binding and cata-
lysis, is coupled to the disordered region D2DGC.
From the cross-correlations, a model involving α2 or
α3 as connection element is less likely since ligand
binding does not affect the dynamical correlation of
these helices.
Two possible pathways remain: either via the
β-sheet or via the disordered regions. Pathway I
involving β2 and β3 is plausible because the
secondary-structure elements connect the two sites
directly and β3 correlations are altered by ligand
binding. This finding is also in accord with the
previously reported β2 balance-like movement of
the I- and A-site loops, based on the superposition of
the minimized structures.2 Pathway II via the
disordered regions, D1D2 and D2DGC, originates
from an observed cascade of direct correlations from
the I-site to the A-site in the DCCM analysis. In
addition, this cascade is only present if the ligand is
Fig. 8. DCCM for ligated and unligated PleD. DCCMs
for ligated (a) and unligated (b) PleD. The following color
code is used for the cross-correlation values: 0.30.4,
green; 0.40.5, yellow; 0.50.6, orange; 0.60.7, red; 0.7
0.8, indigo; 0.80.9, blue; 0.91.0, black. The blue box
marks direct correlations with the ligand. Blue and black
circles, labeled with arabic and roman numerals, mark
correlations that are present exclusively in ligated and
unligated PleD, respectively.
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bound, otherwise the connection I-site loop to
disordered region D1D2 is absent.
Discussion and Conclusions
Currently, it is believed that both structure and
dynamics contribute to protein function.2226 Com-
plementary to experimental work such as point
mutation studies or binding affinity measurements,
computer simulations provide valuable and testable
information at an atomic level. In this work, the
ligated and unligated multidomain DGC PleD
monomer is characterized by using MD simulations.
Studying the monomer is appropriate because it has
been previously proposed that the monomer is
crucial for understanding allosteric inhibition in
PleD.8 This is further supported by investigations of
the single-domain DGC DgcA, which has preserved
the ability for feedback inhibition that indicates that
allostery is an intrinsic characteristic of the DGC
domain.2 Finally, binding of c-di-GMP to the PleD
monomer and dimer has been proposed to eliminate
catalytic activity by domain immobilization.8 This is
in agreement with the observation from the present
simulations that ligation of c-di-GMP leads to a
rigidification of the monomer.
In the present work, the applicability of atomistic
simulations was first validated by calculating
optimized structures and RMSFs around the mini-
mum that can be directly compared to experimental
data (X-ray structure and B-factors). Having estab-
lished that this approach is meaningful, we inves-
tigated the normal modes and the molecular
dynamics in detail. The results suggest that the
inhibition (I-site) and the active site (A-site) of PleD
are dynamically coupled through an elaborate
network of atomic motions that involves the β2-
strand (direct coupling within DGC) and the
structural elements β3, α2 and α3 of DGC (more
delocalized, network coupling).
From the superposition of the energy-minimized
structures of ligated and unligated PleD a balance-
like movement of the β-strand β2 was previously
proposed.2 This motion displaces the I- and A-site
loops simultaneously. The present work extends this
model explicitly to the atomic dynamics and does
not assume that the ligated (experimentally
observed) and the unligated protein structure are
closely related, which is not necessarily the case (see
below). Thus, the results presented here are stronger
evidence that direct communication between I- and
A-site along β2 contributes to allosteric control in
PleD.
The experimentally determined structure for PleD
was obtained through co-crystallization with c-di-
GMP.8 For further understanding of the mechanisms
underlying PleD function additional insight into the
unligated structure is useful. The prediction of the
structural changes upon ligand binding is a difficult
task. Using the protocol described in Materials and
Methods [steepest descent (SD)/adopted Newton
Raphson (ABNR) minimization until RMS gradient
of 10−7, distance-dependent dielectric with ε=4,
decreasing constraints on the backbone atoms],
snapshots along the MD trajectory were minimized.
Assuming a large-scale motion of the DGC domain
with respect to domains D1 and D2, an open
structure (see Fig. 9) that is considerably different
from the ligand-bound structure can be envisaged.
Ten snapshots from a short, high-temperature MD
simulation (10 ps, T=500 K, distance-dependent
dielectric with ε=4) were minimized using the
standard protocol. The final structures are consider-
ably lower in energy (by 95 kcal/mol) compared to
optimized structures of unligated PleD in its X-ray
conformation. Favorable electrostatic interactions
and orientations (dihedral angles) stabilize the
putative open structure by ≈140 kcal/mol relative
to the optimized unligated structure of PleD,
whereas unfavorable van der Waals and valence
angle energies destabilize it by ≈45 kcal/mol. It is
interesting to note that the low-energy character of
this postulated open conformation is in qualitative
agreement with X-ray data of BeF−-activated PleD
structure, although the experimentally found struc-
ture is even more open.27 The open, unligated
structure has no I-site (originally formed by residues
from the DGC and D2 domains), and the A-site is
close to the unstructured region connecting domains
D1 and D2. The existence of two distinct conforma-
tions (unligated open versus ligated closed) strength-
ens the widely known equilibrium shift between
active and inactive structure through binding of the
ligand.9,2831
From the normal mode analysis, no single func-
tional mode with exceptionally high involvement
coefficient was found for the eigenvectors calculated
from the unligated or for the ligated structure (see
Fig. 10). This is in agreement with recent proposi-
tions that single functional modes are characteristic
for motor proteins, but not for signaling proteins.15
In fact, PleD is a signaling protein activated by a
stimulus (phosphorylation at D53 in domain D1).
However, although normal modes can be helpful in
analyzing functionally important motions in a
protein, there are limitations in their interpretation,
as has been discussed recently.32 The present findings
show that binding of c-di-GMP to the I-site does not
affect only one dominant, functionally relevant
mode, but rather influences a network of motional
degrees of freedom that are relevant for PleD func-
tion. From the DCCM, two distinct pathways are
plausible: the first runs along the secondary-structure
elements β2 and β3 with the possibility to include the
α-helices α2 and α3 situated above the β-sheet,
whereas the second pathway includes the disordered
regions connecting the different domains, D1D2 and
D2DGC. The second pathway is only possible if the
ligand is bound, which implies that the ligand can act
as a switch.
A central question in understanding the function
of PleD is to relate its primary function (production
of c-di-GMP) with self-inhibition by c-di-GMP. Since
the I- and A-sites are both located in the DGC
domain, one possibility is that ligation of c-di-GMP
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in the I-site leads to loss of functional modes (flexi-
bility), which restricts motion around the A-site.
Indeed, NMA and RMSF calculations on minimized
PleD structures show that c-di-GMP bound at the
I-site influences the flexibility of the protein such that
specifically both the I- and A-site regions become
more rigid. The dynamics simulations support the
theory that information transfer between the two
functional sites (I- and A-site) might be due to
dynamical coupling via β-strand β2 (pathway I) or
through delocalized global motion of the protein
(pathway II).
To obtain additional information on the proposed
pathway and the correlations in inhibited PleD,
similar calculations were carried out for the point
mutant R390A with c-di-GMP bound at the I-site.2
The mutation is located in the α-helix α3 of the DGC
domain and was obtained by deleting and rebuild-
ing the appropriate residue side chain. Changes in
the correlation pattern are found in all three
domains, which indicates that the R390A mutation
affects the dynamics of the entire protein. Correla-
tions within domains D1 and D2 are strongly
decreased in the mutant compared to the wild-
type protein, whereas the correlation between the
two domains is increased. In the catalytically active
domain DGC a similar number of correlations occur.
However, different structural elements are corre-
lated in the native compared to the mutant protein.
For pathway I (β2 and β3 including the α-helices α2
Fig. 9. Open structure of free PleD. Putative open conformation structure of PleD superimposed on the original crystal
structure (gray): the guanylate cyclase domain (DGC) in green, domains D1 and D2 in red and yellow, respectively.
Protein residues forming the active (cyan) and the former inhibition site (orange) present in the crystal structure are
highlighted.
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and α3) the I- to A-site correlation is largely
preserved, whereas the direct correlation of the
ligand with α2 is missing. In contrast, pathway II
(connecting regions between domains D1D2 and
D2DGC) no longer exists. Overall, the DCCM of
the mutant R390A shows that a single point
mutation considerably influences the overall
dynamics in PleD. The mutation alters the correla-
tions across the entire protein, and both suggested
pathways for I-/A-site communication are affected.
This is in accord with combined mutagenesis and
biochemical experiments on the point mutant
R390A, which show that the decreased feedback
inhibition is mostly due to a strong decrease in c-di-
GMP binding affinity.2
However, to corroborate their existence and to
discriminate between the two pathways, further
experimental and computational investigations are
required. To verify that the DGC domain is sufficient
for feedback inhibition and to exclude pathway II it
will be interesting to study the DGC domain of PleD
individually by biochemically removing the link to
domains D1 and D2. Pathway I involves the motifs
β2 and β3, which are coupled to the α-helices α2 and
α3. Studying the double mutant N357A/H394A
(disruption of hydrogen bond between α2 and α3)
or the single mutant R353 (side-chain backbone
interaction between α2 and α3 will be unavailable)
should lead to decreased interaction between the
α-helices that in turn affects coupling between the
I- and the A-site.
Based on MD simulations, the present work
characterizes the atomic dynamics of ligated and
unligated PleD. The mechanistic model proposed by
Chan et al. is to some extent supported by the
present data; for example, an open structure of
PleD is suggested from preliminary X-ray data and
simulation data where the mobility of DGC with
respect to domains D1/D2 leads to a structure that is
lower in energy.8 However, ligand binding to the
inhibition site leads more likely to the loss of protein
flexibility than to a total immobilization of the three
domains. It was found that upon ligand binding the
protein is rendered less flexible specifically in both
the I- and A-sites, which was shown to be mediated
through dynamical coupling between the two sites.
Simulations found stronger correlations between
D1 and D2 for unligated PleD, which may affect the
dimerization rate. Together with the available
biological data, this is a first step towards a detailed,
atomistic understanding of the important bacterial
second messenger c-di-GMP. Further experimental
and computational work on this rich and interesting
system should provide fundamental information
about allosteric control and the role of dynamics in
proteinligand systems.
Materials and Methods
Setup of the protein and the ligand
All MD simulations were carried out with either
CHARMM33 or NAMD34 using the CHARMM 22/27
force field.35 The starting structure was taken from the
X-ray structure of the PleD dimer [Brookhaven Protein
Data Bank (PDB), code 1W25] resolved at 2.7 Å. For all
subsequent studies the A chain of PleD with the c-di-GMP
molecule in the inhibition (I-) site was considered. The
additional c-di-GMP molecule in the active (A-) site and
the metal ions are omitted because the present study is
primarily concerned with investigating effects upon
inhibition of PleD (the Mg2+ ion close to residue D53 is
important for the phosphorylation reaction). The protein
PleD consists of 460 amino acids and a total of 7140 atoms.
Hydrogen atoms and the missing residues (M1, His-tag
H456H460) were generated and the structure was
relaxed by 500 steps of SD minimization. All titratable
side chains are generated in their standard protonation
state for pH 7. The system has an overall charge of −7 for
PleD and −4 for the ligand. No counterions were intro-
duced to neutralize the systems.
To describe the nonstandard residue c-di-GMP, para-
meters and partial charges were adopted from the
extended CHARMM parameter sets for nucleic acids.
The structure of the intercalated c-di-GMP was optimized
Fig. 10. Involvement coefficients
calculated for the transition between
minimized structures of ligated and
unligated PleD. Involvement coeffi-
cients, CIN, calculated for the transi-
tion between the minimized (free)
structure of ligated and unligated
PleD from the eigenvectors ob-
tained with DIMB (basis set 153).
No single mode contributing most
to the structural transition can be
found for the eigenvectors calcu-
lated from the unligated (top) struc-
ture or for those obtained from the
ligated (bottom) structure. The cu-
mulative sum of the square of the
involvement coefficients is shown
as a black line.
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using 5000 steps of SD minimization followed by ABNR
minimization until a RMS gradient of 10−7 was reached in
a distance-dependent dielectric with ε=4. Also, the ligand
was solvated in a small (37.3 Å×34.1 Å×34.1 Å) water box
and 24 ps of heating and equilibration and 100 ps
productionMD simulations were run to assess its stability.
The structure of the ligated (intercalated c-di-GMP
docked into the inhibition site of PleD) and the unligated
protein was optimized using a distance-dependent dielec-
tric with ε=4 and a cutoff of 12 Å for nonbonded
interactions. Starting from the X-ray structure, 1000 steps
of SD optimization were followed by 7500 steps of ABNR
minimization with gradually decreasing constraints (more
restrictive on the backbone atoms) to prevent large
structural distortions. Initially, the structures were relaxed
until a RMS gradient of 0.01 kcal/mol was reached. Such a
minimization will be referred to as constrained. Starting
from the constraint-optimized structure, further minimi-
zation using no constraints and a RMS gradient of
10−7 kcal/mol as a convergence criterion will be labeled
constrained E-7. In addition, full minimizations until a
RMS gradient of 10−7 kcal/mol without any constraints
were carried out, which are called free.
Normal-mode calculations
Normal mode calculations were carried out with the
VIBRAN module of CHARMM. Since the unligated and
the ligated protein consist of 7140 and 7276 atoms,
respectively, no full NMA is possible because of the
large size of the resulting Hessian matrix. Thus, the
approximate schemes, DIMB and coarse-grained one-
residue-per-block method (BNM) as implemented in
CHARMM were used.21,3638 The normal modes were
calculated for minimized structures of the system. The
minimization was performed using SD and ABNR
minimization until the RMS of the energy gradient
reached a value of 0.01 kcal/mol/Å using gradually
decreasing constraints or 10−7 kcal/mol/Å. A gradient
value of 0.01 kcal/mol/Å has been shown to be satis-
factory for calculating normal modes. RMSD from the
X-ray structure calculated for the backbone atoms
(residues 2454) is 1.77 Å (free) and 0.97 Å (constrained)
for the complex and 1.88 Å (free) and 0.98 Å (constrained)
for the unligated protein. The basis set size was varied
from 50 to 300 to analyze its convergence. The transla-
tionalrotational coupling was removed by shifting these
modes to high frequency. To test the DIMB approach
for the present case, normal modes for the intercalated
c-di-GMP ligand were calculated with diagonalization of
the full Hessian (DIAG command) and compared to
DIMB calculations retaining 103 basis functions.
The BNMs are coarse-grained descriptions that allow
one to calculate normal modes at reduced computational
expense. BNM uses a coarse-graining procedure that
can range from a single residue to a secondary-structure
element. For BNM, the recent implementation into the
CHARMM program was used.38 One residue per block
was chosen and the frequencies were adjusted by scaling
with 0.5882 as suggested.
Molecular dynamics simulations
For the MD simulations the protein was solvated in a
rectangular box. With CHARMM, a 99.3 Å×74.5 Å×96.2 Å
box of pre-equilibrated TIP3P water39 was used and
solvent molecules overlapping with the protein were
removed, which gives a system size of ≈70,640 atoms:
7140 atoms from native protein PleD, 136 atoms from
the ligand (c-di-GMP dimer) and 63,500 solvent atoms
approximately. In the case of NAMD, the solvation
function with a proteinbox distance of 15 Å was used,
resulting in a box with dimensions of 74 Å×112 Å×95 Å.
This system size contains approximately 75,000 atoms.
In all simulations, periodic boundary conditions were
used, images were updated every 10 time steps and a
12 Å cutoff was applied to the shifted electrostatic and
switched van der Waals interactions. All MD simulations
were carried out using SHAKE40 to constrain hydrogen
atoms and with a time step of 1 fs. For simulations with
CHARMM the solvent was equilibrated at 300 K during
29 ps (4 ps solvent heating and 25 ps solvent
equilibration) with the protein kept fixed. The entire
system was then heated to 300 K and equilibrated for
275 ps before starting the production runs. Total
simulation times were 3.0 and 2.0 ns for ligated and
unligated PleD, respectively. In the following, trajectory
(I) is the CHARMM simulation for ligated PleD.
Additional trajectories (II and III, discussed in the
Supplementary Data) for ligated PleD, carried out with
NAMD, were run for 2.5 ns (started from the X-ray
structure and previously equilibrated for 0.5 ns) and
3.5 ns (started from a snapshot at 0.6 ns of the equili-
brated system), respectively.
Analysis of the results
The results of the NMA and the MD simulations were
analyzed by calculating involvement coefficients and
cross-correlated motions.
Involvement coefficients are extracted from the NMA via
Ik ¼
YX1 
YX2
jYX1 
YX2j
d
YLn ð1Þ
where YX1 
Y
X2 is the displacement vector between two
conformations andYLn is the eigenvector of the n-th normal
mode. Involvement coefficients Ik quantify the geometrical
similarity between the n-th normal mode and the
conformational transition between the structures consid-
ered, YX1 and
YX2. In addition, the cumulative involvement
coefficient CIN can be calculated.
CIN ¼
XN
n¼1
I2n ð2Þ
For a complete orthonormal set of normal-mode eigen-
vectors, CIN is expected to be 1. Thus, In2 gives the maximal
percentile contribution of motion along the n-th mode to
the conformational transition between two structures.
Cross-correlated motions were calculated from the MD
simulations as averages over blocks of different lengths
(25, 50 and 70 ps for the CHARMM run and 25, 50, 100,
200 ps for the first NAMD run) after removing the overall
translation and rotation of the system. The cross-correla-
tion coefficient Cij of residues i and j is given by
Cij ¼
DriDrj
 
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
Dr2i
 
hDr2j i
q ð3Þ
where Δri and Δrj are the displacements of the backbone
atoms from the reference position. Cij varies between 1 and
−1, where 1 corresponds to movement in the same
direction (correlated) and −1 to movement in the opposite
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direction (anti-correlated). In a DCCM, motion in the same
direction (correlated) can be found in the upper left tri-
angle, whilemotion in opposite directions (anti-correlated)
is in the lower right panel. Typically, correlated motions
are much more pronounced than anti-correlated motions.
α-Helices are manifest as a broadening of the diagonal,
while β-sheets appear off diagonal (ascending for parallel,
and descending for antiparallel β-sheets). It should be
noted that DCCMs do not give information about the
magnitude or the direction of the motion.
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5 Results
5.3 PleD dimerization process
Introduction
Sensing environmental signals and rapid metabolic response are crucial for bacte-
ria to survive. A typical cascade to integrate external stimuli is the so-called "two-
component" signal transduction system162, i.e. the signal is sensed by a histidine pro-
tein kinase that transfers a phosphoryl group to a conserved aspartate of a response
regulator (RR) protein thereby modulating its activity. The diguanylate cyclase PleD
of Caulobacter crescentus is such a response regulator with its activity controlled by
the kinases DivJ and PleC and is required for polar differentiation in the cell cycle
of the bacteria.137,147,157,163 Cells without functional PleD are hypermobile and fail to
accomplish the swarmer-to-stalked cell transition. PleD synthesizes the bacterial sec-
ond messenger cyclic di-guanylic monophosphate (c-di-GMP)147, a molecule of great
interest since it regulates surface-adhesion properties and motility in bacteria130,141.
In addition, relevance to virulence of pathogenic bacteria and implication in biofilm
formation has been demonstrated.142 The fact that c-di-GMP is found exclusively in
bacteria makes it a potential target for medicinal applications.
The symmetric condensation reaction of two GTP molecules into c-di-GMP requires
the encounter of two loaded active sites, i.e. exclusively dimeric PleD is catalyt-
ically active which has been confirmed by cross-linking experiments.158 Thus, the
overall production rate depends on the dimerization rate. PleD dimerization is sig-
nificantly enhanced upon phosphorylation (or pseudo-phosphorylation by BeF−3 ).
158
This phosphorylation-mediated dimerization control constitutes an additional level
of allosteric regulation. The unit cell in the X-ray structures of both inactive and BeF−3 -
activated PleD51,52 contain dimeric PleD indicating that the stem domains D1/D2
form the dimerization interface. BeF−3 -activated PleD shows an optimal tight-packed
dimer interface that comes about by a shift/rotation of domain D1 with respect to
D2.52 The domains D1 andD2 of PleD are CheY-like receiver domains (REC), whereof
only D1 contains all invariant residues of the active site136, including the phospho-
acceptor residue D53. Structural changes following the phosphorylation have been
studied extensively on the model system CheY and are also characteristic to receiver
domains.37,50,168,169,171 The rather subtle change involves the repositioning of the β4-
α4 loop and sidechain reorientations of conserved Thr/Ser and Phe/Tyr residues also
known as "Y-T" coupling. Threonine forms a hydrogen bond to the phospho-moiety
and makes space for the Phenylalanine to adopt the "buried" position. This raises the
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question of how the local phosphorylation-induced loop repositioning is propagated
to the α4-β5-α5 interface between domains D1 and D2, and in turn promotes domain
reorientation and dimerization. In addition, the exact role of the pseudo-receiver do-
main D2 is unknown. It could either have an adaptive function responding to the
activation state of D1 or solely enlarge the dimerization contact area. And last, mu-
tation experiments showed that the isologuous contact residue Y26 is required for
dimerization.158 This residue is located at the center of a hydrophobic patch which
exists in both the active and inactive state and it is also strictly conserved in PleD
homologs that share the REC-REC-DGC domain architecture. However, its exact role
in the dimerization process is unidentified. The present computational study focuses
on the characterization of processes associated with the spontaneous relaxation from
the active to the non-active state.
Materials & Methods
Setup of the "PleD" dimers
All MD simulations were carried out with NAMD172 using the CHARMM22 force
field74. From the X-ray structures of inactive and BeF−3 -activated PleD (PDB codes
1W2551 and 2V0N52), residues 1 to 285 which correspond to domains D1 and D2
were kept, deleting all other residues, ions and additional ligand molecules. Simula-
tion of domains D1/D2 should be sufficient to investigate the dimerization process
including the observed rearrangement of domains D1 and D2 of PleD. The catalyti-
cally active domain DGC shows different orientations in the two X-ray structures ar-
guing for substantial orientational freedom of the domain vs. the PleD D1/D2 stem.
Absence of the stabilizing BeF−3 moiety in the active conformation will possibly lead
to spontaneous active-inactive transition events. All titratable sidechains were gen-
erated in their standard protonation state for pH 7, the HSD model was applied to
all Histidine residues and the overall charge of −3 in each monomer was not neutral-
ized by adding counterions. Positions of added hydrogen atoms were relaxed using
200 steps of steepest descent minimization. Mutations were introduced by deleting
and rebuilding the sidechain of the specific amino acid. The systems studied here
are the dimers of domains D1/D2 of PleD in the inactive (dimer) and BeF−3 -activated
state (adimer) and the mutants Y26A in the active conformation, A_Y26A and B_Y26A
introducing the mutation in monomer A or B, respectively.
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Molecular dynamics simulations
MD simulations were carried out in explicit TIP3 water solvent. The NAMD solva-
tion package was used with a protein-box distance of 15 Å resulting in system sizes of
80,000 and 50,000 atoms approximately for dimeric and monomeric D1/D2, respec-
tively. Periodic boundary conditions were used in all simulations and images were
updated every 10 steps. A 9 Å cutoff was used for shifted electrostatic and switched
van der Waals interactions, hydrogen atoms were constrained with SHAKE173 and a
timestep of 1 fs was used. Starting from the solvated X-ray structure, the system was
minimized for 1,000 steps and simulations were carried out at T = 300 K and constant
pressure of 1 atm. 3 ns trajectories were run and analyzed after 5 ps of equilibration.
Data analysis
The β4-α4 loop conformation which is related to the activation state of response regu-
lators can be quantified by the pseudodihedral angle formed by the Cα-atoms of the
loop residues (residue 83 to 86 in domain D1, residue 232 to 235 in domain D2).37,169
An angle of 113◦ corresponds to the fully active conformation, whereas 14◦ is found
in the inactive state.
Interface residues are defined as all residues that have at least one atom within 5 Å
distance of the other monomer or domain.
The dimerization contact area is calculated by the difference in solvent accessible surface
area (SASA) between the individual monomers and the complex. To calculate the
SASA a probe radius of 1.4 Å was used.
The secondary structure was assigned for snapshots taken every 10 ps using the se-
quence analyzer174 implemented in VMD175.
Cross-correlated motionswere calculated fromMD simulations as averages over blocks
of 50 ps after removing the overall translation and rotation of the system. The cross-
correlation coefficient Cij of residues i and j is given by
Cij =
〈∆ri∆rj〉√
〈∆r2i 〉〈∆r
2
j 〉
(5.1)
where ∆ri and ∆rj are the displacements of the backbone atoms from the reference
position. Cij varies between 1 for perfect correlation (motion in same direction) and
-1 for anti-correlation (motion in opposite direction), but gives no information about
the magnitude or the direction of the motion.
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Results & Discussion
The PleD dimerization process is studied using domains D1/D2 which are known
to interact. Considering only the D1/D2 stem domains should be legitimate since
the DGC domain is attached via a flexible linker and can move substantially as seen
from the two X-ray structures.51,52 This truncated PleD, the stem D1/D2, is hence-
forth called PleD. Simulations were initiated from both the BeF−3 -activated structure
(1V0N) and the inactive one (1W25), named hereafter adimer and dimer, respectively.
Because force field parameters for BeF−3 or aspartyl-phosphate are not available the
BeF−3 moiety was removed from the active conformation before starting the simu-
lations. Instead of studying the active state, the relaxation from the active to the
inactive form is investigated here and events accompanying this transition are re-
ported. Moreover, the contact residue Y26 is being mutated to an Alanine in one of
the monomer to study its effect on the dimerization. These simulations start from
the active conformation and are denoted A_Y26A and B_Y26A depending in which
monomer the mutation is introduced.
Structural changes characteristic to receiver domains
Spontaneous relaxation of the β4-α4 loop
Domains D1 and D2 of PleD are both assigned to the class of CheY-like receiver do-
mains. These regulatory domains undergo a repositioning of the β4-α4 loop which is
accompanied by a sidechain rotation of the residues Threonine and Tyrosine, a pro-
cess often termed "Y-T" coupling. The conformation of the β4-α4 loop can be quan-
tified by the pseudodihedral angle of the loop’s Cα-atoms37,169, residues 83 to 86 in
domain D1 and residues 232 to 235 in D2 according to the alignment by Hecht et
al.136. X-ray structures showed that an angle of 113◦ corresponds to the fully active
conformation, while 14◦ is found in the inactive state.
The pseudodihedral angle values of the β4-α4 loop sampled during the 3 ns simula-
tion are shown in Figure 7.
Active-to-inactive transition in domain D1. In the X-ray structure of BeF−3 -activated PleD
an angle of 100◦ approximately is found which is consistent with findings in CheY
and confirms the active conformation. In all three simulations starting from the ac-
tive form with the BeF−3 moiety removed, a spontaneous active-to-inactive transition
of the β4-α4 loop is observed in at least one of the monomers (see red and blue lines
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Figure 7: β4-α4 loop conformation
The pseudodihedral angle of the β4-α4 loop in domains D1 and D2 is shown for simulations (A)
dimer, (B) adimer, (C) A_Y26A and (D) B_Y26A. Loop relaxation from the active to the inactive state,
indicated by a drop of the pseudodihedral angle value from 113◦ to 14◦, is observed in domain D1
during the 3 ns trajectory, while in D2 no change is observed. Color coding is as follows: red and
yellow for domains D1 and D2 in monomer A, blue and green for D1 and D2 in monomer B.
in Figure 7 B, C and D). In adimer the loop repositioning is observed at 1.8 ns for
monomer B. In the Y26A mutants the first loop transition occurs earlier compared
to wildtype PleD, namely at 1.1 and 0.3 ns in simulations A_Y26A and B_Y26A, re-
spectively. The relaxation process is fairly fast and is completed within 0.5 ns ap-
proximately. In contrast, the deactivation of the second monomer in B_Y26A is much
slower and takes 1.3 ns to complete. Interestingly, this transition closely follows the
fast deactivation in the other monomer. On the other hand, in the inactive crystal
structure an angle of -91◦ is found which is significantly different from the 14◦ ob-
served in inactive CheY, the model system of RRs. It is possible that this deviation
is due to crystal contacts. Moreover, during the dimer simulation the pseudodihedral
angle changes from -91◦ to -20◦ approximately (see Figure 7 A), which is closer to the
commonly found 14◦. Although the value 14◦ is not reached during the 3 ns simula-
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tion time, it indicates that the β4-α4 loop position found in the X-ray structure is an
artefact and an angle between 0◦ and -25◦ is more representative for the inactive state
of PleD.
The dimer stabilizes the active state conformation. In addition to dynamics simulations of
PleD dimer, monomeric PleD was studied to elucidate the influence of an associated
monomer. In monomer A of the wildtype (wt) and the Y26A mutant the active-to-
inactive transition occurs at 1.2 ns, which is the same time as in the A_Y26A simu-
lation (results for monomer simulations not shown), but does not complete entirely
and remains at an angle of 50◦ approximately. In contrast, for monomer B differences
between the wt and mutant are observed. In the former the loop reorientation takes
place at 0.2 ns which is much earlier than the 1.6 ns in the dimer simulation. On
the contrary, the loop conformation does not change for the Y26A mutant, at least
not within the 3 ns calculated. In the case of the inactive monomer the β4-α4 loop
stays significantly longer in the unusual conformation found in the X-ray structure
and the pseudodihedral angle changes to a value close to 0◦ only for monomer B af-
ter 2.4 ns. Altogether in PleD wt the loop relaxation occurs earlier in the monomer
than in the dimer arguing that an associated monomer slows down the deactivation
process by stabilizing the active conformation. This suggestion is in accord with the
fact that phosphorylation increases the dimeric fraction. Moreover, the fact that the
pseudodihedral angle in the inactive form ranges from -90◦ to +100◦, -90◦ for inac-
tive monomer, 0◦ for inactive dimer and +100◦ in the active state, potentially allows
"stepwise" regulation.
Domain D2 shows no change in the loop conformation. Since domain D2 is also annotated
CheY-like domain, we monitored the β4-α4 loop conformation (see yellow and green
lines in Figure 7). D2 shares the common (βα)5 domain fold, though it lacks sev-
eral conserved residues constituting the active site, including the phospho-acceptor
aspartate. In all simulations, dimeric and monomeric PleD in the different activation
states, the pseudodihedral angle of the β4-α4 loop stays close to -130◦ the value found
in both X-ray structures. Thus, it seems that the β4-α4 loop positioning in domain D2
is invariant and not correlated to the activation state of PleD. The functional role of
D2 is still unknown, yet it seems that domain D2 is not responding to the activation
state of D1 in a REC-like fashion, i.e. changing the loop conformation. It is more
likely that activation of D1 alters the domain interaction surface and enables domain
rearrangement eventually enlargening the dimerization area.
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"Y-T" coupling
The concurrent movement of residues Tyr/Phe and Thr/Ser (F102 and T83 in PleD)
is a key signaling cascade in CheY known as "Y-T" coupling. Phosphorylation trans-
fer is followed by the sidechain reorientation of Tyr/Phe from a solvent exposed (g+)
to a "buried" position (trans). Simultaneously Thr/Ser rearranges to form a hydro-
gen bond to the phospho moiety. The sidechain orientation can be characterized by
the dihedral angle χ1. Thus, we monitored the residue’s χ1 angle in order to detect
any reorientation. Specifically the rotameric state of residues F102 and T83 were ana-
lyzed and in general no reorientation is observed during the 3 ns simulations. Only in
monomer A of the active trajectory a transition from trans indicating the active form
to gauche− is observed at 2.5 ns. It is possible that the sidechain rotation of F102 may
be observed at longer time scales. However, in PleD residue F102 is located in the
D1/D2 interface, while in CheY it is positioned at the surface. This may hinder ro-
tation and in addition there’s no "protein-solvent" change between the two rotamers.
The counterparts in domain D2, residues I251 and V232, are more flexible. As do-
main D2 is likely to have a function different from REC domains, there is no relation
between their rotameric state and protein activity. Hence, the rotamer sampling is
less restricted than for residues involved in the signaling cascade. All characteristics
regarding the state of CheY-like RRs are summarized in Table 6 together with events
observed in the dynamics simulations.
D1/D2 domain reorientation
α4-β5-α5 modulated interface area
Comparison of the experimental structures revealed a substantial reorientation of the
two receiver domains upon phospho-activation which results in a two-fold symmet-
ric domain arrangement (see Figure 8). This rearrangement within the monomer is
also reflected by different sizes of the contact area between domains D1 and D2. Cal-
culation of the buried solvent accessible surface area (SASA) shows an increase from
2,700 Å2 to 3,500 Å2 indicating a more optimal domain interface in the active state.
Interestingly, in the adimer simulation, a sharp decrease of 300 Å2 in the interaction
area is observed at 2.2 and 2.6 ns for monomer A and B, respectively, which is ap-
proximately 0.5 ns after the β4-α4 loop relaxation in monomer B. This event needs
to be investigated further to draw any conclusions on whether loop repositioning is
related to the interface change.
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Table 6: Characteristics of phospho-activation in CheY-like RRs
active inactive during MD simulation
β4-α4 loop conformation
Cα 83-86 104◦ / 100◦ -91◦ / -91◦ transitions observed
Cα 232-235 -136◦ / -146◦ -142◦ / -146◦ unchanged
F102 sidechain orientation
χ1 F102 -177◦ / -179◦ -58◦ / -57◦ unchanged,
except monomer A (active):
t→ g− at 2.5 ns
χ1 I251 -80◦ / -37◦ 47◦ / -28◦ inactive: unchanged
active: t, g− and g+ sampled
T83 sidechain orientation
χ1 T83 173◦ / 172◦ 59◦ / 60◦ unchanged (active: t, inactive: g−)
χ1 V232 -63◦ / -59◦ -59◦ / -62◦ unchanged,
except monomer B (A_Y26A):
t→ g− → t at 1.2 and 1.3 ns
All values are indicated for monomer A and B, respectively. Corresponding residues in domain D2
from alignment in ref. 136.
Figure 8: Reorientation of domains D1 and D2
Cartoon representation of the D1/D2 interface in the (A) active and (B) inactive X-ray structure.
The α4-β5-α5 face of domain D1 (red) is highlighted (yellow), while domain D2 is colored grey.
Arrows and axis indicate the reorientation of domain D1 with respect to D2 upon activation. Note
the symmetry in the active state.
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Extended helix α5 has leverage effect
Figure 9: Motion of the extended helix α5
A) Representative structures for the active (red, blue) and inactive (orange, cyan) state. Rearrange-
ments at the α4-β5-α5 face lead to large shifts at the C-terminal end of the helix α5. B) Domains
D1 and D2 in cartoon representation with helix α5 indicated in the activated (red) and inactive
(grey) state. Secondary structure annotation obtained with the module STRIDE174 implemented in
VMD175 for the two X-ray structures. α-helices colored in red, β-strands in yellow and unstructured
parts in grey.
To study structural differences within one monomer that were induced by the active-
to-inactive transition of the β4-α4 loop, snapshots taken every 100 ps were super-
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imposed on the backbone atoms of domain D2. Two distinct conformations are ob-
served, one for the time before and one after loop repositioning (see Figure 9 A). Re-
arrangements in the α4-β5-α5 face were observed, e.g. displacement of the β5 strand.
Yet, largest shifts are found for the C-terminal end of the extended helix α5. The
α4-β5-α5 surface is well known as adaptive region, for example binding of CheY
to FliM168 or in homodimerization of the OmpR/PhoB response regulator subfam-
ily176–179 which is very similar to PleD. In the latter the two-fold symmetric interac-
tion is promoted by phosphorylation and specific H-bonds and salt-bridges formed
between highly conserved residues. Several of these residues are also found in PleD.
However, common RR domains have a globular structure whereas domains D1 and
D2 of PleD are "P-shaped". The main globular part of the domain is located at the
N-terminal end of the unique extended helix α5. Based on the result that the α5 C-
terminal end is displaced most when the β4-α4 loop is relaxed the following model
can be suggested. A slight domain adjustment at the adaptive interface α4-β5-α5 is
amplified towards the C-terminal end by the remarkable length of the helix α5 in a
leverage fashion.
Furthermore, in the active state the long helix α5 is extended at the C-terminal end
by 4-5 residues which correspond to a little more than one turn (see Figure 9 B). The
secondary structure was predicted for snapshots taken every 10 ps using the STRIDE
module174 implemented in VMD175. Overall, the structure is preserved in all simu-
lations. The least stable is the region around helix α3 which is sometimes assigned as
turn, α- or α3_10-helix.
Dimerization interface
It is found from the X-ray structures that PleD in the BeF−3 activated form has a more
optimal dimerization interface reflected in an increase from 900 Å2 to 1,436 Å2 per
monomer.52 The contact area is calculated as the buried solvent accessible surface
area (SASA) using a probe of the radius 1.4 Å. A difference of 1,000 Å2 is also cal-
culated from the simulations (see Figure 10 A black vs. blue, red and green line).
The Y26A mutation is thought to decrease the dimerization area due to the smaller
volume of the residue sidechain. However, a similar area is observed for the mutant
Y26A_B and an even larger value is found for Y26A_A. In the adimer simulation, a dip
from 4,400 to 4,000 Å2 is detected around 2 ns. Interestingly, this event occurs shortly
after the β4-α4 loop relaxation. Calculation of the interface residues, i.e. residues
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Figure 10: Dimer contact area and interface residues
A) The difference in solvent accessible surface area (SASA) between complex and individual
monomers corresponds to the dimerization contact area and is shown for dimer (black), adimer
(blue), A_Y26A (red) and B_Y26A (green). In the active state, the dimerization interface is sig-
nificantly larger by 1,000 Å2 approximately. A probe radius of 1.4 Å was used to calculate the
SASA. Note the drop in buried SASA for adimer at 2 ns. B) The number of interface residues in
adimer are shown in blue, and the contributions of monomer A and B are colored purple and cyan,
respectively. Interface residues are defined as residues which have atoms within 5 Å of the other
monomer.
which have at least one atom within a distance of 5 Å of the other monomer, showed
the loss of 5 interface residues in each monomer simultaneously (see Figure 10 B).
The fact that the buried SASA recovers partly after the structural change argues for
adaptation of the interacting surfaces similar to the induced fit phenomenon. Further-
more, in simulation B_Y26A monomer B responds 0.5 ns after changes in monomer
A which is indicated by the number of contact residues (data not shown).
System dynamics
Cross-correlated motions
Structure elements of the protein system which move in a coupled fashion are often
depicted in dynamical cross-correlation maps (DCCMs). Residual correlation coeffi-
cients Cij between residues i and j are calculated from the 3 ns trajectories and can
adopt a value between -1 and 1 corresponding to anti-correlation and correlation.
Persistent correlations are interesting because they can potentially transmit signals
over long-range distances, in particular if correlations are found between different
domains or subunits. In Figure 11 A and B the DCCM are shown for dimer and
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Figure 11: Cross-correlated motion and protein flexibility
Top: Residual correlation coefficients Cij are calculated from simulations (A) dimer and (B) adimer
using a window length of 50 ps. Correlations are shown in the upper left triangle while anti-
correlations are at the lower right. Differences in the α4-β5-α5 region are indicated by violet circles
and coupling between domains are highlighted in blue. Bottom: Calculated root mean-squared
fluctuations are shown for (C) dimer and (D) adimer and are a measure of the protein flexibility.
Monomers A and B are colored red and blue, respectively. Differences are indicated with arrows.
adimer. The DCCM for mutants A_Y26A and B_Y26A are similar to adimer and not
shown here. Overall, the pattern within the individual domains shows little changes
between the active and inactive conformation. In contrast, couplings between differ-
ent domains and subunits are enhanced or newly formed in the active form. Most
prominent differences concern interactions with helix α5 (marked violet in Figure 11
A and B). In the active state the core β-sheet is less coupled to α5 in domain D1 but
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not in D2. In addition changes in the D1/D2 interface α4-β5-α5 are observed, where
β5 is no longer correlated to helix α5 of the other domain when activated. However,
correlations between helices α4 and α5 remain. Correlations between the monomers
(marked blue in Figure 11 A and B) are mainly through interactions of the globular
part of the protein and additional correlations between the α5 helices in the active
state reflecting the tight helix bundle structure. Thus, results from cross-correlated
motion analysis also indicate the special role of the extended helix α5 in that it inter-
acts with the different domains and subunit, and differs in the modulated α4-β5-α5
area between the active and inactive state.
Root mean-square fluctuations
The protein flexibility can be characterized by root mean-square fluctuations (RMSFs)
calculated from the trajectory, where large RMSF values indicate highly mobile re-
gions. In general, the RMSFs are smaller in the active than in the inactive state (see
Figure 11 C and D), stating that the protein in the active conformation is overall less
flexible. In detail, prominent differences are observed for the region linking domains
D1 and D2 in monomer A (residues 130-150) being more rigid in adimer. This differ-
ence in amplitude between monomer A and B introduces some sort of asymmetry to
the dimer system. Moreover, the β4-α4 loop residues are more flexible in the inac-
tive form (residues 83-86 and correspondingly at position 368-371). This finding may
be of interest since the β4-α4 loop is part of the functional activation process. In the
mutant systems the previously described features resemble more the inactive state.
In contrast, the flexibility of helix α1 (residues 13-25) in domain D1 is enhanced in
adimer, while in all other simulations this part is slightly more rigid. Regarding the
mutant simulations this is somewhat surprising since the replacement of Tyrosine by
the small Alanine is thought to decrease interactions and thus provide more flexibil-
ity.
Even though differences between simulations of the active and inactive system are
found in both the cross-correlated motions and protein flexibility, 3 ns trajectories
most probably are not sufficient to capture the entire dynamics intrinsic to the system
and longer simulation times are needed.
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Conclusions & Outlook
Molecular dynamics simulations have the advantage of atomistic resolution, inherent
high time resolution and the possibility to study species not characterized thus far by
experiments. The present work shows that it is possible to observe and analyze the
active-to-inactive transition in PleD within 3 ns simulation time. The β4-α4 loop re-
laxation is found to be faster in monomeric PleD arguing for a stabilization effect
from the associated monomer. In addition, the loop repositioning leads to structural
rearrangements in the D1/D2 interface, particularly involving the α4-β5-α5 region.
Based on structure comparison the following model was proposed: Small angle re-
orientations at the N-terminal end of the extended helix α5 are amplified towards the
C-terminal end, having a leverage effect. Helix α5 has strong correlations to other
domains and subunits corroborating its importance to protein function. However,
no conclusions on how the contact residue Y26 mediates dimerization can be drawn
and further simulations are necessary. For example, calculation of residual interac-
tion energies can clarify if residue Y26 is a "hot-spot" residue, a residue contributing
significantly to the overall interaction energy. Furthermore, biased simulations can be
envisaged. Steered MD where the monomers are pulled apart can give information
about which contacts are broken first and may also reveal interaction networks and
the functional role of residue Y26.
Another interesting aspect to study is the effect from the associated monomer, for ex-
ample whether it is able to activate its partner. MD simulations are especially suited
to analyze mixed dimers, i.e. an activated monomer interacting with an inactive one
or wildtype PleD with mutants. Genetics experiments discovered a constitutively
active PleD mutant147,157,158, PleD∗, which is locked in the active state and is pre-
dominantly present as dimers in solution.
Acknowledgments
Generous allocation of computing time at the CSCS in Manno, Switzerland is ac-
knowledged.
103
5 Results
104
6 Discussion
Extensive research on the small signaling molecule cyclic diguanosine monophos-
phate (c-d-GMP) has highlighted its central role in bacterial metabolism (see re-
views141,142). Mutation and/or overexpression experiments combined with pheno-
typic evaluation linked c-di-GMP turnover with proteins containing GGDEF and
EAL domains and demonstrated the implication of the signaling molecule in cell
motility, virulence and biofilm formation. Experimental results from co-workers
showed that the c-di-GMP concentration is tightly regulated via feedback inhibi-
tion, a property intrinsic to the GGDEF domain148, and that the response regula-
tor PleD is additionally controlled by phosphorylation-mediated dimerization52,158.
Based on PleDX-ray structures a "domain immobilization"mechanismwas proposed,
where contact between the active sites and subsequent c-di-GMP production is pre-
vented.51,52 Results from the present work contribute to the mechanistic understand-
ing of DGC activity regulation, in particular the system’s dynamics and effects from
ligand-binding and phospho-activation.
Communication between allosteric and active site
Comparison of energy optimized structures of monomeric PleD with and without c-
di-GMP present in the allosteric site have indicated a balancelike movement of the
β-strand β2, that physically connects the active with the allosteric site.148 Thus, lig-
and binding repositioning the I-site loop may potentially lead to misalignment of the
enzymatic residues and prevent catalysis. This structure based mechanism works
not only for PleD, but can be applied to the GGDEF domain in general. In addition, a
substantial drop in flexibility is observed for I- and A-site residues simultaneously, ar-
guing for dynamical coupling.81 This finding emphasizes the dynamic contribution
to allostery. In order to elucidate dynamic signaling pathways, correlated motions
were calculated from trajectories. Results suggest two possible communication cas-
cades running either along nearby secondary structure elements, including the previ-
ously mentioned strand β2, or across the disordered regions that link the neighboring
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domains. It was also found that the presence or absence of the ligand alters the corre-
lation between domains such that the interaction between D1 and D2 is enhanced in
free PleD. This long-range effect is of potential interest since it is known that domains
D1 and D2 rearrange upon activation.
Flexibility of the DGC domain vs. the stem domains
Conformation and energetics of unliganded PleD were probed using high-tempera-
ture dynamics simulations and biased domain repositioning.81 An "open" form of
PleD, being considerably lower in energy than the starting X-ray structure where
bound c-di-GMP was removed, is in accord with the recent X-ray structure of acti-
vated PleD52. The fact that both conformations, and possibly still more conforma-
tions are energetically stable corroborates the model of the DGC domain being flex-
ibly attached to the D1/D2 stem. This aspect is the basis for the suggested "domain
immobilization" model where ligand binding fixes one non-productive domain ori-
entation. However, nothing is known about the actual energy barriers for the domain
to adopt different conformations.
Activation mechanism in view of the dimerization process
Dynamics simulations were carried out using D1/D2 dimers in the inactive and
BeF−3 -activated conformation. Spontaneous relaxation of the β4-α4 loop was ob-
served within the 3 ns simulation time. This active-to-inactive transition is found
to be correlated with rearrangements in the D1/D2 interface and leads to a slight
decrease of the dimerization contact area. Specifically, adjustments in the α4-β5-α5
modulating region are amplified towards the C-terminal end of the extended helix
α5. Moreover, this α5 helix is implicated in interactions between different domains
and subunits as indicated by cross-correlation maps.
Contribution of computational methods to understand protein function
Molecular visualization of structural motion is an important element to build mech-
anistic models to explain protein function. Immense advances in computer technol-
ogy now allow simulations approaching the µs regime and computational sciences
are increasingly recognized to provide detailed insight into protein motion, residue
interplay and energetics. In PleD, for example, dynamics information and potential
communication routes were found using molecular simulations. Each of the meth-
ods reviewed has its own strengths and weaknesses with respect to sensitivity and
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specificity emphasizing their complementarity. Thus, general consensus from many
techniques, theoretical and experimental, increases the reliability of the proposed
mechanism. Subdividing the complexity of supramolecular assemblies in biology
into simple but quantitatively precise questions that can be solved by specific "exper-
iments" should prove important. The focus of computational approaches lies in char-
acterizing sequential events to understand how information is transferred.180 Protein
allostery surely is interdisciplinary, and brings together researchers with very dis-
tinct but complementary expertise in molecular biology, computational science, and
physics. Easy-to-use web-based programs and standardized setups for molecular dy-
namics simulations could encourage experimentalists to interpret and complement
their data with calculations, enabling a closer collaboration with theoreticians. In
turn, simulation and programming experts might focus on force field improvements
and the development of efficient algorithms.
Protein allostery: a constantly evolving concept
The combined efforts of different disciplinary fields have provided new ideas and
concepts on allosteric regulation over time. The two most widely accepted are the
population-shift of co-existing states and the propagation of structural change along
predefined pathways when triggered by effector binding. In addition, protein dy-
namics undoubtedly contribute to function and even allow allostery to take place
without visible structural change.26,27,29 All these views on protein allostery are not
mutually exclusive and may be true to some extent. In PleD, suggested models
involve structurally distinct states and dynamical structural pathways. It is possi-
ble that there exists a common mechanism that holds for all biomolecular systems,
but which has not yet been found because the different features are differently pro-
nounced, and may be even too small to detect with current methods. In any case,
allosteric regulation is vital for a cell to respond to environmental signals, and de-
tailed insight may be used for practical application in drug and protein design.181
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Characterization of binding mode & drug design
The design of potent DGC inhibitors is of substantial medical interest to combat infec-
tions caused by bacterial biofilms. For drug molecules to be successful, high affinity
which allows medication in the nM to µM range and receptor specificity are most im-
portant. Computational methods to estimate binding free energies110–112 can be used
in the drug discovery process to discriminate binding ligands from non-binding lig-
ands, and even rank the ligands according to their binding affinity. Though, it should
be noted that the accuracy of prediction is important to be of pharmacological use.
In contrast with experimental affinity measurements, computational studies have the
advantage that they combine binding free energies with structural features. The in-
dividual contributions from chemical groups and the different interaction types are
easily calculated. Structural properties such as sidechain conformations, salt-bridges,
H-bonds and the size of the binding pocket can be combined into fingerprints and the
subsequent use of clustering techniques may detect features that distinguish binders
from non-binders. Such insight is valuable to rational drug design.
A suitable system to study c-di-GMP binding is the single domain protein DgcA of C.
crescentus (CC3285) for which inhibition constants, Ki, have beenmeasured for several
I-site mutants.148 In contrast to common ligand screening, here the ligand c-di-GMP
stays the same but the protein binding site differs. Once the determinants of bind-
ing are known, computational and experimental ligand modification to increase the
affinity to the allosteric site can be envisaged. So far, c-di-GMP binding sites contain
a significant number of Arginine residues, in both PleD and the first identified c-di-
GMP receptor domain, the PilZ domain153–155. Detection of important protein-ligand
interactions in the DgcA system is relevant due to the fact that the conserved motif
RxxD (residues 359 to 362 in PleD) required for inhibition is found in more than 60%
of DGCs.
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Force field extension to study protein phosphorylation
Modulation of protein activity is often achieved by chemical modifications, whereof
phosphotransfers between kinases and response regulators are most common form-
ing "two-component" signaling pathways.162 However, common force fields include
parameters for phospho-groups for RNA and DNA molecules but mainly lack suit-
able phospho-aminoacid parameters. In the present study the problem of missing
parameters is circumvented by removing the phospho-group (or BeF−3 moiety) from
the active conformation structure and analyzing the relaxation process from the ac-
tive to the inactive form. However, for future studies it is desirable to have force
field parameters which will allow the study of energetics. A first attempt to find
parameters that reproduce geometries and energies from ab initio calculations has
been made.182 In addition, treating phosphorylation as a perturbation to the energy
landscape proved useful to predict local structural changes, and helps to understand
energetic components driving the structural rearrangement.183
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